Profile Image

Professor Amanda Baker

Research Academic

School of Medicine and Public Health (Psychiatry)

Research of substance

Professor Amanda Baker is a National Health and Medical Research Council Senior Research Fellow at the University of Newcastle. An award winning innovator, she specializes in the treatment of co-existing mental health and substance use problems.

Professor Amanda BakerEarly in her career as a clinical psychologist, Professor Baker identified a lack of integration between mental health supports, and drug and alcohol treatments as a major barrier to behaviour change.

Rather than treating co-occurring problems in a consolidated manner, patients were often refused treatment from one targeted service, if they also needed treatment from the other.

"What drives me are the dualities in the system between mental health and drug and alcohol," Amanda explains.

"People often have more than one problem, and mental health and drug and alcohol use go hand in hand."

Over one hundred and fifty publications later - including five national amphetamine treatment clinician guidelines and eight treatment manuals for comorbidity - Amanda and her team have made significant progress toward the recognition of the need to integrate the treatment of co-existing issues.

INTEGRATION AND COMMUNITY

By the time Amanda graduated in the early 1980s, the push to de-institutionalise mental health in Australia had begun in earnest. Research and practice from around the world showed that mental health patients, who had previously been institutionalised, had better health outcomes when transitioned back into the community.

A stint practicing in community health in Manchester, the United Kingdom, gave Amanda a new perspective on how psychologists could successfully aid this transition. During this time, Amanda experienced first-hand the positive outcomes of a system where practice and research were highly integrated, and was eager to facilitate a change in this direction back home.

Returning to Australia three years later, Amanda took up a position at the National Drug and Alcohol Research Centre, where she completed her PhD on reducing HIV risk in injecting drug users, before working in the drug and alcohol facility at Westmead Hospital, Sydney.

In 1995 Amanda was appointed to head up a graduate course in Drug and Alcohol Studies for clinicians at the University of Newcastle. Armed with experience in the clinical and research spheres of both mental health, and drugs and alcohol, Amanda's input into the Faculty of Health and Medicine has been invaluable. Her attention shifted from teaching and research to research in 2003, where has been continuously funded by NHRMC fellowships ever since. Known as a generous mentor and supporter of early career researchers, Amanda was appointed Deputy Head of the School of Medicine and Public Health (Research) in 2010 for a three year term.

METHAMPHETAMINE TREATMENT OPTIONS

A consistent area of focus in Amanda's research has been the use of methamphetamines by people with mental health problems. Leading a Commonwealth funded trial in the early 2000s, Amanda found counselling to have favourable outcomes for methamphetamine users. The treatment framework was disseminated nationally, but unfortunately, the model was not sustained.

Amanda points to several factors including poly-drug use, presenting behaviours such as paranoia or violence, and sector worker turnover as barriers to methamphetamine users accessing drug and alcohol services.

"Methamphetamine is the drug that makes you confront that overlap between mental health and substance use," she says.

"It really draws out the psychotic symptomatology and edginess in people."

"Users can be angry or violent, and workers need training to be confident on how to proceed from there."

As immediate past president of the Australasian Professional Society for Alcohol and other Drugs (APSAD) Amanda represented this peak body in consultations with the Federal Government's National Ice Taskforce. Called upon to help inform the community response to ice use as a major public health issue in Australia, she presented at the National Methamphetamine Symposium in early May 2015.

WHERE THERE'S SMOKE

More recently, another drug has almost completely captured Amanda's attention.

"In the last ten years or so I have become very interested in tobacco, the drug that everyone forgets."

"Because it is legal, people don't understand that it can create so much harm," she adds.

Amanda has been an advisor during the transition of forensic hospitals to smoke-free facilities, and is currently working on a phone delivered smoking cessation program for people with mental health problems in partnership with Quitline Victoria.

"I'm very passionate about trying to help people with mental health problems give up smoking," she declares.

"They die 20 years earlier than people in the general community from tobacco related causes."

Amanda is also currently involved in an NHMRC trial, testing the efficacy of iPad delivered smoking cessation programs targeting hospital patients who have suffered orthopaedic trauma.

The trial, led by Associate Professor Billie Bonevski, is attempting to decrease the healing time and amputation risk of participants by helping them quit smoking.

WHERE TO FROM HERE

When asked about her future, Amanda conveys her enthusiasm for the Quitline telephone delivered smoking cessation program. She sees this as her direct future, evaluating phone interventions in real life delivery.

"I think telephone interventions are where I can make an impact," she avows.

"It's always assumed that people with severe mental illness need intensive individual intervention with face-to-face treatment."

"But we have proved that phone intervention, which everyone loved, was simpler, briefer and just as effective."

Amanda also speaks eagerly about a related project she is undertaking with Doctor Peter Kelly from the University of Wollongong.  This project trains peer workers to deliver healthy living interventions with a focus on diet and activity, to people with mental health problems, again via telephone.

Although it may seem incongruous for Amanda to be focusing on diet and activity she points out that changing dietary intake (like levels of fruit and vegetables) and reducing TV watching may impact positively on the other behaviours that affect cardio-vascular health – smoking, alcohol, and snacking on high fat foods.

"They are all addictive behaviours," she explains.  

"In today's society, you can buy so much food, so much packaged food. Forty years ago it wasn't available. Food really is the new tobacco."

Professor Amanda Baker

Research of substance

Professor Amanda Baker is a National Health and Medical Research Council Senior Research Fellow at the University of Newcastle. An award winning innovator, she

Read more

Career Summary

Biography

Professor Amanda Baker is a National Health and Medical Research Council (NHMRC) Senior Research Fellow. She is a senior clinical psychologist who has practised in the United Kingdom and Australia. Her research focuses on the challenging area of psychological treatment of comorbidity (co-existing mental health and tobacco, alcohol and other drug problems). Since 2000, she has been a Chief Investigator on 16 NHMRC grants (total $10,093,086), with 9 as CIA. These projects have typically involved multi-site randomized controlled trials of psychological interventions among people with severe mental disorders and substance use problems. Her total research income since appointment to the University of Newcastle in 1995 is $18,064,559. Professor Baker’s research has been supported by NHMRC fellowships continuously since 2003: firstly by a Career Development Award (2003-2007), then by the five-year Senior Research Fellowship (2008-2012) followed by a second five-year Senior Research Fellowship in conjunction with the Trans Tasman Award (2013-2017). (Total NHMRC CDA/SRF funding: $1,731,838; bringing total NHMRC funding to $11,824,924). She is the recipient of numerous prizes and awards, including the 2011 Hunter Medical Research Institute Senior Researcher Award for Research Excellence, the 2010 Senior Scientist Award: Australasian Professional Society for Alcohol and Other Drugs, and the 2009 Excellence in Research, National Drug and Alcohol Awards: Alcohol and Drug Council of Australia. Professor Baker has over 150 publications. These include 109 articles in peer reviewed journals (37 first author), including 9 papers (6 first author) in the leading journal in the alcohol and other drug field, and recent publications in the American and British Journals of Psychiatry. She is the chief editor of two books: National Drug Strategy Monograph 32: “Models of intervention and care for psychostimulant users, 2nd edition” (Commonwealth of Australia, 2004) and “Clinical Handbook of Co-existing Mental Health and Drug and Alcohol Problems”, co-edited by Professor Richard Velleman, (Routledge, 2007). She has co-authored 5 national amphetamine treatment clinician guidelines and 8 treatment manuals for comorbidity. In 2006, Prof Baker was appointed Convenor, Services and Intervention Division, Research Management Committee of the newly formed University of Newcastle Priority Research Centre for Brain and Mental Health, and in March 2008 was promoted to Deputy Director of the Priority Research Centre (relinquished in March 2010). In July 2010 she was appointed Deputy Head of School – Research (School of Medicine and Public Health, Faculty of Health, University of Newcastle), embedding her mentoring programme, ‘Strategies Targeting Academic Researchers’ (STARs). When she took up her position at the University of Newcastle, NSW, Australia, in 1995, Professor Baker successfully initiated and developed a Graduate Certificate, Master and Masters (Hons) of Health Science (Drug and Alcohol Studies), initially available on-campus and then via distance learning mode. She was awarded a National Teaching Grant in 1997, together with the National Centre for Education and Training on Addiction, for the project titled “Clinical Skills Training: Effective Approaches to Alcohol and Other Drug Problems”. She is renowned for her generous research supervision and mentoring of early career researchers. During the last few years she has made important contributions to the research and professional communities as a member of the NSW Health Department Centre for Drug and Alcohol Research Advisory Committee (2006-2009), the NHMRC Training Fellowship Population Health Review Panel (2008, 2009, 2010, 2011) and the NHMRC Project Grants Review Panel (2009, 2011) and as Vice-President (2010-2012) and President (2012-2014) of the Australasian Professional Society on Alcohol and other Drugs.

Research Expertise
Randomised controlled trials evaluating psychological interventions for mental health problems, substance use problems and comorbid problems.

Qualifications

  • PhD, University of New South Wales
  • Master of Psychology, University of Sydney
  • Bachelor of Arts (Psychology), University of New South Wales

Keywords

  • CBT
  • Comorbidity
  • Psychosis
  • Substance Use
  • clinical trials
  • depression
  • mental health
  • psychological treatment

Fields of Research

Code Description Percentage
170199 Psychology not elsewhere classified 45
110399 Clinical Sciences not elsewhere classified 20
111799 Public Health and Health Services not elsewhere classified 35

Professional Experience

UON Appointment

Title Organisation / Department
Professor University of Newcastle
School of Medicine and Public Health
Australia

Academic appointment

Dates Title Organisation / Department
1/01/2013 -  Fellow NHMRC

NHMRC - Research Fellowships Scheme

University of Newcastle
School of Medicine and Public Health
Australia
1/01/2009 -  Senior Fellow Gladys M Brawn Memorial Fellowship
Australia
1/01/2008 -  Deputy Director University of Newcastle
Prioirty Research Centre for Brain and Mental Health Research
Australia
1/01/2007 -  Editor - Mental Health and Substance Use: Dual Diagnosis Journal Mental Health and Substance Use: Dual Diagnosis Journal
Australia
1/01/2006 -  Fellow NHMRC

NHMRC - Research Fellowships Scheme

National Health & Medical Research Council
1/05/2004 -  Conjoint Academic The University of New South Wales
Australia
1/01/2003 - 1/06/2006 Fellowship

NHMRC - Career Development Fellowships (Formerly Career Development Awards)

National Health & Medical Research Council
1/01/2001 -  Editor - Drug and Alcohol Review Journal Drug and Alcohol Review Journal
Australia
1/09/1991 - 1/12/1994 Conjoint Lecturer The University of Sydney
Australia
1/07/1989 - 1/09/1991 Clinical Psychologist The University of New South Wales
National Drug and Alcohol Research Centre
Australia

Membership

Dates Title Organisation / Department
1/01/2006 -  Membership - Australian Professional Society for Alcohol and Other Drugs Australian Professional Society for Alcohol and Other Drugs
Australia

Professional appointment

Dates Title Organisation / Department
1/09/1991 - 1/12/1994 Senior Clinical psychologist Westmead Hospital
Drug and Alcohol Service
1/08/1987 - 1/07/1989 Clinical Psychologist Prescott House Community Mental Health Centre, Salford
United Kingdom
1/02/1987 - 1/07/1987 Clinical Psychologist Prestwich Hospital, Salford
United Kingdom
1/08/1984 - 1/01/1987 Clinical Psychologist Ashfield Community Mental Health Centre, Sydney
Australia

Awards

Research Award

Year Award
2011 Award for Research Excellence
Hunter Medical Research Institute
Edit

Publications

For publications that are currently unpublished or in-press, details are shown in italics.


Book (3 outputs)

Year Citation Altmetrics Link
2015 Caillé S, Baker AL, Todd J, Turner A, Dayas CV, Smoking and mental health problems, S. Karger AG (2015)

Patients with mental illness have greater rates of smoking during their lifetime and experience severe social, health and psychological disadvantages, and stigma. This chapter beg... [more]

Patients with mental illness have greater rates of smoking during their lifetime and experience severe social, health and psychological disadvantages, and stigma. This chapter begins by providing a brief update on the neurobiology of nicotine addiction and we present evidence that an imbalance in the brain reward and aversion systems, and specific nicotinic acetylcholine receptor subtypes expressed in these pathways, may lead to dependence. Then, in a special case review, we highlight recent advances regarding the knowledge on the association between nicotine dependence and schizophrenia. Further understanding these mechanistic links, including nicotine-induced improvements in cognitive deficits, might provide new insights into improving smoking cessation success in people diagnosed with schizophrenia. Additionally, we discuss data indicating that smoking cessation does not worsen mental health symptoms or increase other drug and alcohol use. Indeed, smoking cessation interventions should be available within mental health and substance use treatment settings. Treatments for nicotine addiction include psychological interventions and pharmacological agents such as nicotine replacement therapies (e.g. gums and lozenges) or medications such as the partial agonist varenicline. Importantly, the outcomes for smokers with mental illness are enhanced when these approaches are combined and may need to be administered over the long term.

DOI 10.1159/000369483
Co-authors Christopher Dayas, Juanita Todd
2007 Baker AL, Velleman R, Clinical Handbook of Co-existing Mental Health and Drug and Alcohol Problems, Routledge, London, 402 (2007) [A3]
2006 Jenner L, Spain D, Whyte IM, Baker AL, Carr VJ, Crilly J, Management of patients with Psychostimulant Toxicity, Commonwealth of Australia, Canberra, 28 (2006) [A2]

Chapter (10 outputs)

Year Citation Altmetrics Link
2013 Baker A, Hiles S, Thornton L, Searl A, Kelly P, Kay-Lambkin F, 'From Comorbidity to Multiple Health Behaviour Change', Emerging Perspectives on Substance Misuse, Wiley, Oxford 152-169 (2013) [B1]
DOI 10.1002/9781118306604.ch9
2010 Hides L, Carroll S, Lubman DI, Baker AL, 'Brief motivational interviewing for depression and anxiety', Oxford Guide to Low Intensity CBT Interventions, Oxford University Press, Oxford 177-185 (2010) [B1]
2009 Wade D, Hides L, Baker A, Lubman D, 'Substance misuse in first-episode psychosis', The Recognition and Management of Early Psychosis: A Preventive Approach, Second Edition, Cambridge University Press 243-256 (2009)

Introduction Substance misuse is one of the most challenging issues for clinicians in the management and treatment of first-episode psychosis (FEP). The aims of this chapter are t... [more]

Introduction Substance misuse is one of the most challenging issues for clinicians in the management and treatment of first-episode psychosis (FEP). The aims of this chapter are to (1) review current knowledge about substance misuse and regular tobacco use in FEP, (2) describe hypotheses that have been proposed to explain the high rate of substance misuse among individuals with psychosis, (3) review the evidence for the efficacy of psychological interventions for substance misuse and regular tobacco use in psychosis, and (4) provide guidance to clinicians in implementing psychological interventions for substance misuse in FEP. In the current chapter, substance misuse refers to substance abuse or dependence, although low levels of substance use may be associated with problems in people with severe mental disorders (Kavanagh, Mueser & Baker, 2003a). Substance misuse and regular tobacco use in first-episode psychosis Rate and patterns Individuals with psychotic disorders are at increased risk for substance misuse compared with individuals with other common psychiatric disorders (Regier et al., 1990) and the general population (Degenhardt & Hall, 2001; Regier et al., 1990). Consistent with these findings, individuals with FEP have a significantly higher rate of substance misuse than their non-psychotic peers (DeLisi et al., 1991; Hambrecht & Häfner, 1996). Estimates of the rate of lifetime substance misuse in individuals treated for FEP have varied widely, ranging from 10% (Verma et al., 2002) to 74% (Lambert et al., 2005), with most studies in Australia and the USA reporting a rate of at least 40% (DeLisi et al. 1991; Lambert et al., 2005; Rabinowitz et al., 1998; Strakowski et al., 1998; Wade et al., 2005).

DOI 10.1017/CBO9780511576287.015
Citations Scopus - 1
2008 Lee NK, Kay-Lambkin FJ, McKetin R, Baker AL, 'Everything old is new again: The application of drug treatment to the emerging challenge of methamphetamine use and dependence', Drugs and Public Health: Australian Perspectives on Policy and Practice, Oxford University Press, Oxford 73-84 (2008) [B1]
Co-authors F Kaylambkin
2007 Baker AL, Kay-Lambkin FJ, Lewin TJ, 'Co-existing mental health and drug and alcohol problems: Steps towards better treatment', Clinical Handbook of Co-existing Mental Health and Drug and Alcohol Problems, Routledge, London 1-19 (2007) [B1]
Co-authors F Kaylambkin
2007 Baker AL, Bucci S, Kay-Lambkin FJ, Hides L, 'Cognitive behaviour therapy for people with co-existing mental health and drug and alcohol problems', Clinical Handbook of Co-existing Mental Health and Drug and Alcohol Problems, Routledge, London 55-73 (2007) [B1]
Co-authors F Kaylambkin
2007 Hides L, Lubman DI, Kay-Lambkin FJ, Baker AL, 'Young people with co-existing mental health and drug and alcohol problems', Clinical Handbook of Co-existing Mental Health and Drug and Alcohol Problems, Routledge, London 132-158 (2007) [B1]
Co-authors F Kaylambkin
2007 Kay-Lambkin FJ, Baker AL, Carr VJ, 'Depression and drug and alcohol problems', Clinical Handbook of Co-existing Mental Health and Drug and Alcohol Problems, Routledge, London 218-240 (2007) [B1]
Co-authors F Kaylambkin
2007 Baker AL, Velleman R, 'Where to from here?', Clinical Handbook of Co-existing Mental Health and Drug and Alcohol Problems, Routledge, London 388-394 (2007) [B1]
2006 Gerada C, Johns K, Baker A, Castle D, 'Substance use and abuse in women', Mood and Anxiety Disorders in Women, Cambridge University Press 39-58 (2006)

Over the last century, in most Western countries, women have made many great strides in social equality, including winning the right to vote and to equal wages. This chapter descr... [more]

Over the last century, in most Western countries, women have made many great strides in social equality, including winning the right to vote and to equal wages. This chapter describes how and why women may also be gaining ground on their male counterparts in the consumption of alcohol and illicit substances. While women have “come a long way” (a phrase employed in a cigarette advertising campaign in the 1980s) in their drug use, researchers and treatment providers have been slow to identify women's treatment needs, and to develop newer services sensitive to the needs of women with substance abuse or dependence. Thus, we also describe the characteristics of women-sensitive services and recommend that existing services adopt these features. Mostly we concentrate on alcohol abuse and dependence, as alcohol is the substance that has been most well studied in terms of gender differences; many of the general findings extrapolate to other drugs. We do not explicitly address nicotine dependence here Epidemiology and clinical issues Epidemiology of substance use and abuse: gender differences Surveys of substance abuse and dependence in the general population fairly consistently show overall rates in females to be lower than those in males. For example, the United States (US) Epidemiological Catchment Area (ECA) Study (Helzer et al., 1991) reported an overall rate for alcohol abuse and dependence of 13.6%, with a male:female ratio of around 5:1 (males 23.8%, females 4.6%).

DOI 10.1017/CBO9780511543647.005
Citations Scopus - 1
Show 7 more chapters

Journal article (183 outputs)

Year Citation Altmetrics Link
2015 Stockings EAL, Bowman JA, Bartlem KM, Mcelwaine KM, Baker AL, Terry M, et al., 'Implementation of a smoke-free policy in an inpatient psychiatric facility: Patient-reported adherence, support, and receipt of nicotine-dependence treatment', International Journal of Mental Health Nursing, 24 342-349 (2015)

The implementation of smoke-free policies in inpatient psychiatric facilities, including patient adherence, mental health nursing staff support, and provision of nicotine-dependen... [more]

The implementation of smoke-free policies in inpatient psychiatric facilities, including patient adherence, mental health nursing staff support, and provision of nicotine-dependence treatment to patients, has been reported to be poor. The extent to which the quality of smoke-free policy implementation is associated with patient views of a policy is unknown. We conducted a cross-sectional survey of 181 patients (53.6%, n = 97 smokers; and 46.4%, n = 84 non-smokers) in an Australian inpatient psychiatric facility with a total smoke-free policy. Smokers' adherence to the policy was poor (83.5% smoked). Only half (53.6%) perceived staff to be supportive of the policy. Most smokers used nicotine-replacement therapy (75.3%); although few received optimal nicotine-dependence treatment (19.6%). Overall, 45.9% of patients viewed the smoke-free policy in the unit as positive (29.9% smokers; 64.3% non-smokers). For smokers, adhering to the ban, perceiving staff to be supportive, and reporting that the nicotine-replacement therapy reduced cravings to smoke were associated with a more positive view towards the smoke-free policy. These findings support the importance of patient adherence, mental health nursing staff support, and adequate provision of nicotine-dependence treatment in strengthening smoke-free policy implementation in inpatient psychiatric settings.

DOI 10.1111/inm.12128
Co-authors Kim Colyvas, Jenny Bowman, John Wiggers, Richard Clancy
2015 Hiles SA, Baker AL, de Malmanche T, McEvoy M, Boyle M, Attia J, 'Unhealthy lifestyle may increase later depression via inflammation in older women but not men', Journal of Psychiatric Research, 63 65-74 (2015)

Depression and inflammatory markers have a reliable cross-sectional association although less is known about the prospective relationship. The current study investigated whether p... [more]

Depression and inflammatory markers have a reliable cross-sectional association although less is known about the prospective relationship. The current study investigated whether pro-inflammatory markers are prospectively associated with depression, and whether indicators of unhealthy lifestyle, physical health and psychosocial functioning may drive this association. Participants were drawn from the Hunter Community Study, a community-dwelling cohort of individuals aged 55-85 years (N=1410). Participants completed baseline physiological assessment, health-related questionnaires, and blood sampling for the analysis of inflammatory markers, C-reactive protein (CRP) and interleukin (IL)-6. Participants completed the same depressive symptom questionnaire again after 3.5-5.5 years. Depression outcomes at follow-up were analysed dichotomously using established scale cut-off scores and continuously as a "residual score", representing the variation in follow-up depressive symptoms not explained by baseline symptoms and age. Analyses were conducted on males and females separately. At baseline, indicators of unhealthy lifestyle, physical health and psychosocial functioning were associated with depressive symptoms and inflammatory markers. For males, there were no relationships between inflammatory markers and follow-up depression outcomes. In females, IL-6 was significantly associated with depression outcomes in univariate, but not multivariate analyses. However, IL-6 significantly mediated the association between the predictors of waist-to-hip ratio, smoking and psychological coping at baseline, and follow-up depression outcomes. The results support the inflammatory hypothesis of depression, although females may be more vulnerable to effects. The findings raise the possibility that unhealthy lifestyle and psychosocial stress may drive inflammation and subsequent depressive symptoms.

DOI 10.1016/j.jpsychires.2015.02.010
Citations Scopus - 1
Co-authors John Attia
2015 Hunt SA, Kay-Lambkin FJ, Baker AL, Michie PT, 'Systematic review of neurocognition in people with co-occurring alcohol misuse and depression', Journal of Affective Disorders, 179 51-64 (2015)

Background Alcohol misuse and depression represent two major social and health problems globally. These conditions commonly co-occur and both are associated with significant cogni... [more]

Background Alcohol misuse and depression represent two major social and health problems globally. These conditions commonly co-occur and both are associated with significant cognitive impairment. Despite this, few studies have examined the impact on cognitive functioning of co-occurring alcohol misuse and depression. This study aims to critically review findings from peer-reviewed published articles examining neuropsychological test performance among samples of people with co-occurring alcohol misuse and depression. Method A comprehensive literature search was conducted, yielding six studies reporting neuropsychological profiles of people with co-occurring alcohol misuse and depression. Results comparing cognitive functioning of people with this comorbidity to those with alcohol misuse alone, depression alone, healthy controls and published norms were examined as well as those describing the correlation between depressive symptoms and cognitive functioning in people with alcohol use disorders. Results In the majority of instances, the comorbid groups did not differ significantly from those with depression only or alcohol misuse only, nor from healthy controls or published norms. In the cases where a difference in neuropsychological test scores between groups was found, it was not consistently identified across studies. However, visual memory was identified in two studies as being impaired in comorbid samples and is worthy of inclusion in future studies. Limitations Due to the small number of included studies and the large variation in inclusion criteria as well as differing assessment tools and methodologies between studies, the review did not include a quantitative synthesis. Conclusions Research into cognitive deficits among people with singly occurring versus co-occurring alcohol misuse and depression is accumulating. Evidence suggests that the neuropsychological performance among samples with this comorbidity is generally not severely impaired and is unlikely to preclude benefit from treatment.

DOI 10.1016/j.jad.2015.03.024
Co-authors Pat Michie
2015 Kelly PJ, Deane FP, Baker AL, 'Group Cohesion and Between Session Homework Activities Predict Self-Reported Cognitive-Behavioral Skill Use Amongst Participants of SMART Recovery Groups', JOURNAL OF SUBSTANCE ABUSE TREATMENT, 51 53-58 (2015)
DOI 10.1016/j.jsat.2014.10.008
2015 Kelly PJ, Deane FP, Baker AL, 'Group cohesion and between session homework activities predict self-reported cognitive-behavioral skill use amongst participants of smart recovery groups', Journal of Substance Abuse Treatment, 51 53-58 (2015)

SMART Recovery groups are cognitive-behaviorally oriented mutual support groups for individuals with addictions. The aim of the study was to assess the extent to which the quality... [more]

SMART Recovery groups are cognitive-behaviorally oriented mutual support groups for individuals with addictions. The aim of the study was to assess the extent to which the quality of group facilitation, group cohesion and the use of between session homework activities contribute to self-rated use of cognitive-behavioral skills amongst group participants. Participants attending SMART Recovery groups in Australia completed a cross sectional survey (N = 124). The survey included measures of cognitive and behavioral skill utilization, group cohesion, quality of group facilitation and a rating of how frequently participants leave group meetings with an achievable between session homework plan. On average, participants had been attending SMART Recovery meetings for 9. months. Participants were most likely to attend SMART Recovery for problematic alcohol use. Regression analyses indicated that group cohesion significantly predicted use of cognitive restructuring, but that only provision of homework at the end of each group session predicted self-reported behavioral activation. Both group cohesion and leaving a group with an achievable homework plan predicted participant use of cognitive behavioral skills. The concrete actions associated with homework activities may facilitate behavioral activation. There is a need for longitudinal research to examine the relationship between the utilization of cognitive and behavioral skills and participant outcomes (e.g. substance use, mental health) for people attending SMART Recovery groups.

DOI 10.1016/j.jsat.2014.10.008
2015 Stockings EAL, Bowman JA, Bartlem KM, Mcelwaine KM, Baker AL, Terry M, et al., 'Implementation of a smoke-free policy in an inpatient psychiatric facility: Patient-reported adherence, support, and receipt of nicotine-dependence treatment', International Journal of Mental Health Nursing, 24 342-349 (2015)

The implementation of smoke-free policies in inpatient psychiatric facilities, including patient adherence, mental health nursing staff support, and provision of nicotine-dependen... [more]

The implementation of smoke-free policies in inpatient psychiatric facilities, including patient adherence, mental health nursing staff support, and provision of nicotine-dependence treatment to patients, has been reported to be poor. The extent to which the quality of smoke-free policy implementation is associated with patient views of a policy is unknown. We conducted a cross-sectional survey of 181 patients (53.6%, n = 97 smokers; and 46.4%, n = 84 non-smokers) in an Australian inpatient psychiatric facility with a total smoke-free policy. Smokers' adherence to the policy was poor (83.5% smoked). Only half (53.6%) perceived staff to be supportive of the policy. Most smokers used nicotine-replacement therapy (75.3%); although few received optimal nicotine-dependence treatment (19.6%). Overall, 45.9% of patients viewed the smoke-free policy in the unit as positive (29.9% smokers; 64.3% non-smokers). For smokers, adhering to the ban, perceiving staff to be supportive, and reporting that the nicotine-replacement therapy reduced cravings to smoke were associated with a more positive view towards the smoke-free policy. These findings support the importance of patient adherence, mental health nursing staff support, and adequate provision of nicotine-dependence treatment in strengthening smoke-free policy implementation in inpatient psychiatric settings.

DOI 10.1111/inm.12128
Co-authors Jenny Bowman, John Wiggers, Kim Colyvas, Richard Clancy
2015 Kelly PJ, Baker AL, Deane FP, Callister R, Collins CE, Oldmeadow C, et al., 'Study protocol: a stepped wedge cluster randomised controlled trial of a healthy lifestyle intervention for people attending residential substance abuse treatment.', BMC Public Health, 15 465 (2015)
DOI 10.1186/s12889-015-1729-y
Co-authors Robin Callister, John Attia, Christopher Oldmeadow, Clare Collins
2015 Babic MJ, Morgan PJ, Plotnikoff RC, Lonsdale C, Eather N, Skinner G, et al., 'Rationale and study protocol for 'Switch-off 4 Healthy Minds' (S4HM): A cluster randomized controlled trial to reduce recreational screen time in adolescents', Contemporary Clinical Trials, 40 150-158 (2015)

Introduction: Excessive recreational screen time (i.e., screen use for entertainment) is a global public health issue associated with adverse mental and physical health outcomes. ... [more]

Introduction: Excessive recreational screen time (i.e., screen use for entertainment) is a global public health issue associated with adverse mental and physical health outcomes. Considering the growing popularity of screen-based recreation in adolescents, there is a need to identify effective strategies for reducing screen time among adolescents. The aim of this paper is to report the rationale and study protocol for the 'Switch-off 4 Healthy Minds' (S4HM) study, an intervention designed to reduce recreational screen time among adolescents. Methods: The S4HM intervention will be evaluated using a cluster randomized controlled trial in eight secondary schools (. N=. 322 students) in New South Wales, Australia. The 6-month multi-component intervention will encourage adolescents to manage their recreational screen time using a range of evidence-based strategies. The intervention is grounded in Self-Determination Theory (SDT) and includes the following components: an interactive seminar for students, eHealth messaging, behavioral contract and parental newsletters. All outcomes will be assessed at baseline and at 6-months (i.e., immediate post-test). The primary outcome is recreational screen time measured by the Adolescent Sedentary Activity Questionnaire (ASAQ). Secondary outcomes include: self-reported psychological well-being, psychological distress, global physical self-concept, resilience, pathological video gaming and aggression, and objectively measured physical activity (accelerometry) and body mass index (BMI). Hypothesized mediators of behavior change will also be explored. Discussion: The S4HM study will involve the evaluation of an innovative, theory-driven, multi-component intervention that targets students and their parents and is designed to reduce recreational screen time in adolescents. The intervention has been designed for scalability and dissemination across Australian secondary schools.

DOI 10.1016/j.cct.2014.12.001
Co-authors David Lubans, Ron Plotnikoff, Narelle Eather, Geoff Skinner, Philip Morgan
2015 Adamson SJ, Kay-Lambkin FJ, Baker A, Frampton CMA, Sellman D, Lewin TJ, 'Measuring change in cannabis use', Addiction Research and Theory, 23 43-49 (2015)

We examined the ability of the Cannabis User Disorders Identification Test - Revised (CUDIT-R) to detect change in a treatment sample, including correlation with changes in other ... [more]

We examined the ability of the Cannabis User Disorders Identification Test - Revised (CUDIT-R) to detect change in a treatment sample, including correlation with changes in other clinically relevant areas of functioning, and to determine reliable and clinically significant change thresholds. 133 cannabis-using patients taking part in a treatment trial for concurrent substance use and mood disorder were administered the 8-item CUDIT-R at baseline, 6 and 12 months, in addition to assessment of current cannabis use disorder, mood, alcohol use, motivation and employment status. Significant reductions in CUDIT-R scores were observed and were correlated with change in cannabis diagnosis, and improvement in mood. Higher motivation at baseline predicted greater reduction in CUDIT-R score. Reliable change was identified as occurring when CUDIT-R score changed by two or more, while clinically significant change, benchmarked against an increase or decrease of one DSM-IV cannabis dependence symptom, was equated to a CUDIT-R score changing by 3 or more points.

DOI 10.3109/16066359.2014.926895
Co-authors F Kaylambkin, Terry Lewin
2015 Hunt SA, Baker A, Michie PT, 'How does change in alcohol misuse and depression comorbidity impact on neuropsychological test performance after 12 months?', Drug and Alcohol Dependence, 146 e145 (2015)
Co-authors Pat Michie
2015 Kelly PJ, Baker AL, Deane FP, Callister R, Collins CE, Oldmeadow C, et al., 'Study protocol: A stepped wedge cluster randomised controlled trial of a healthy lifestyle intervention for people attending residential substance abuse treatment', BMC Public Health, (2015)

Background: Cardiovascular disease and cancer are leading causes of mortality for people with a history of alcohol or other substance use disorders. These chronic diseases share t... [more]

Background: Cardiovascular disease and cancer are leading causes of mortality for people with a history of alcohol or other substance use disorders. These chronic diseases share the same four primary behavioural risk factors i.e. excessive alcohol use, smoking, low intake of fruit and vegetables and physical inactivity. In addition to addressing problematic alcohol use, there is the potential for substance abuse treatment services to also address these other behaviours. Healthy Recovery is an 8-session group-based intervention that targets these multiple behavioural health risk factors and was developed specifically for people attending substance abuse treatment. This protocol describes a Cancer Institute NSW funded study that assesses the effectiveness of delivering Healthy Recovery for people who are attending residential alcohol and other substance abuse treatment. Methods/Design: The study uses a stepped wedge randomised controlled design, where randomisation occurs at the service level. Participants will be recruited from residential rehabilitation programs provided by The Australian Salvation Army. All participants who (1) currently smoke tobacco and (2) are expected to be in the residential program for the duration of the 5-week intervention will be asked to participate in the study. Those participants residing at the facilities assigned to the treatment condition will complete Healthy Recovery. The intervention is manual guided and will be delivered over a 5-week period, with participants attending 8 group sessions. All participants will continue to complete The Salvation Army residential program, a predominantly 12-step based, modified therapeutic community. Participants in the control condition will complete treatment as usual. Research staff blind to treatment allocation will complete the primary and secondary outcome assessments at baseline and then at weeks 8, 20 and 32 weeks post intervention. Discussion: This study will provide comprehensive data on the effect of delivering a healthy lifestyle intervention (i.e. Healthy Recovery) within a residential substance abuse setting. If shown to be effective, this intervention can be disseminated within other residential substance abuse programs. Trial registration: Australian and New Zealand Clinical Trials Register (ANZCTR): ACTRN12615000165583. Registered 19th February 2015.

DOI 10.1186/s12889-015-1729-y
Co-authors Clare Collins, Christopher Oldmeadow, John Attia, Robin Callister
2015 Cohen M, Johnston P, Ehlkes T, Fulham R, Ward P, Thienel R, et al., 'Functional magnetic resonance brain imaging of executive cognitive performance in young first-episode schizophrenia patients and age-matched long-term cannabis users', Neurology Psychiatry and Brain Research, 21 51-63 (2015) [C1]

Converging evidence from epidemiological, clinical and neuropsychological research suggests a link between cannabis use and increased risk of psychosis. Long-term cannabis use has... [more]

Converging evidence from epidemiological, clinical and neuropsychological research suggests a link between cannabis use and increased risk of psychosis. Long-term cannabis use has also been related to deficit-like "negative" symptoms and cognitive impairment that resemble some of the clinical and cognitive features of schizophrenia. The current functional brain imaging study investigated the impact of a history of heavy cannabis use on impaired executive function in first-episode schizophrenia patients. Whilst performing the Tower of London task in a magnetic resonance imaging scanner, event-related blood oxygenation level-dependent (BOLD) brain activation was compared between four age and gender-matched groups: 12 first-episode schizophrenia patients; 17 long-term cannabis users; seven cannabis using first-episode schizophrenia patients; and 17 healthy control subjects. BOLD activation was assessed as a function of increasing task difficulty within and between groups as well as the main effects of cannabis use and the diagnosis of schizophrenia. Cannabis users and non-drug using first-episode schizophrenia patients exhibited equivalently reduced dorsolateral prefrontal activation in response to task difficulty. A trend towards additional prefrontal and left superior parietal cortical activation deficits was observed in cannabis-using first-episode schizophrenia patients while a history of cannabis use accounted for increased activation in the visual cortex. Cannabis users and schizophrenia patients fail to adequately activate the dorsolateral prefrontal cortex, thus pointing to a common working memory impairment which is particularly evident in cannabis-using first-episode schizophrenia patients. A history of heavy cannabis use, on the other hand, accounted for increased primary visual processing, suggesting compensatory imagery processing of the task.

DOI 10.1016/j.npbr.2014.09.002
Co-authors Renate Thienel, Ulrich Schall
2015 Beck AK, Baker AL, Todd J, 'Smoking in schizophrenia: Cognitive impact of nicotine and relationship to smoking motivators', Schizophrenia Research: Cognition, 2 26-32 (2015) [C1]

Smoking prevalence in schizophrenia is significantly elevated relative to other clinical and to non-clinical groups. The cognitive self-medication hypothesis attributes this to th... [more]

Smoking prevalence in schizophrenia is significantly elevated relative to other clinical and to non-clinical groups. The cognitive self-medication hypothesis attributes this to the beneficial effects of nicotine on illness-related cognitive deficits. Significant effects of nicotine have been observed on visual spatial working memory (VSWM), sustained attention (Continuous Performance Test - Identical Pairs; CPT-IP) and prepulse inhibition (PPI). It remains unclear whether these neurophysiological and neurocognitive effects of nicotine influence self-reported smoking motivation. To explore the relationship between nicotine effects on cognition and self-reported smoking motivation in schizophrenia and non-psychiatric control smokers, the impact of smoking abstinence and reinstatement was examined across three cognitive indices (VSWM, CPT-IP, PPI) and compared to self-reported smoking motivation (Modified Reasons for Smoking Scale revised to include 'cognitive motivators'). Cognitive function was assessed after 'typical' smoking and overnight abstinence. Schizophrenia smokers (but not controls) demonstrated significantly less error on the VSWM task in the smoking relative to abstinent condition. Control (but not schizophrenia) smokers, showed evidence of CPT-IP improvement in the smoking relative to abstinent condition. The overall profile of smoking motivation was comparable between groups. However, significant relationships between subjective and objective indices of smoking related cognitive change were observed for controls. Differential effects of nicotine on cognition have been hypothesised to influence the pattern and persistence of smoking in schizophrenia. These preliminary findings indicate that evidence for such effects is apparent even in small samples - particularly for VSWM. This is the first study to show that neurocognitive effects of smoking may influence self-reported smoking motivation.

DOI 10.1016/j.scog.2014.12.001
Co-authors Juanita Todd
2015 Britton B, Baker A, Bauer J, Wolfenden L, Wratten C, McElduff P, Carter G, 'Eating As Treatment: A stepped wedge multi-centre trial of a psycho-nutrition intervention to improve outcomes in head and neck cancer patients undergoing radiotherapy', PSYCHO-ONCOLOGY, 24 8-8 (2015)
Co-authors Luke Wolfenden, Gregory Carter, Patrick Mcelduff
2015 Hiles SA, Baker AL, de Malmanche T, McEvoy M, Boyle M, Attia J, 'Unhealthy lifestyle may increase later depression via inflammation in older women but not men', Journal of Psychiatric Research, 63 65-74 (2015)

Depression and inflammatory markers have a reliable cross-sectional association although less is known about the prospective relationship. The current study investigated whether p... [more]

Depression and inflammatory markers have a reliable cross-sectional association although less is known about the prospective relationship. The current study investigated whether pro-inflammatory markers are prospectively associated with depression, and whether indicators of unhealthy lifestyle, physical health and psychosocial functioning may drive this association. Participants were drawn from the Hunter Community Study, a community-dwelling cohort of individuals aged 55-85 years (N=1410). Participants completed baseline physiological assessment, health-related questionnaires, and blood sampling for the analysis of inflammatory markers, C-reactive protein (CRP) and interleukin (IL)-6. Participants completed the same depressive symptom questionnaire again after 3.5-5.5 years. Depression outcomes at follow-up were analysed dichotomously using established scale cut-off scores and continuously as a "residual score", representing the variation in follow-up depressive symptoms not explained by baseline symptoms and age. Analyses were conducted on males and females separately. At baseline, indicators of unhealthy lifestyle, physical health and psychosocial functioning were associated with depressive symptoms and inflammatory markers. For males, there were no relationships between inflammatory markers and follow-up depression outcomes. In females, IL-6 was significantly associated with depression outcomes in univariate, but not multivariate analyses. However, IL-6 significantly mediated the association between the predictors of waist-to-hip ratio, smoking and psychological coping at baseline, and follow-up depression outcomes. The results support the inflammatory hypothesis of depression, although females may be more vulnerable to effects. The findings raise the possibility that unhealthy lifestyle and psychosocial stress may drive inflammation and subsequent depressive symptoms.

DOI 10.1016/j.jpsychires.2015.02.010
Citations Scopus - 1
Co-authors John Attia
2015 Kelly PJ, Deane FP, Baker AL, 'Group cohesion and between session homework activities predict self-reported cognitive-behavioral skill use amongst participants of smart recovery groups', Journal of Substance Abuse Treatment, 51 53-58 (2015) [C1]

SMART Recovery groups are cognitive-behaviorally oriented mutual support groups for individuals with addictions. The aim of the study was to assess the extent to which the quality... [more]

SMART Recovery groups are cognitive-behaviorally oriented mutual support groups for individuals with addictions. The aim of the study was to assess the extent to which the quality of group facilitation, group cohesion and the use of between session homework activities contribute to self-rated use of cognitive-behavioral skills amongst group participants. Participants attending SMART Recovery groups in Australia completed a cross sectional survey (N = 124). The survey included measures of cognitive and behavioral skill utilization, group cohesion, quality of group facilitation and a rating of how frequently participants leave group meetings with an achievable between session homework plan. On average, participants had been attending SMART Recovery meetings for 9. months. Participants were most likely to attend SMART Recovery for problematic alcohol use. Regression analyses indicated that group cohesion significantly predicted use of cognitive restructuring, but that only provision of homework at the end of each group session predicted self-reported behavioral activation. Both group cohesion and leaving a group with an achievable homework plan predicted participant use of cognitive behavioral skills. The concrete actions associated with homework activities may facilitate behavioral activation. There is a need for longitudinal research to examine the relationship between the utilization of cognitive and behavioral skills and participant outcomes (e.g. substance use, mental health) for people attending SMART Recovery groups.

DOI 10.1016/j.jsat.2014.10.008
2015 Kelly PJ, Baker AL, Deane FP, Callister R, Collins CE, Oldmeadow C, et al., 'Study protocol: A stepped wedge cluster randomised controlled trial of a healthy lifestyle intervention for people attending residential substance abuse treatment', BMC Public Health, (2015)

Background: Cardiovascular disease and cancer are leading causes of mortality for people with a history of alcohol or other substance use disorders. These chronic diseases share t... [more]

Background: Cardiovascular disease and cancer are leading causes of mortality for people with a history of alcohol or other substance use disorders. These chronic diseases share the same four primary behavioural risk factors i.e. excessive alcohol use, smoking, low intake of fruit and vegetables and physical inactivity. In addition to addressing problematic alcohol use, there is the potential for substance abuse treatment services to also address these other behaviours. Healthy Recovery is an 8-session group-based intervention that targets these multiple behavioural health risk factors and was developed specifically for people attending substance abuse treatment. This protocol describes a Cancer Institute NSW funded study that assesses the effectiveness of delivering Healthy Recovery for people who are attending residential alcohol and other substance abuse treatment. Methods/Design: The study uses a stepped wedge randomised controlled design, where randomisation occurs at the service level. Participants will be recruited from residential rehabilitation programs provided by The Australian Salvation Army. All participants who (1) currently smoke tobacco and (2) are expected to be in the residential program for the duration of the 5-week intervention will be asked to participate in the study. Those participants residing at the facilities assigned to the treatment condition will complete Healthy Recovery. The intervention is manual guided and will be delivered over a 5-week period, with participants attending 8 group sessions. All participants will continue to complete The Salvation Army residential program, a predominantly 12-step based, modified therapeutic community. Participants in the control condition will complete treatment as usual. Research staff blind to treatment allocation will complete the primary and secondary outcome assessments at baseline and then at weeks 8, 20 and 32 weeks post intervention. Discussion: This study will provide comprehensive data on the effect of delivering a healthy lifestyle intervention (i.e. Healthy Recovery) within a residential substance abuse setting. If shown to be effective, this intervention can be disseminated within other residential substance abuse programs. Trial registration: Australian and New Zealand Clinical Trials Register (ANZCTR): ACTRN12615000165583. Registered 19th February 2015.

DOI 10.1186/s12889-015-1729-y
Co-authors Robin Callister, John Attia, Christopher Oldmeadow, Clare Collins
2015 Hiles SA, Baker AL, de Malmanche T, McEvoy M, Boyle M, Attia J, 'The role of inflammatory markers in explaining the association between depression and cardiovascular hospitalisations', Journal of Behavioral Medicine, 38 609-619 (2015)

This study investigated whether inflammation may explain the relationship between depression and incident cardiovascular hospitalisations. Participants (55¿85¿years) completed b... [more]

This study investigated whether inflammation may explain the relationship between depression and incident cardiovascular hospitalisations. Participants (55¿85¿years) completed baseline depression and physical assessment. Those without self-reported cardiovascular events were followed prospectively for hospital admissions for angina, myocardial infarction and cerebral infarction (median 937¿days). Across 5140 person-years of risk (N¿=¿1692), there were 47 incident cardiovascular hospitalisations (2.8¿%). Controlling for age and gender, interleukin (IL)-6, C-reactive protein (CRP), body mass index (BMI) and waist-to-hip ratio were associated with future cardiovascular events. Mediation analysis showed that CRP accounted for 8.1¿% and IL-6 10.9¿% of the effect of depression on cardiovascular events, and including the indirect effect in the model substantially reduced the direct relationship between depression and cardiovascular hospitalisations. BMI and waist-to-hip ratio accounted for indirect effects of 7.7 and 10.4¿%, respectively. Inflammatory markers partly explain the association between depression and cardiovascular events, although other shared factors also likely contribute.

DOI 10.1007/s10865-015-9637-2
Co-authors John Attia
2015 Cohen M, Johnston P, Ehlkes T, Fulham R, Ward P, Thienel R, et al., 'Functional magnetic resonance brain imaging of executive cognitive performance in young first-episode schizophrenia patients and age-matched long-term cannabis users', Neurology Psychiatry and Brain Research, 21 51-63 (2015)

Converging evidence from epidemiological, clinical and neuropsychological research suggests a link between cannabis use and increased risk of psychosis. Long-term cannabis use has... [more]

Converging evidence from epidemiological, clinical and neuropsychological research suggests a link between cannabis use and increased risk of psychosis. Long-term cannabis use has also been related to deficit-like "negative" symptoms and cognitive impairment that resemble some of the clinical and cognitive features of schizophrenia. The current functional brain imaging study investigated the impact of a history of heavy cannabis use on impaired executive function in first-episode schizophrenia patients. Whilst performing the Tower of London task in a magnetic resonance imaging scanner, event-related blood oxygenation level-dependent (BOLD) brain activation was compared between four age and gender-matched groups: 12 first-episode schizophrenia patients; 17 long-term cannabis users; seven cannabis using first-episode schizophrenia patients; and 17 healthy control subjects. BOLD activation was assessed as a function of increasing task difficulty within and between groups as well as the main effects of cannabis use and the diagnosis of schizophrenia. Cannabis users and non-drug using first-episode schizophrenia patients exhibited equivalently reduced dorsolateral prefrontal activation in response to task difficulty. A trend towards additional prefrontal and left superior parietal cortical activation deficits was observed in cannabis-using first-episode schizophrenia patients while a history of cannabis use accounted for increased activation in the visual cortex. Cannabis users and schizophrenia patients fail to adequately activate the dorsolateral prefrontal cortex, thus pointing to a common working memory impairment which is particularly evident in cannabis-using first-episode schizophrenia patients. A history of heavy cannabis use, on the other hand, accounted for increased primary visual processing, suggesting compensatory imagery processing of the task.

DOI 10.1016/j.npbr.2014.09.002
Co-authors Renate Thienel, Ulrich Schall
2015 Filia SL, Gurvich CT, Horvat A, Shelton CL, Katona LJ, Baker AL, et al., 'Inpatient views and experiences before and after implementing a totally smoke-free policy in the acute psychiatry hospital setting', International Journal of Mental Health Nursing, (2015)

In the present study, we examined the views and experiences of patients admitted to an acute psychiatry unit before and after the implementation of a totally smoke-free policy. Fo... [more]

In the present study, we examined the views and experiences of patients admitted to an acute psychiatry unit before and after the implementation of a totally smoke-free policy. Forty-six inpatients completed a questionnaire assessing their views before the smoking ban. Another 52 inpatients completed a questionnaire assessing their views and experiences after the smoking ban. Before the totally smoke-free policy, 69.6% smoked, with 67.7% smoking more when admitted to the psychiatry ward. Before the smoking ban, 54.4% reported that the totally smoke-free policy would be 'negative' or 'very negative,' and 30.5% said it would be 'positive' or 'very positive.' After the totally smoke-free policy, 57.7% smoked heavily before hospital (mean cigarettes/day=24.9), with consumption dramatically reducing following admission to a totally smoke-free psychiatric unit (mean cigarettes/day=8.3). After the totally smoke-free policy, 36.5% reported that it was 'negative' or 'very negative,' and 50% reported that it was 'positive' or 'very positive.' Overall, inpatients reported improved acceptance of the policy following implementation. Inpatients stated that the most difficult thing about the smoking ban was experiencing increased negative emotions, while the most positive aspect was the improved physical environment of the ward. Inpatients who smoke must be appropriately supported using a range of strategies, and in the present study, we suggest relevant clinical implications.

DOI 10.1111/inm.12123
2015 Thornton LK, Harris K, Baker A, Johnson M, Kay-Lambkin FJ, 'Recruiting for addiction research via Facebook.', Drug Alcohol Rev, (2015)
DOI 10.1111/dar.12305
2015 Hiles SA, Baker AL, de Malmanche T, McEvoy M, Boyle M, Attia J, 'The role of inflammatory markers in explaining the association between depression and cardiovascular hospitalisations', Journal of Behavioral Medicine, 38 609-619 (2015)

This study investigated whether inflammation may explain the relationship between depression and incident cardiovascular hospitalisations. Participants (55¿85¿years) completed b... [more]

This study investigated whether inflammation may explain the relationship between depression and incident cardiovascular hospitalisations. Participants (55¿85¿years) completed baseline depression and physical assessment. Those without self-reported cardiovascular events were followed prospectively for hospital admissions for angina, myocardial infarction and cerebral infarction (median 937¿days). Across 5140 person-years of risk (N¿=¿1692), there were 47 incident cardiovascular hospitalisations (2.8¿%). Controlling for age and gender, interleukin (IL)-6, C-reactive protein (CRP), body mass index (BMI) and waist-to-hip ratio were associated with future cardiovascular events. Mediation analysis showed that CRP accounted for 8.1¿% and IL-6 10.9¿% of the effect of depression on cardiovascular events, and including the indirect effect in the model substantially reduced the direct relationship between depression and cardiovascular hospitalisations. BMI and waist-to-hip ratio accounted for indirect effects of 7.7 and 10.4¿%, respectively. Inflammatory markers partly explain the association between depression and cardiovascular events, although other shared factors also likely contribute.

DOI 10.1007/s10865-015-9637-2
Co-authors John Attia
2015 Beck AK, Baker AL, Todd J, 'Smoking in schizophrenia: Cognitive impact of nicotine and relationship to smoking motivators', Schizophrenia Research: Cognition, 2 26-32 (2015)

Smoking prevalence in schizophrenia is significantly elevated relative to other clinical and to non-clinical groups. The cognitive self-medication hypothesis attributes this to th... [more]

Smoking prevalence in schizophrenia is significantly elevated relative to other clinical and to non-clinical groups. The cognitive self-medication hypothesis attributes this to the beneficial effects of nicotine on illness-related cognitive deficits. Significant effects of nicotine have been observed on visual spatial working memory (VSWM), sustained attention (Continuous Performance Test - Identical Pairs; CPT-IP) and prepulse inhibition (PPI). It remains unclear whether these neurophysiological and neurocognitive effects of nicotine influence self-reported smoking motivation. To explore the relationship between nicotine effects on cognition and self-reported smoking motivation in schizophrenia and non-psychiatric control smokers, the impact of smoking abstinence and reinstatement was examined across three cognitive indices (VSWM, CPT-IP, PPI) and compared to self-reported smoking motivation (Modified Reasons for Smoking Scale revised to include 'cognitive motivators'). Cognitive function was assessed after 'typical' smoking and overnight abstinence. Schizophrenia smokers (but not controls) demonstrated significantly less error on the VSWM task in the smoking relative to abstinent condition. Control (but not schizophrenia) smokers, showed evidence of CPT-IP improvement in the smoking relative to abstinent condition. The overall profile of smoking motivation was comparable between groups. However, significant relationships between subjective and objective indices of smoking related cognitive change were observed for controls. Differential effects of nicotine on cognition have been hypothesised to influence the pattern and persistence of smoking in schizophrenia. These preliminary findings indicate that evidence for such effects is apparent even in small samples - particularly for VSWM. This is the first study to show that neurocognitive effects of smoking may influence self-reported smoking motivation.

DOI 10.1016/j.scog.2014.12.001
Co-authors Juanita Todd
2015 Britton B, McCarter K, Baker A, Wolfenden L, Wratten C, Bauer J, et al., 'Eating As Treatment (EAT) study protocol: a stepped-wedge, randomised controlled trial of a health behaviour change intervention provided by dietitians to improve nutrition in patients with head and neck cancer undergoing radiotherapy.', BMJ Open, 5 e008921 (2015)
DOI 10.1136/bmjopen-2015-008921
Co-authors Patrick Mcelduff, Sean Halpin, Gregory Carter, Luke Wolfenden
2015 Hiles SA, Baker AL, de Malmanche T, McEvoy M, Boyle M, Attia J, 'The role of inflammatory markers in explaining the association between depression and cardiovascular hospitalisations.', J Behav Med, 38 609-619 (2015)
DOI 10.1007/s10865-015-9637-2
Co-authors John Attia
2015 Hiles SA, Baker AL, de Malmanche T, McEvoy M, Boyle M, Attia J, 'Unhealthy lifestyle may increase later depression via inflammation in older women but not men.', J Psychiatr Res, 63 65-74 (2015)
DOI 10.1016/j.jpsychires.2015.02.010
2015 Baker AL, Richmond R, Kay-Lambkin FJ, Filia SL, Castle D, Williams JM, et al., 'Randomized Controlled Trial of a Healthy Lifestyle Intervention Among Smokers With Psychotic Disorders.', Nicotine Tob Res, 17 946-954 (2015)
DOI 10.1093/ntr/ntv039
Co-authors F Kaylambkin, Terry Lewin, Robin Callister, Natasha Weaver
2015 Stockings EA, Bowman JA, Bartlem KM, McElwaine KM, Baker AL, Terry M, et al., 'Implementation of a smoke-free policy in an inpatient psychiatric facility: Patient-reported adherence, support, and receipt of nicotine-dependence treatment.', Int J Ment Health Nurs, 24 342-349 (2015)
DOI 10.1111/inm.12128
Co-authors Richard Clancy, Jenny Bowman, Kim Colyvas, John Wiggers
2014 Hunt SA, Baker AL, Michie PT, Kay-Lambkin F, 'Change in neurocognition in people with co-occurring alcohol misuse and depression: 12-month follow-up', Journal of Addiction Research & Therapy, S10:004 (2014) [C1]
DOI 10.4172/2155-6105.S10-004
Co-authors F Kaylambkin, Pat Michie
2014 Stockings EA, Bowman JA, Prochaska JJ, Baker AL, Clancy R, Knight J, et al., 'The impact of a smoke-free psychiatric hospitalization on patient smoking outcomes: A systematic review', Australian and New Zealand Journal of Psychiatry, 48 617-633 (2014) [C1]

Objective: Smoke-free policies have been introduced in inpatient psychiatric facilities in most developed nations. Such a period of supported abstinence during hospitalization may... [more]

Objective: Smoke-free policies have been introduced in inpatient psychiatric facilities in most developed nations. Such a period of supported abstinence during hospitalization may impact smoking behaviours post discharge, yet little quantitative evidence exists. The aim of this review was to provide the first synthesis of the research evidence examining the impact of a smoke-free psychiatric hospitalization on patients smoking-related behaviours, motivation, and beliefs. Methods: We conducted a systematic review of electronic databases PubMed, MEDLINE, PsycINFO, and EMBASE from inception to June 2013. Studies were included if they were conducted in an inpatient psychiatric facility with a smokefree policy and if they examined any change in patients smoking-related behaviours, motivation, or beliefs either during admission, post discharge, or both. Risk of bias was assessed using the Cochrane Collaboration Risk of Bias Tool. Results: Fourteen studies were included in the review. Of the four studies that assessed change in smoking from admission to post discharge, two indicated a significant decline in cigarette consumption up to 3 months post discharge. Positive changes in motivation to quit and beliefs about quitting ability were identified in two studies. One study reported an increase in the rate of quit attempts and one reported a decline in nicotine dependence levels. Conclusions: A smoke-free psychiatric hospitalization may have © The Royal Australian and New Zealand College of Psychiatrists 2014.

DOI 10.1177/0004867414533835
Citations Scopus - 3Web of Science - 2
Co-authors Jenny Bowman, Richard Clancy, John Wiggers
2014 Filia SL, Baker AL, Gurvich CT, Richmond R, Lewin TJ, Kulkarni J, 'Gender differences in characteristics and outcomes of smokers diagnosed with psychosis participating in a smoking cessation intervention', Psychiatry Research, 215 586-593 (2014)
DOI 10.1016/j.psychres.2014.01.002
Co-authors Terry Lewin
2014 Filia SL, Baker AL, Gurvich CT, Richmond R, Lewin TJ, Kulkarni J, 'Gender differences in characteristics and outcomes of smokers diagnosed with psychosis participating in a smoking cessation intervention', Psychiatry Research, 215 586-593 (2014) [C1]

While research has identified gender differences in characteristics and outcomes of smokers in the general population, no studies have examined this among smokers with psychosis. ... [more]

While research has identified gender differences in characteristics and outcomes of smokers in the general population, no studies have examined this among smokers with psychosis. This study aimed to explore gender differences among 298 smokers with psychosis (schizophrenia, schizoaffective and bipolar affective disorder) participating in a smoking intervention study. Results revealed a general lack of gender differences on a range of variables for smokers with psychosis including reasons for smoking/quitting, readiness and motivation to quit, use of nicotine replacement therapy, and smoking outcomes including point prevalence or continuous abstinence, and there were no significant predictors of smoking reduction status according to gender at any of the follow-up time-points. The current study did find that female smokers with psychosis were significantly more likely than males to report that they smoked to prevent weight gain. Furthermore, the females reported significantly more reasons for quitting smoking and were more likely to be driven by extrinsic motivators to quit such as immediate reinforcement and social influence, compared to the male smokers with psychosis. Clinical implications include specifically focussing on weight issues and enhancing intrinsic motivation to quit smoking for female smokers with psychosis; and strengthening reasons for quitting among males with psychosis. © 2014 Elsevier Ireland Ltd.

DOI 10.1016/j.psychres.2014.01.002
Citations Scopus - 1Web of Science - 1
Co-authors Terry Lewin
2014 Baker AL, Turner A, Kelly PJ, Spring B, Callister R, Collins CE, et al., ''Better Health Choices' by telephone: A feasibility trial of improving diet and physical activity in people diagnosed with psychotic disorders', Psychiatry Research, (2014) [C1]

The study objective was to evaluate the feasibility of a telephone delivered intervention consisting of motivational interviewing and cognitive behavioural strategies aimed at imp... [more]

The study objective was to evaluate the feasibility of a telephone delivered intervention consisting of motivational interviewing and cognitive behavioural strategies aimed at improving diet and physical activity in people diagnosed with psychotic disorders. Twenty participants diagnosed with a non-acute psychotic disorder were recruited. The intervention consisted of eight telephone delivered sessions targeting fruit and vegetable (F&V) consumption and leisure screen time, as well as smoking and alcohol use (as appropriate). F&V frequency and variety, and overall diet quality (measured by the Australian Recommended Food Score, ARFS), leisure screen time, overall sitting and walking time, smoking, alcohol consumption, mood, quality of life, and global functioning were examined before and 4-weeks post-treatment. Nineteen participants (95%) completed all intervention sessions, and 17 (85%) completed follow-up assessments. Significant increases from baseline to post-treatment were seen in ARFS fruit, vegetable and overall diet quality scores, quality of life and global functioning. Significant reductions in leisure screen time and overall sitting time were also seen. Results indicated that a telephone delivered intervention targeting key cardiovascular disease risk behaviours appears to be feasible and relatively effective in the short-term for people diagnosed with psychosis. A randomized controlled trial is warranted to replicate and extend these findings. © 2014 Elsevier Ireland Ltd. All rights reserved.

DOI 10.1016/j.psychres.2014.06.035
Citations Scopus - 2Web of Science - 1
Co-authors Terry Lewin, F Kaylambkin, Clare Collins, Robin Callister
2014 Baker AL, Kavanagh DJ, Kay-Lambkin FJ, Hunt SA, Lewin TJ, Carr VJ, McElduff P, 'Randomized controlled trial of MICBT for co-existing alcohol misuse and depression: Outcomes to 36-months', Journal of Substance Abuse Treatment, 46 281-290 (2014)
DOI 10.1016/j.jsat.2013.10.001
Citations Scopus - 3
Co-authors F Kaylambkin, Patrick Mcelduff, Terry Lewin
2014 Baker AL, Kavanagh DJ, Kay-Lambkin FJ, Hunt SA, Lewin TJ, Carr VJ, McElduff P, 'Randomized controlled trial of MICBT for co-existing alcohol misuse and depression: Outcomes to 36-months', Journal of Substance Abuse Treatment, 46 281-290 (2014) [C1]

Integrated psychological treatment addressing co-existing alcohol misuse and depression has not been compared with single-focused treatment. This trial evaluates changes over 36. ... [more]

Integrated psychological treatment addressing co-existing alcohol misuse and depression has not been compared with single-focused treatment. This trial evaluates changes over 36. months following randomization of 284 outpatients to one of four motivational interviewing and cognitive-behavior therapy (MICBT) based interventions: (1) brief integrated intervention (BI); or BI plus 9 further sessions with (2) an integrated-, (3) alcohol-, or (4) depression-focus. Outcome measures included changes in alcohol consumption, depression (BDI-II: Beck Depression Inventory) and functioning (GAF: Global Assessment of Functioning), with average improvements from baseline of 21.8 drinks per week, 12.6 BDI-II units and 8.2 GAF units. Longer interventions tended to be more effective in reducing depression and improving functioning in the long-term, and in improving alcohol consumption in the short-term. Integrated treatment was at least as good as single-focused MICBT. Alcohol-focused treatment was as effective as depression-focused treatment at reducing depression and more effective in reducing alcohol misuse. The best approach seems to be an initial focus on both conditions followed by additional integrated- or alcohol-focused sessions. © 2014 Elsevier Inc.

DOI 10.1016/j.jsat.2013.10.001
Citations Scopus - 3Web of Science - 3
Co-authors F Kaylambkin, Patrick Mcelduff, Terry Lewin
2014 Cohen M, Johnston P, Ehlkes T, Fulham R, Ward P, Thienel R, et al., 'Functional magnetic resonance brain imaging of executive cognitive performance in young first-episode schizophrenia patients and age-matched long-term cannabis users', Neurology Psychiatry and Brain Research, (2014)

Converging evidence from epidemiological, clinical and neuropsychological research suggests a link between cannabis use and increased risk of psychosis. Long-term cannabis use has... [more]

Converging evidence from epidemiological, clinical and neuropsychological research suggests a link between cannabis use and increased risk of psychosis. Long-term cannabis use has also been related to deficit-like ¿negative¿ symptoms and cognitive impairment that resemble some of the clinical and cognitive features of schizophrenia. The current functional brain imaging study investigated the impact of a history of heavy cannabis use on impaired executive function in first-episode schizophrenia patients. Whilst performing the Tower of London task in a magnetic resonance imaging scanner, event-related blood oxygenation level-dependent (BOLD) brain activation was compared between four age and gender-matched groups: 12 first-episode schizophrenia patients; 17 long-term cannabis users; seven cannabis using first-episode schizophrenia patients; and 17 healthy control subjects. BOLD activation was assessed as a function of increasing task difficulty within and between groups as well as the main effects of cannabis use and the diagnosis of schizophrenia. Cannabis users and non-drug using first-episode schizophrenia patients exhibited equivalently reduced dorsolateral prefrontal activation in response to task difficulty. A trend towards additional prefrontal and left superior parietal cortical activation deficits was observed in cannabis-using first-episode schizophrenia patients while a history of cannabis use accounted for increased activation in the visual cortex. Cannabis users and schizophrenia patients fail to adequately activate the dorsolateral prefrontal cortex, thus pointing to a common working memory impairment which is particularly evident in cannabis-using first-episode schizophrenia patients. A history of heavy cannabis use, on the other hand, accounted for increased primary visual processing, suggesting compensatory imagery processing of the task.

DOI 10.1016/j.npbr.2014.09.002
Co-authors Renate Thienel, Ulrich Schall
2014 Filia SL, Baker AL, Gurvich CT, Richmond R, Kulkarni J, 'The perceived risks and benefits of quitting in smokers diagnosed with severe mental illness participating in a smoking cessation intervention: Gender differences and comparison to smokers without mental illness', DRUG AND ALCOHOL REVIEW, 33 78-85 (2014) [C1]
DOI 10.1111/dar.12091
Citations Scopus - 1Web of Science - 1
2014 Kelly PJ, Baker AL, Kay-Lambkin F, 'ADDRESSING MULTIPLE HEALTH RISK BEHAVIOURS IN DISADVANTAGED POPULATIONS: RESEARCH BEING LED BY THE NATIONAL HEALTH AND MEDICAL RESEARCH COUNCIL CENTRE OF RESEARCH EXCELLENCE IN MENTAL HEALTH AND SUBSTANCE USE', DRUG AND ALCOHOL REVIEW, 33 37-37 (2014) [E3]
Co-authors F Kaylambkin
2014 Filia SL, Baker AL, Gurvich CT, Richmond R, Kulkarni J, 'The perceived risks and benefits of quitting in smokers diagnosed with severe mental illness participating in a smoking cessation intervention: Gender differences and comparison to smokers without mental illness', Drug and Alcohol Review, 33 78-85 (2014)
DOI 10.1111/dar.12091
Citations Scopus - 1
2014 Bonevski B, Regan T, Paul C, Baker AL, Bisquera A, 'Associations between alcohol, smoking, socioeconomic status and comorbidities: Evidence from the 45 and Up Study', Drug and Alcohol Review, 33 169-176 (2014) [C1]

Introduction and Aims.: Understanding how tobacco, alcohol and mental health are related is important for developing population-level policies and individual-level treatments that... [more]

Introduction and Aims.: Understanding how tobacco, alcohol and mental health are related is important for developing population-level policies and individual-level treatments that target comorbidities. The current study aimed to examine sociodemographic characteristics and mental health comorbidities associated with the odds of using tobacco and harmful levels of alcohol concurrently. Design and Methods.: Data were drawn from the 45 and Up Study, a large cohort study with 267153 adults aged 45 years and over in New South Wales, Australia. Participants completed a survey assessing alcohol, smoking, psychological distress, treatment for depression and anxiety, and a range of socioeconomic status indicators. Univariate analyses and three multiple-logistic regression models were used to determine associations with (i) tobacco but not alcohol use; (ii) alcohol but not tobacco use; and (iii) concurrent tobacco and risky levels of alcohol use. Results.: Being female, younger, lower individual and area-level socioeconomic status (SES) and depression and psychological distress were associated with tobacco use alone. Factors associated with alcohol use alone were older age, male gender, higher SES, and lower psychological distress and no recent depression treatment. Factors associated with concurrent risky alcohol consumption and tobacco use included being 45-64, being male, less education, earning <$30000, being employed, and living in lower-SES areas, treatment for depression, and high distress on the Kessler-10. Discussion and Conclusions.: Results suggest strong links between SES, treatment for depression, psychological distress, and concurrent tobacco and alcohol use. This has implications for public health policies and clinical treatment for tobacco and alcohol use, suggesting greater emphasis on addressing multiple health and social concerns. © 2013 Australasian Professional Society on Alcohol and other Drugs.

DOI 10.1111/dar.12104
Citations Scopus - 4Web of Science - 3
Co-authors Timothy Regan, Billie Bonevski, Chris Paul
2014 Mcketin R, Butterworth P, Lubman DI, Najman JM, Dawe S, Baker AL, 'Does methamphetamine use increase violent behaviour? Evidence from a prospective longitudinal study', Addiction, (2014) [C1]

Aims: To determine whether violent behaviour increases during periods of methamphetamine use and whether this is due to methamphetamine-induced psychotic symptoms. Design: A fixed... [more]

Aims: To determine whether violent behaviour increases during periods of methamphetamine use and whether this is due to methamphetamine-induced psychotic symptoms. Design: A fixed-effects (within-subject) analysis of four non-contiguous 1-month observation periods from a longitudinal prospective cohort study. Setting: Sydney and Brisbane, Australia. Participants: A total of 278 participants aged 16 years or older who met DSM-IV criteria for methamphetamine dependence on entry to the study but who did not meet DSM-IV criteria for life-time schizophrenia or mania. Measurements: Violent behaviour was defined as severe hostility in the past month on the Brief Psychiatric Rating Scale (BPRS) (corresponding to assault/damage to property). Days of methamphetamine and other substance use in the past month were assessed using the Opiate Treatment Index. Positive psychotic symptoms in the past month were identified using the BPRS. Findings: There was a dose-related increase in violent behaviour when an individual was using methamphetamine compared with when they were not after adjusting for other substance use and socio-demographics [cf. no use in the past month: 1-15 days of use odds ratio (OR)=2.8, 95% confidence interval (CI)=1.6-4.9; 16+ days of use OR=9.5, 95% CI=4.8-19.1]. The odds of violent behaviour were further increased by psychotic symptoms (OR=2.0, 95% CI=1.1-3.6), which accounted for 22-30% of violent behaviour related to methamphetamine use. Heavy alcohol consumption also increased the risk of violent behaviour (OR=3.1, 95% CI=1.4-7.0) and accounted for 12-18% of the violence risk related to methamphetamine use. Conclusions: There is a dose-related increase in violent behaviour during periods of methamphetamine use that is largely independent of the violence risk associated with psychotic symptoms. © 2014 Society for the Study of Addiction.

DOI 10.1111/add.12474
Citations Scopus - 7Web of Science - 5
2014 Hjorthoj CR, Baker A, Fohlmann A, Nordentoft M, 'Intervention Efficacy in Trials Targeting Cannabis Use Disorders in Patients with Comorbid Psychosis Systematic Review and Meta-analysis', CURRENT PHARMACEUTICAL DESIGN, 20 2205-2211 (2014) [C1]
Citations Scopus - 2Web of Science - 2
2014 Filia SL, Baker AL, Gurvich CT, Richmond R, Kulkarni J, 'The perceived risks and benefits of quitting in smokers diagnosed with severe mental illness participating in a smoking cessation intervention: Gender differences and comparison to smokers without mental illness', Drug and Alcohol Review, 33 78-85 (2014) [C1]

Introduction and Aims: This study aimed to examine the perceived risks and benefits of quitting in smokers diagnosed with psychosis, including potential gender differences and com... [more]

Introduction and Aims: This study aimed to examine the perceived risks and benefits of quitting in smokers diagnosed with psychosis, including potential gender differences and comparisons to smokers in the general population. Design and Methods: Data were collected from 200 people diagnosed with psychosis participating in a randomised controlled trial testing the effectiveness of a multi-component intervention for smoking cessation and cardiovascular disease risk reduction in people with severe mental illness. Results were compared with both treatment and non-treatment seeking smokers in the general population. Results: Male and female smokers with psychosis generally had similar perceived risks and benefits of quitting. Females rated it significantly more likely that they would experience weight gain and negative affect upon quitting than males diagnosed with psychosis. Compared with smokers in the general population also seeking smoking cessation treatment, this sample of smokers with psychosis demonstrated fewer gender differences and lower ratings of perceived risks and benefits of quitting. The pattern of risk and benefit ratings in smokers diagnosed with psychosis was similar to those of non-treatment seeking smokers in the general population. Discussion and Conclusions: These results increase our understanding of smoking in people with severe mental illness, and can directly inform smoking interventions to maximise successful abstinence for this group of smokers. For female smokers with psychosis, smoking cessation interventions need to address concerns regarding weight gain and negative affect. Intervention strategies aimed at enhancing beliefs about the benefits of quitting smoking for both male and female smokers with psychosis are necessary. © 2013 Australasian Professional Society on Alcohol and other Drugs.

DOI 10.1111/dar.12091
Citations Scopus - 2Web of Science - 2
2014 Mills KL, Ewer P, Dore G, Teesson M, Baker A, Kay-Lambkin F, Sannibale C, 'The feasibility and acceptability of a brief intervention for clients of substance use services experiencing symptoms of post traumatic stress disorder', Addictive Behaviors, 39 1094-1099 (2014) [C1]

Background: Trauma exposure and post traumatic stress disorder (PTSD) are common among clients of substance use services. Existing treatments for these co-occurring conditions ten... [more]

Background: Trauma exposure and post traumatic stress disorder (PTSD) are common among clients of substance use services. Existing treatments for these co-occurring conditions tend to be lengthy, treatment retention is relatively poor, and they require extensive training and clinical supervision. The aim of the present study was to conduct a preliminary examination of the feasibility and acceptability of a brief intervention for PTSD symptoms among individuals seeking substance use treatment. Methods: An uncontrolled open-label pilot study was conducted among 29 inpatients of a medicated detoxification unit in Sydney, Australia. All participants completed a baseline interview followed by the brief intervention. The intervention consists of a single, one-hour manualised session providing psychoeducation pertaining to common trauma reactions and symptom management. PTSD and substance use outcomes were assessed at 1-week, 1-month and 3-month post-intervention. Results: PTSD symptom severity (assessed using the Clinicians Administered PTSD Scale) decreased significantly from baseline to 1-week follow up (ß - 10.87, 95%CI: - 19.75 to - 1.99) and again between the 1-week and 3-month follow-ups (ß - 15.38, 95%CI: - 23.20 to - 7.57). Despite these reductions, the majority of participants continued to meet criteria for a diagnosis of PTSD and there was no change in participants' negative post-traumatic cognitions. Participants expressed high levels of satisfaction with the intervention. Conclusions: Brief psychoeducation for traumatised clients attending substance use services appears to be feasible, acceptable, and may be of some benefit in reducing PTSD symptoms. However, participants continued to experience symptoms at severe levels; thus, brief intervention may best be conceptualised as a "stepping stone" to further trauma treatment. © 2014 Elsevier Ltd.

DOI 10.1016/j.addbeh.2014.03.013
Co-authors F Kaylambkin
2014 Beck AK, Baker AL, Todd J, 'Smoking in schizophrenia: Cognitive impact of nicotine and relationship to smoking motivators', Schizophrenia Research: Cognition, (2014)

Smoking prevalence in schizophrenia is significantly elevated relative to other clinical and to non-clinical groups. The cognitive self-medication hypothesis attributes this to th... [more]

Smoking prevalence in schizophrenia is significantly elevated relative to other clinical and to non-clinical groups. The cognitive self-medication hypothesis attributes this to the beneficial effects of nicotine on illness-related cognitive deficits. Significant effects of nicotine have been observed on visual spatial working memory (VSWM), sustained attention (Continuous Performance Test - Identical Pairs; CPT-IP) and prepulse inhibition (PPI). It remains unclear whether these neurophysiological and neurocognitive effects of nicotine influence self-reported smoking motivation.To explore the relationship between nicotine effects on cognition and self-reported smoking motivation in schizophrenia and non-psychiatric control smokers, the impact of smoking abstinence and reinstatement was examined across three cognitive indices (VSWM, CPT-IP, PPI) and compared to self-reported smoking motivation (Modified Reasons for Smoking Scale revised to include 'cognitive motivators'). Cognitive function was assessed after 'typical' smoking and overnight abstinence. Schizophrenia smokers (but not controls) demonstrated significantly less error on the VSWM task in the smoking relative to abstinent condition. Control (but not schizophrenia) smokers, showed evidence of CPT-IP improvement in the smoking relative to abstinent condition. The overall profile of smoking motivation was comparable between groups. However, significant relationships between subjective and objective indices of smoking related cognitive change were observed for controls.Differential effects of nicotine on cognition have been hypothesised to influence the pattern and persistence of smoking in schizophrenia. These preliminary findings indicate that evidence for such effects is apparent even in small samples - particularly for VSWM. This is the first study to show that neurocognitive effects of smoking may influence self-reported smoking motivation.

DOI 10.1016/j.scog.2014.12.001
Co-authors Juanita Todd
2014 Stockings EAL, Bowman JA, Baker AL, Terry M, Clancy R, Wye PM, et al., 'Impact of a postdischarge smoking cessation intervention for smokers admitted to an inpatient psychiatric facility: A randomized controlled trial', Nicotine and Tobacco Research, 16 1417-1428 (2014) [C1]

Introduction: Persons with a mental disorder smoke at higher rates and suffer disproportionate tobacco-related burden compared with the general population. The aim of this study w... [more]

Introduction: Persons with a mental disorder smoke at higher rates and suffer disproportionate tobacco-related burden compared with the general population. The aim of this study was to determine if a smoking cessation intervention initiated during a psychiatric hospitalization and continued postdischarge was effective in reducing smoking behaviors among persons with a mental disorder. Methods: A randomized controlled trial was conducted at an Australian inpatient psychiatric facility. Participants were 205 patient smokers allocated to a treatment as usual control (n = 101) or a smoking cessation intervention (n = 104) incorporating psychosocial and pharmacological support for 4 months postdischarge. Follow-up assessments were conducted at 1 week, 2, 4, and 6 months postdischarge and included abstinence from cigarettes, quit attempts, daily cigarette consumption, and nicotine dependence. Results: Rates of continuous and 7-day point prevalence abstinence did not differ between treatment conditions at the 6-month follow-up; however, point prevalence abstinence was significantly higher for intervention (11.5%) compared with control (2%) participants at 4 months (OR = 6.46, p = .01). Participants in the intervention condition reported significantly more quit attempts (F[1, 202.5] = 15.23, p = .0001), lower daily cigarette consumption (F[4, 586] = 6.5, p < .001), and lower levels of nicotine dependence (F[3, 406] = 8.5, p < .0001) compared with controls at all follow-up assessments. Conclusions: Postdischarge cessation support was effective in encouraging quit attempts and reducing cigarette consumption up to 6 months postdischarge. Additional support strategies are required to facilitate longer-term cessation benefits for smokers with a mental disorder.

DOI 10.1093/ntr/ntu097
Co-authors John Wiggers, Kim Colyvas, Richard Clancy, Jenny Bowman
2013 Stockings E, Bowman J, McElwaine K, Baker A, Terry M, Clancy R, et al., 'Readiness to quit smoking and quit attempts among Australian mental health inpatients.', Nicotine Tob Res, 15 942-949 (2013) [C1]
DOI 10.1093/ntr/nts206
Citations Scopus - 11Web of Science - 7
Co-authors Richard Clancy, Jenny Bowman, John Wiggers
2013 Thornton LK, Baker AL, 'The importance of investigating alcohol use among people with schizophrenia', ACTA PSYCHIATRICA SCANDINAVICA, 128 96-96 (2013) [C3]
DOI 10.1111/acps.12114
2013 Turner A, Hambridge J, Baker A, Bowman J, McElduff P, 'Randomised controlled trial of group cognitive behaviour therapy versus brief intervention for depression in cardiac patients', AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 47 235-243 (2013) [C1]
DOI 10.1177/0004867412460592
Citations Scopus - 2Web of Science - 2
Co-authors Jenny Bowman, Patrick Mcelduff
2013 Hides L, Carroll S, Scott R, Cotton S, Baker A, Lubman DI, 'Quik Fix: A Randomized Controlled Trial of an Enhanced Brief Motivational Interviewing Intervention for Alcohol/Cannabis and Psychological Distress in Young People', PSYCHOTHERAPY AND PSYCHOSOMATICS, 82 122-124 (2013) [C1]
DOI 10.1159/000341921
Citations Scopus - 3Web of Science - 1
2013 Handley TE, Kay-Lambkin FJ, Baker AL, Lewin TJ, Kelly BJ, Inder KJ, et al., 'Incidental treatment effects of CBT on suicidal ideation and hopelessness', JOURNAL OF AFFECTIVE DISORDERS, 151 275-283 (2013) [C1]
DOI 10.1016/j.jad.2013.06.005
Citations Scopus - 1Web of Science - 1
Co-authors John Attia, Terry Lewin, Brian Kelly, F Kaylambkin, Kerry Inder
2013 Connolly JM, Kavanagh DJ, Baker AL, Kay-Lambkin FJ, Lewin TJ, Davis PJ, Quek L-H, 'Craving as a predictor of treatment outcomes in heavy drinkers with comorbid depressed mood', ADDICTIVE BEHAVIORS, 38 1585-1592 (2013) [C1]
DOI 10.1016/j.addbeh.2012.06.003
Citations Scopus - 3Web of Science - 3
Co-authors F Kaylambkin, Terry Lewin
2013 Thornton LK, Baker AL, Johnson MP, Lewin T, 'Perceived risk associated with tobacco, alcohol and cannabis use among people with and without psychotic disorders', ADDICTIVE BEHAVIORS, 38 2246-2251 (2013) [C1]
DOI 10.1016/j.addbeh.2013.02.003
Citations Scopus - 6Web of Science - 6
Co-authors Terry Lewin, Martin Johnson
2013 Baker AL, Kay-Lambkin FJ, Gilligan C, Kavanagh DJ, Baker F, Lewin TJ, 'When does change begin following screening and brief intervention among depressed problem drinkers?', Journal of Substance Abuse Treatment, 44 264-270 (2013) [C1]

Brief interventions are effective for problem drinking and reductions are known to occur in association with screening and assessment. The present study sought to assess, among pa... [more]

Brief interventions are effective for problem drinking and reductions are known to occur in association with screening and assessment. The present study sought to assess, among participants (N= 202) in a clinical trial, how much change occurred between baseline assessment and a one-session brief intervention (S1), and the predictors of early change. The primary focus was on changes in the Beck Depression Inventory Fast Screen scores and alcohol consumption (standard drinks per week) prior to random allocation to nine further sessions addressing either depression, alcohol, or both problems. There were large and clinically significant reductions between baseline and S1, with the strongest predictors being baseline scores in the relevant domain and change in the other domain. Client engagement was also predictive of early depression changes. Monitoring progress in both domains from first contact, and provision of empathic care, followed by brief intervention appear to be useful for this high prevalence comorbidity. © 2013 Elsevier Inc.

DOI 10.1016/j.jsat.2012.07.009
Citations Scopus - 2Web of Science - 2
Co-authors F Kaylambkin, Terry Lewin, Conor Gilligan
2013 McKetin R, Dunlop AJ, Holland RM, Sutherland RA, Baker AL, Salmon AM, Hudson SL, 'Treatment outcomes for methamphetamine users receiving outpatient counselling from the Stimulant Treatment Program in Australia', DRUG AND ALCOHOL REVIEW, 32 80-87 (2013) [C1]
DOI 10.1111/j.1465-3362.2012.00471.x
2013 Baker A, 'Treating Addiction: A Guide for Professionals by AU - William R. Miller , AU - Alyssa A. Forcehimes & AU - Allen Zweben New York', Drug and Alcohol Review, 32 445-446 (2013) [C3]
DOI 10.1111/dar.12013
2013 Allen J, Inder KJ, Lewin TJ, Attia JR, Kay-Lambkin FJ, Baker AL, et al., 'Integrating and extending cohort studies: lessons from the eXtending Treatments, Education and Networks in Depression (xTEND) study', BMC Medical Research Methodology, 13 (2013) [C1]
DOI 10.1186/1471-2288-13-122
Citations Scopus - 1Web of Science - 1
Co-authors Terry Lewin, Brian Kelly, Kerry Inder, John Attia, F Kaylambkin
2013 Kay-Lambkin F, Edwards S, Baker A, Kavanagh D, Kelly B, Bowman J, Lewin T, 'The Impact of Tobacco Smoking on Treatment for Comorbid Depression and Alcohol Misuse', International Journal of Mental Health and Addiction, 11 619-633 (2013) [C1]
DOI 10.1007/s11469-013-9437-2
Co-authors Terry Lewin, F Kaylambkin, Brian Kelly, Jenny Bowman
2013 McKetin R, Lubman DI, Baker AL, Dawe S, Ali RL, 'Dose-Related Psychotic Symptoms in Chronic Methamphetamine Users Evidence From a Prospective Longitudinal Study', JAMA PSYCHIATRY, 70 319-324 (2013) [C1]
DOI 10.1001/jamapsychiatry.2013.283
Citations Scopus - 20Web of Science - 20
2012 Baker AL, Hiles SA, Thornton LK, Hides L, Lubman DI, 'A systematic review of psychological interventions for excessive alcohol consumption among people with psychotic disorders', Acta Psychiatrica Scandinavica, 126 243-255 (2012) [C1]
Citations Scopus - 6Web of Science - 11
2012 Thornton LK, Baker AL, Johnson MP, Lewin TJ, 'Attitudes and perceptions towards substances among people with mental disorders: A systematic review', Acta Psychiatrica Scandinavica, 126 87-105 (2012) [C1]
Citations Scopus - 7Web of Science - 6
Co-authors Terry Lewin, Martin Johnson
2012 Filia SL, Gurvish CT, Baker AL, Kulkarni J, 'Response to Anandarajan et al.: Manic exacerbation induced by nicotine patch', Australian and New Zealand Journal of Psychiatry, 46 484-485 (2012) [C3]
2012 Hiles SA, Baker AL, De Malmanche T, Attia JR, 'Interleukin-6, C-reactive protein and interleukin-10 after antidepressant treatment in people with depression: A meta-analysis', Psychological Medicine, 42 2015-2026 (2012) [C1]
DOI 10.1017/S0033291712000128
Citations Scopus - 26Web of Science - 26
Co-authors John Attia
2012 Mills KL, Teesson M, Back SE, Brady KT, Baker AL, Hopwood S, et al., 'Integrated exposure-based therapy for co-occurring posttraumatic stress disorder and substance dependence: A randomized controlled trial', Jama-Journal of the American Medical Association, 308 690-699 (2012) [C1]
Citations Scopus - 53Web of Science - 49
2012 Nasstasia Y, Baker AL, Callister R, Halpin SA, 'Born to run, workout or maybe try Zumba: Managing depression with exercise', In Psych, 34 18-19 (2012) [C3]
Co-authors Sean Halpin, Robin Callister
2012 Baker AL, Thornton LK, Hiles SA, Hides L, Lubman DI, 'Psychological interventions for alcohol misuse among people with co-occurring depression or anxiety disorders: A systematic review', Journal of Affective Disorders, 139 217-229 (2012) [C1]
Citations Scopus - 20Web of Science - 17
2012 Thornton LK, Baker AL, Lewin TJ, Kay-Lambkin FJ, Kavanagh D, Richmond R, et al., 'Reasons for substance use among people with mental disorders', Addictive Behaviors, 37 427-434 (2012) [C1]
Citations Scopus - 18Web of Science - 13
Co-authors Brian Kelly, F Kaylambkin, Martin Johnson, Terry Lewin
2012 Hiles SA, Baker AL, De Malmanche T, Attia JR, 'A meta-analysis of differences in IL-6 and IL-10 between people with and without depression: Exploring the causes of heterogeneity', Brain, Behavior, and Immunity, 26 1180-1188 (2012) [C1]
Citations Scopus - 48Web of Science - 43
Co-authors John Attia
2012 Thornton LK, Baker AL, Johnson MP, Kay-Lambkin FJ, Lewin TJ, 'Reasons for substance use among people with psychotic disorders: Method triangulation approach', Psychology of Addictive Behaviors, 26 279-288 (2012) [C1]
Citations Scopus - 6Web of Science - 7
Co-authors Martin Johnson, Terry Lewin, F Kaylambkin
2012 Bonevski B, Baker AL, Twyman LH, Paul CL, Bryant JL, 'Addressing smoking and other health risk behaviours using a novel telephone-delivered intervention for homeless people: A proof-of-concept study', Drug and Alcohol Review, 31 709-713 (2012) [C1]
Citations Scopus - 9Web of Science - 7
Co-authors Billie Bonevski, Chris Paul
2012 Kelly PJ, Baker AL, Deane FP, Kay-Lambkin FJ, Bonevski B, Tregarthen J, 'Prevalence of smoking and other health risk factors in people attending residential substance abuse treatment', Drug and Alcohol Review, 31 638-644 (2012) [C1]
Citations Scopus - 4Web of Science - 5
Co-authors Billie Bonevski, F Kaylambkin
2012 Bonevski B, Baker AL, 'Tobacco smoking as a social justice issue: Advances in research', Drug and Alcohol Review, 31 599-601 (2012) [C3]
Citations Scopus - 1
Co-authors Billie Bonevski
2012 Bailey KA, Webster RA, Baker AL, Kavanagh DJ, 'Exposure to dysfunctional parenting and trauma events and posttraumatic stress profiles among a treatment sample with coexisting depression and alcohol use problems', Drug and Alcohol Review, 31 529-537 (2012) [C1]
Citations Scopus - 4Web of Science - 3
2012 Baker AL, Callister R, Kelly PJ, Kypri K, ''Do more, smoke less!' Harm reduction in action for smokers with mental health/substance use problems who cannot or will not quit', Drug and Alcohol Review, 31 714-717 (2012) [C3]
Citations Scopus - 2Web of Science - 2
Co-authors Kypros Kypri, Robin Callister
2012 McKetin R, Najman JM, Baker AL, Lubman DI, Dawe S, Ali R, et al., 'Evaluating the impact of community-based treatment options on methamphetamine use: Findings from the Methamphetamine Treatment Evaluation Study (MATES)', Addiction, 107 1998-2008 (2012) [C1]
Citations Scopus - 14Web of Science - 9
2012 Castle D, Baker AL, Richmond R, Filia SL, Harris D, Pirola-Merlo AJ, 'Varenicline plus healthy lifestyle intervention for smoking cessation in psychotic disorders', Annals of Clinical Psychiatry, 24 285-291 (2012) [C1]
Citations Scopus - 3
2012 Baker AL, Thornton LK, Hides L, Dunlop AJ, 'Treatment of cannabis use among people with psychotic disorders: A critical review of randomised controlled trials', Current Pharmaceutical Design, 18 4923-4937 (2012) [C1]
Citations Scopus - 5Web of Science - 4
2012 Cohen M, Rasser PE, Peck G, Carr VJ, Ward PB, Thompson PM, et al., 'Cerebellar grey-matter deficits, cannabis use and first-episode schizophrenia in adolescents and young adults', International Journal of Neuropsychopharmacology, 15 297-307 (2012) [C1]
Citations Scopus - 11Web of Science - 9
Co-authors Ulrich Schall
2012 Kay-Lambkin FJ, Baker AL, Healey A, Wolfe S, Simpson A, Brooks M, et al., 'Study protocol: A dissemination trial of computerized psychological treatment for depression and alcohol/other drug use comorbidity in an Australian clinical service', BMC Psychiatry, 12 77 (2012) [C3]
Citations Scopus - 2
Co-authors Jenny Bowman, F Kaylambkin
2012 Kelly PJ, Kay-Lambkin FJ, Baker AL, Deane FP, Brooks AC, Mitchell A, et al., 'Study protocol: A randomized controlled trial of a computer-based depression and substance abuse intervention for people attending residential substance abuse treatment', BMC Public Health, 12 113 (2012) [C3]
Citations Scopus - 2Web of Science - 2
Co-authors F Kaylambkin
2012 Kay-Lambkin FJ, Baker AL, Kelly BJ, Lewin TJ, 'It's worth a try: The treatment experiences of rural and urban participants in a randomized controlled trial of computerized psychological treatment for comorbid depression and alcohol/other drug use', Journal of Dual Diagnosis, 8 262-276 (2012) [C1]
Citations Scopus - 8Web of Science - 6
Co-authors Brian Kelly, Terry Lewin, F Kaylambkin
2012 Filia SL, Baker AL, Kulkarni J, Williams JM, 'Sequential behavioral treatment of smoking and weight control in bipolar disorder', Translational Behavioral Medicine, 2 290-295 (2012) [C3]
Citations Scopus - 2Web of Science - 2
2012 Deady M, Kay-Lambkin F, Thornton LK, Baker AL, Teesson M, 'Social influence, addictions and the internet: the potential of web 2.0 technologies in enhancing treatment for alcohol/other drug use problems', Journal of Addiction Research & Therapy, S8 1-7 (2012) [C2]
DOI 10.4172/2155-6105.S8-002
2011 Kay-Lambkin FJ, White A, Baker AL, Kavanagh DJ, Klein B, Proudfoot J, et al., 'Assessment of function and clinical utility of alcohol and other drug web sites: An observational, qualitative study', BMC Public Health, 11 277 (2011) [C1]
Citations Scopus - 3Web of Science - 2
Co-authors F Kaylambkin
2011 Baker AL, Kay-Lambkin FJ, Richmond R, Filia S, Castle D, Williams J, Lewin TJ, 'Study protocol: A randomised controlled trial investigating the effect of a healthy lifestyle intervention for people with severe mental disorders', BMC Public Health, 11 10 (2011) [C3]
Citations Scopus - 11Web of Science - 14
Co-authors F Kaylambkin, Terry Lewin
2011 Stockings EA, Bowman JA, Wiggers JH, Baker AL, Terry M, Clancy R, et al., 'A randomised controlled trial linking mental health inpatients to community smoking cessation supports: A study protocol', BMC Public Health, 11 570 (2011) [C3]
DOI 10.1186/1471-2458-11-570
Citations Scopus - 5Web of Science - 5
Co-authors John Wiggers, Jenny Bowman, Richard Clancy
2011 Farrugia PL, Mills KL, Barrett E, Back SE, Teesson M, Baker AL, et al., 'Childhood trauma among individuals with co-morbid substance use and post-traumatic stress disorder', Mental Health and Substance Use, 4 314-326 (2011) [C1]
Citations Scopus - 9
2011 Thornton LK, Baker AL, Johnson MP, Kay-Lambkin FJ, 'Perceptions of anti-smoking public health campaigns among people with psychotic disorders', Mental Health and Substance Use: Dual Diagnosis, 4 110-115 (2011) [C1]
DOI 10.1080/17523281.2011.555066
Citations Scopus - 10
Co-authors Martin Johnson, F Kaylambkin
2011 Filia SL, Baker AL, Richmond R, Castle DJ, Kay-Lambkin FJ, Sakrouge RE, et al., 'Health behaviour risk factors for coronary heart disease (CHD) in smokers with a psychotic disorder: Baseline results', Mental Health and Substance Use: Dual Diagnosis, 4 158-171 (2011) [C1]
DOI 10.1080/17523281.2011.555088
Citations Scopus - 8
Co-authors F Kaylambkin
2011 Baker AL, Kay-Lambkin FJ, Richmond R, Filia S, Castle D, Williams J, Thornton LK, 'Healthy lifestyle intervention for people with severe mental disorders', Mental Health and Substance Use: Dual Diagnosis, 4 144-157 (2011) [C1]
DOI 10.1080/17523281.2011.555086
Citations Scopus - 6
Co-authors F Kaylambkin
2011 Baker AL, McNeill A, 'Beyond the smokescreen: Reducing smoking among people with mental health problems', Mental Health and Substance Use: Dual Diagnosis, 4 93-95 (2011) [C3]
DOI 10.1080/17523281.2011.555063
2011 Kay-Lambkin FJ, Baker AL, Kelly BJ, Lewin TJ, 'Clinician-assisted computerised versus therapist-delivered treatment for depressive and addictive disorders: A randomised controlled trial', Medical Journal of Australia, 195 S44-S50 (2011) [C1]
Citations Scopus - 39Web of Science - 30
Co-authors F Kaylambkin, Brian Kelly, Terry Lewin
2011 Kay-Lambkin FJ, Baker AL, Lee NM, Jenner L, Lewin TJ, 'The influence of depression on treatment for methamphetamine use', Medical Journal of Australia, 195 S38-S43 (2011) [C1]
Citations Scopus - 2Web of Science - 2
Co-authors F Kaylambkin, Terry Lewin
2011 De Ville M, Baker AL, Lewin TJ, Bucci S, Loughland CM, 'Associations between substance use, neuropsychological functioning and treatment response in psychosis', Psychiatry Research, 186 190-196 (2011) [C1]
DOI 10.1016/j.psychres.2010.08.025
Citations Scopus - 1Web of Science - 1
Co-authors Carmel Loughland, Terry Lewin
2011 Lee N, Jenner L, Baker AL, Ritter A, Hides L, Norman J, et al., 'Screening and intervention for mental health problems in alcohol and other drug settings: Can training change practitioner behaviour?', Drugs: Education, Prevention and Policy, 18 157-160 (2011) [C1]
DOI 10.3109/09687631003727847
Citations Scopus - 5Web of Science - 2
Co-authors F Kaylambkin
2011 Barrowclough C, Baker AL, Lewin TJ, 'Psychosis and comorbid substance misuse: Integrated motivational interviewing and cognitive behavioural therapy reduces alcohol intake', Evidence-Based Mental Health, 14 51 (2011) [C3]
Co-authors Terry Lewin
2011 Kay-Lambkin F, Baker AL, Lewin TJ, Carr V, 'Acceptability of a clinician-assisted computerized psychological intervention for comorbid mental health and substance use problems: Treatment adherence data from a randomized controlled trial', Journal of Medical Internet Research, 13 254-264 (2011) [C1]
Citations Scopus - 10Web of Science - 7
Co-authors F Kaylambkin, Terry Lewin
2011 Hides L, Baker AL, Kavanagh D, Proctor D, 'Psychological interventions for co-occurring depression and substance misuse', Cochrane Database of Systematic Reviews, 12 CD009501 (2011) [C1]
DOI 10.1002/14651858.CD009501
2010 Conrad A, Lewin TJ, Carr VJ, Baker AL, Terry MA, Taylor A, 'Pathways to care and community-based service contact patterns among clients with a dual diagnosis', Mental Health and Substance Use: Dual Diagnosis, 3 10-24 (2010) [C1]
DOI 10.1080/17523280903523488
Citations Scopus - 2
Co-authors Terry Lewin
2010 Bucci S, Baker AL, Halpin SA, Hides L, Lewin TJ, Carr VJ, Startup MJ, 'Intervention for cannabis use in young people at ultra high risk for psychosis and in early psychosis', Mental Health and Substance Use: Dual Diagnosis, 3 66-73 (2010) [C1]
DOI 10.1080/17523280903523983
Citations Scopus - 4
Co-authors Terry Lewin, Sean Halpin
2010 Staiger PK, Long C, Baker AL, 'Health service systems and comorbidity: Stepping up to the mark', Mental Health and Substance Use: Dual Diagnosis, 3 148-161 (2010) [C1]
DOI 10.1080/17523281003733514
Citations Scopus - 7
2010 Baker AL, Richmond R, Lewin TJ, Kay-Lambkin FJ, 'Cigarette smoking and psychosis: Naturalistic follow up 4 years after an intervention trial', Australian and New Zealand Journal of Psychiatry, 44 342-350 (2010) [C1]
DOI 10.3109/00048670903489841
Citations Scopus - 9Web of Science - 8
Co-authors F Kaylambkin, Terry Lewin
2010 Turner A, Phillips L, Hambridge JA, Baker AL, Bowman JA, Colyvas KJ, 'Clinical outcomes associated with depression, anxiety and social support among cardiac rehabilitation attendees', Australian and New Zealand Journal of Psychiatry, 44 658-666 (2010) [C1]
DOI 10.3109/00048671003646751
Citations Scopus - 15Web of Science - 14
Co-authors Kim Colyvas, Jenny Bowman
2010 Baker AL, Hides L, Lubman DI, 'Treatment of cannabis use among people with psychotic or depressive disorders: A systematic review', Journal of Clinical Psychiatry, 71 247-254 (2010) [C1]
DOI 10.4088/JCP.09r05119gry
Citations Scopus - 30Web of Science - 27
2010 Hides L, Carroll S, Catania L, Cotton SM, Baker AL, Scaffidi A, Lubman DI, 'Outcomes of an integrated cognitive behaviour therapy (CBT) treatment program for co-occurring depression and substance misuse in young people', Journal of Affective Disorders, 121 169-174 (2010) [C1]
DOI 10.1016/j.jad.2009.06.002
Citations Scopus - 19Web of Science - 15
2010 Lubman DI, Baker AL, 'Cannabis and mental health: Management in primary care', Australian Family Physician, 39 554-557 (2010) [C1]
Citations Scopus - 1Web of Science - 1
2010 Adamson SJ, Kay-Lambkin FJ, Baker AL, Lewin TJ, Thornton LK, Kelly BJ, Sellman JD, 'An improved brief measure of cannabis misuse: The Cannabis Use Disorders Identification Test-Revised (CUDIT-R)', Drug and Alcohol Dependence, 110 137-143 (2010) [C1]
DOI 10.1016/j.drugalcdep.2010.02.017
Citations Scopus - 30Web of Science - 28
Co-authors Terry Lewin, Brian Kelly, F Kaylambkin
2010 Lee NK, Pohlman S, Baker AL, Femis J, Kay-Lambkin FJ, 'It's the thought that counts: Craving metacognitions and their role in abstinence from methamphetamine use', Journal of Substance Abuse Treatment, 38 245-250 (2010) [C1]
DOI 10.1016/j.jsat.2009.12.006
Citations Scopus - 5Web of Science - 4
Co-authors F Kaylambkin
2010 Bailey K, Webster R, Baker A, Kavanagh D, 'TRAUMA EVENTS AND PSYCHOLOGICAL SEQUALAE', DRUG AND ALCOHOL REVIEW, 29 3-3 (2010) [E3]
2010 Hides L, Carroll S, Scaffidi A, Scott R, Baker A, Lubman DI, 'STEPPED CARE FOR YOUNG PEOPLE WITH CO-EXISTING DEPRESSION AND SUBSTANCE USE', DRUG AND ALCOHOL REVIEW, 29 5-5 (2010)
2010 Mills KL, Teesson M, Barrett EL, Merz S, Rosenfeld J, Farrugia P, et al., 'FEASIBILITY OF STEPPED CARE FOR POSTTRAUMATIC STRESS DISORDER AND SUBSTANCE USE DISORDER', DRUG AND ALCOHOL REVIEW, 29 5-5 (2010)
2010 White A, Kavanagh DJ, Stallman HM, Klein B, Kay-Lambkin F, Proudfoot J, et al., 'ONLINE ALCOHOL INTERVENTIONS: A SYSTEMATIC REVIEW', DRUG AND ALCOHOL REVIEW, 29 13-13 (2010)
Co-authors F Kaylambkin
2010 Kay-Lambkin F, White A, Baker A, Kavanagh DJ, Klein B, Proudfoot J, et al., 'ASSESSMENT OF FUNCTION AND CLINICAL UTILITY OF ALCOHOL AND OTHER DRUG WEB SITES: AN OBSERVATIONAL, QUALITATIVE STUDY', DRUG AND ALCOHOL REVIEW, 29 13-14 (2010)
Co-authors F Kaylambkin
2010 Thornton L, Baker A, Johnson M, 'PERCEPTIONS OF PUBLIC HEALTH CAMPAIGNS AND KNOWLEDGE REGARDING TOBACCO, ALCOHOL AND CANNABIS AMONG PEOPLE WITH PSYCHOTIC DISORDERS: A MIXED METHOD EXPLORATION', DRUG AND ALCOHOL REVIEW, 29 77-77 (2010)
2010 Baker AL, 'New methodological directions for psychological intervention research among substance users', Drug and Alcohol Review, 29 467-468 (2010) [C3]
DOI 10.1111/j.1465-3362.2010.00230.x
Citations Scopus - 1
2010 Kay-Lambkin FJ, Baker AL, McKetin R, Lee N, 'Stepping through treatment: Reflections on an adaptive treatment strategy among methamphetamine users with depression', Drug and Alcohol Review, 29 475-482 (2010) [C1]
DOI 10.1111/j.1465-3362.2010.00203.x
Citations Scopus - 7Web of Science - 6
Co-authors F Kaylambkin
2010 Baker AL, Kavanagh DJ, Kay-Lambkin FJ, Hunt SA, Lewin TJ, Carr VJ, Connolly J, 'Randomized controlled trial of cognitive-behavioural therapy for coexisting depression and alcohol problems: Short-term outcome', Addiction, 105 87-99 (2010) [C1]
DOI 10.1111/j.1360-0443.2009.02757.x
Citations Scopus - 50Web of Science - 38
Co-authors Terry Lewin, F Kaylambkin
2010 Baker AL, Lubman DI, Hides L, 'Smoking and schizophrenia: Treatment approaches within primary care', Primary Psychiatry, 17 49-54 (2010) [C1]
Citations Scopus - 6
2010 Wye PM, Bowman JA, Wiggers JH, Baker AL, Carr VJ, Terry MA, et al., 'An audit of the prevalence of recorded nicotine dependence treatment in an Australian psychiatric hospital', Australian and New Zealand Journal of Public Health, 34 298-303 (2010) [C1]
DOI 10.1111/j.1753-6405.2010.00530.x
Citations Scopus - 15Web of Science - 10
Co-authors Jenny Bowman, Richard Clancy, John Wiggers
2010 Wye P, Bowman JA, Wiggers J, Baker AL, Carr V, Terry M, et al., 'Providing nicotine dependence treatment to psychiatric inpatients: the views of Australian nurse managers', Journal of Psychiatric and Mental Health Nursing, 17 319-327 (2010) [C1]
DOI 10.1111/j.1365-2850.2009.01524.x
Citations Scopus - 12Web of Science - 8
Co-authors Richard Clancy, John Wiggers, Jenny Bowman
2010 Klein B, White A, Kavanagh D, Shandley K, Kay-Lambkin FJ, Proudfoot J, et al., 'Content and functionality of alcohol and other drug websites: Results of an online survey', Journal of Medical Internet Research, 12 e51 (2010) [C1]
DOI 10.2196/jmir.1449
Citations Scopus - 11Web of Science - 7
Co-authors F Kaylambkin
2010 White A, Kavanagh D, Stallman H, Klein B, Kay-Lambkin FJ, Proudfoot J, et al., 'Online alcohol Interventions: A systematic review', Journal of Medical Internet Research, 12 1-9 (2010) [C1]
DOI 10.2196/jmir.1479
Citations Scopus - 91Web of Science - 69
Co-authors F Kaylambkin
2010 Wye PM, Bowman JA, Wiggers JH, Baker AL, Knight JJ, Carr V, et al., 'Total smoking bans in psychiatric inpatient services: a survey of perceived benefits, barriers and support among staff', BMC Public Health, 10 372-383 (2010) [C1]
DOI 10.1186/1471-2458-10-372
Citations Scopus - 20Web of Science - 13
Co-authors John Wiggers, Richard Clancy, Jenny Bowman
2009 Johns K, Baker AL, Webster RA, Lewin TJ, 'Factors associated with retention in a long-term residential rehabilitation programme for women with substance use problems', Mental Health and Substance Use: Dual Diagnosis, 2 40-51 (2009) [C1]
DOI 10.1080/17523280802593285
Citations Scopus - 4
Co-authors Terry Lewin
2009 Baker AL, Kay-Lambkin FJ, Lee N, 'When less is more: Addressing symptoms of mental health problems in drug and alcohol treatment settings', Mental Health and Substance Use: Dual Diagnosis, 2 130-139 (2009) [C1]
DOI 10.1080/17523280902930106
Citations Scopus - 3
Co-authors F Kaylambkin
2009 Baker AL, Velleman R, 'Helping non-specialist professionals to detect and assist with co-existing mental health and drug and alcohol problems', Mental Health and Substance Use: Dual Diagnosis, 2 173-181 (2009) [C1]
DOI 10.1080/17523280903200194
Citations Scopus - 3
2009 Baker AL, Richmond R, Castle D, Kulkarni J, Kay-Lambkin FJ, Sakrouge RE, et al., 'Coronary heart disease risk reduction intervention among overweight smokers with a psychotic disorder: Pilot trial', Australian and New Zealand Journal of Psychiatry, 43 129-135 (2009) [C1]
DOI 10.1080/00048670802607147
Citations Scopus - 22Web of Science - 18
Co-authors F Kaylambkin, Terry Lewin
2009 Hambridge JA, Turner A, Baker AL, 'BraveHeart begins: Pilot results of group cognitive behaviour therapy for depression and anxiety in cardiac patients', Australian and New Zealand Journal of Psychiatry, 43 1171-1177 (2009) [C1]
DOI 10.3109/00048670903270415
Citations Scopus - 8Web of Science - 9
2009 Hunt SA, Baker AL, Michie PT, Kavanagh DJ, 'Neurocognitive profiles of people with comorbid depression and alcohol use: Implications for psychological interventions', Addictive Behaviors, 34 878-886 (2009) [C1]
DOI 10.1016/j.addbeh.2009.03.036
Citations Scopus - 12Web of Science - 10
Co-authors Pat Michie
2009 Baker AL, Turner A, Kay-Lambkin FJ, Lewin TJ, 'The long and the short of treatments for alcohol or cannabis misuse among people with severe mental disorders', Addictive Behaviors, 34 852-858 (2009) [C1]
DOI 10.1016/j.addbeh.2009.02.002
Citations Scopus - 16Web of Science - 17
Co-authors Terry Lewin, F Kaylambkin
2009 Baker AL, 'New directions for research on psychological interventions for drug and alcohol problems', Drug and Alcohol Review, 28 219-221 (2009) [C3]
DOI 10.1111/j.1465-3362.2009.00069.x
2009 Baker AL, 'Motivational interviewing in the treatment of psychological problems', Drug and Alcohol Review, 28 696 (2009) [C3]
2009 Kay-Lambkin FJ, Baker AL, Lewin TJ, Carr VJ, 'Computer-based psychological treatment for comorbid depression and problematic alcohol and/or cannabis use: A randomized controlled trial of clinical efficacy', Addiction, 104 378-388 (2009) [C1]
DOI 10.1111/j.1360-0443.2008.02444.x
Citations Scopus - 98Web of Science - 79
Co-authors F Kaylambkin, Terry Lewin
2009 Wye PM, Bowman JA, Wiggers JH, Baker AL, Knight JJ, Carr VJ, et al., 'Smoking restrictions and treatment for smoking: Policies and procedures in psychiatric inpatient units in Australia', Psychiatric Services, 60 100-107 (2009) [C1]
DOI 10.1176/appi.ps.60.1.100
Citations Scopus - 23Web of Science - 20
Co-authors Richard Clancy, John Wiggers, Jenny Bowman
2008 Degenhardt L, Baker AL, Maher L, 'Methamphetamine: Geographic areas and populations at risk, and emerging evidence for effective interventions', Drug and Alcohol Review, 27 217-219 (2008) [C3]
DOI 10.1080/09595230801956538
2008 Spain D, Crilly J, Whyte IM, Jenner L, Carr VJ, Baker AL, 'Safety and effectiveness of high-dose midazolam for severe behavioural disturbance in an emergency department with suspected psychostimulant-affected patients', Emergency Medicine Australasia: EMA, 20 112-120 (2008) [C1]
DOI 10.1111/j.1742-6723.2008.01066.x
Citations Scopus - 11Web of Science - 6
2008 Velleman R, Baker AL, 'Moving away from medicalised and partisan terminology: A contribution to the debate', Mental Health and Substance Use, 1 2-9 (2008) [C1]
DOI 10.1080/17523280701712366
2008 Bucci SR, Startup MJ, Wynn PL, Heathcote AJ, Baker AL, Lewin TJ, 'Referential delusions of communication and reality discrimination deficits in psychosis', British Journal of Clinical Psychology, 47 323-334 (2008) [C1]
DOI 10.1348/014466508x280952
Citations Scopus - 4Web of Science - 3
Co-authors Andrew Heathcote, Terry Lewin
2008 Bucci SR, Startup MJ, Wynn PL, Baker AL, Lewin TJ, 'Referential delusions of communication and interpretations of gestures', Psychiatry Research, 158 27-34 (2008) [C1]
DOI 10.1016/j.psychres.2007.07.004
Citations Scopus - 7Web of Science - 7
Co-authors Terry Lewin
2008 McKetin R, Ross J, Kelly E, Baker AL, Lee N, Lubman DI, Mattick R, 'Characteristics and harms associated with injecting versus smoking methamphetamine among methamphetamine treatment entrants', Drug and Alcohol Review, 27 277-285 (2008) [C1]
DOI 10.1080/09595230801919486
Citations Scopus - 25Web of Science - 22
2007 Baker AL, 'Medication treatments for nicotine dependence', Drug and Alcohol Review, 26 455-456 (2007) [C3]
DOI 10.1080/09595230701373958
2007 Baker AL, Lewin TJ, 'Readiness to quit and smoking reduction outcomes - Drs Baker and Lewin reply', American Journal of Psychiatry, 164 828 (2007) [C3]
2007 Bradley AC, Baker AL, Lewin TJ, 'Group intervention for coexisting psychosis and substance use disorders in rural Australia: Outcomes over 3 years', Australian and New Zealand Journal of Psychiatry, 41 501-508 (2007) [C1]
DOI 10.1080/00048670701332300
Citations Scopus - 14Web of Science - 10
Co-authors Terry Lewin
2007 Baker AL, Richmond R, Haile M, Lewin TJ, Carr VJ, Taylor RL, et al., 'Characteristics of smokers with a psychotic disorder and implications for smoking interventions', Psychiatry Research, 150 141-152 (2007) [C1]
DOI 10.1016/j.psychres.2006.05.021
Citations Scopus - 42Web of Science - 35
Co-authors Terry Lewin
2006 Turner A, Hambridge J, Baker A, Grace C, Kay-Lambkin F, Bowman J, 'BraveHeart: a new development in cognitive behaviour therapy for co-existing depression and coronary heart disease', JOURNAL OF AFFECTIVE DISORDERS, 91 S27-S27 (2006)
Co-authors Jenny Bowman, F Kaylambkin
2006 Baker A, 'Talking with college students about alcohol', DRUG AND ALCOHOL REVIEW, 25 651-651 (2006)
DOI 10.1080/09595230600972868
2006 Baker AL, Ivers RG, Bowman JA, Butler T, Kay-Lambkin FJ, Wye PM, et al., 'Where there's smoke, there's fire: high prevalence of smoking among some sub-populations and recommendations for intervention', Drug and Alcohol Review, 25 85-96 (2006) [C1]
DOI 10.1080/09595230500459552
Citations Scopus - 69Web of Science - 61
Co-authors Jenny Bowman, F Kaylambkin
2006 Greig RL, Baker AL, Lewin TJ, Webster RA, Carr VJ, 'Long-term follow-up of people with co-existing psychiatric and substance use disorders: patterns of use and outcomes', Drug and Alcohol Review, 25 249-258 (2006) [C1]
DOI 10.1080/09595230600657741
Citations Scopus - 10Web of Science - 7
Co-authors Terry Lewin
2006 Baker AL, 'Talking with college students about alcohol (Book review)', Drug and Alcohol Review, 25 651 (2006) [C3]
2006 Bucci S, Baker A, Kay-Lambkin F, Lewin T, Carr V, 'A randomized controlled trial of cognitive-behaviour therapy among people with a psychotic illness and coexisting alcohol and other drug problems', ACTA PSYCHIATRICA SCANDINAVICA, 114 57-57 (2006)
Co-authors F Kaylambkin, Terry Lewin
2006 Baker AL, Richmond R, Haile MJ, Lewin TJ, Carr VJ, Taylor RL, et al., 'A randomized controlled trial of a smoking cessation intervention among people with a psychotic disorder', American Journal of Psychiatry, 163 1934-1942 (2006) [C1]
DOI 10.1176/appi.ajp.163.11.1934
Citations Scopus - 114Web of Science - 102
Co-authors Terry Lewin
2006 Baker AL, Bucci SR, Lewin TJ, Kay-Lambkin FJ, Constable PM, Carr VJ, 'Cognitive-behavioural therapy for substance use disorders in people with psychotic disorders - Randomised controlled trial', British Journal of Psychiatry, 188 439-448 (2006) [C1]
DOI 10.1192/bjp.188.5.439
Citations Scopus - 83Web of Science - 67
Co-authors Terry Lewin, F Kaylambkin
2005 Kelly B, Underwood L, Baker A, 'Computerised cognitive behavioural therapy for coexisting depression and alcohol/other drug use problems: A rural and remote perspective', AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 39 A99-A100 (2005)
Co-authors Brian Kelly
2005 Underwood L, Kelly B, Baker A, 'Treating co-morbid diabetes type II and depression: The development of a computer assisted cognitive behavioural intervention "made it"', AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 39 A100-A100 (2005)
Co-authors Brian Kelly
2005 Baker AL, Dawe S, 'Amphetamine use and co-occurring psychological problems: Review of the literature and implications for treatment', Australian Psychologist, 40 88-95 (2005) [C1]
DOI 10.1080/00050060500094654
Citations Scopus - 23Web of Science - 17
2005 Baker AL, Bucci SR, Lewin TJ, Richmond R, Carr VJ, 'Comparisons between psychosis samples with different patterns of substance use recruited for clinical and epidemiological studies', Psychiatry Research, 134 241-250 (2005) [C1]
DOI 10.1016/j.psychres.2005.02.006
Citations Scopus - 16Web of Science - 16
Co-authors Terry Lewin
2005 Baker AL, 'Cognitive-behavioural integrated treatment (C-BIT): A treatment manual for substance misuse in people with severe mental health problems (book review)', Drug and Alcohol Review, 24 200-201 (2005) [C3]
2004 Baker A, 'Treating alcohol dependence, 2nd edition', DRUG AND ALCOHOL REVIEW, 23 127-128 (2004)
DOI 10.1080/09595230410001645628
2004 Baker A, 'Motivational interviewing: Preparing people for change, 2nd edition', DRUG AND ALCOHOL REVIEW, 23 127-128 (2004)
DOI 10.1080/09595230410001645628
2004 Bailey KA, Baker AL, Webster RA, Lewin TJ, 'Pilot randomized controlled trial of a brief alcohol intervention group for adolescents', Drug and Alcohol Review, 23 157-166 (2004) [C1]
DOI 10.1080/09595230410001704136
Citations Scopus - 33Web of Science - 31
Co-authors Terry Lewin
2004 Kay-Lambkin FJ, Baker AL, Lewin TJ, 'The 'co-morbidity roundabout': a framework to guide assessment and intervention strategies and engineer change among people with co-morbid problems', Drug and Alcohol Review, 23 407-423 (2004) [C1]
DOI 10.1080/09595230412331324536
Citations Scopus - 35Web of Science - 29
Co-authors F Kaylambkin, Terry Lewin
2004 Kavanagh DJ, Baker AL, Teesson M, 'Special Section- Co-morbidity of mental disorders and substance misuse. Introduction', Drug and Alcohol Review, 23 405-406 (2004) [C3]
Citations Web of Science - 6
2004 Baker AL, Lee NK, Claire MR, Lewin TJ, Grant T, Pohlman S, et al., 'Drug use patterns and mental health of regular ampthetamine users during a reported 'heroin drought'', Addiction, 99 875-884 (2004) [C1]
DOI 10.1111/j.1360-0443.2004.00741.x
Citations Scopus - 26Web of Science - 22
Co-authors F Kaylambkin, Terry Lewin
2003 Baker AL, Lee NK, 'A review of psychosocial interventions for amphetamine use', Drug and Alcohol Review, 22 323-335 (2003) [C1]
DOI 10.1080/0959523031000154472
Citations Scopus - 15Web of Science - 13
2003 Claire M, Baker A, Lee N, Pohlman S, Saunders J, Lewin T, et al., 'Nonpharmacological interventions for psychostimulant use', AUSTRALIAN JOURNAL OF PSYCHOLOGY, 55 101-101 (2003)
Co-authors Terry Lewin, F Kaylambkin
2003 Claire M, Baker A, Lewin T, Lee N, Grant T, Pohlman S, 'Cognitive behaviour therapy, aggression and psychostimulant use', AUSTRALIAN JOURNAL OF PSYCHOLOGY, 55 101-101 (2003)
Co-authors Terry Lewin
2003 Haile M, Baker A, Richmond R, Carr V, Lewin T, Wilhelm K, et al., 'A randomised controlled trial of an intervention for tobacco dependence among people with a psychotic illness', AUSTRALIAN JOURNAL OF PSYCHOLOGY, 55 102-103 (2003)
Co-authors F Kaylambkin, Terry Lewin
2003 Kay-Lambkin F, Baker A, Bucci S, Lewin T, Rajkumar S, Carr V, 'Computer-based therapy for depression and alcohol/other drug (AOD) problems', AUSTRALIAN JOURNAL OF PSYCHOLOGY, 55 104-104 (2003)
Co-authors Terry Lewin, F Kaylambkin
2003 Bucci SR, Baker AL, Kay-Lambkin FJ, Lewin (Ext) T, Carr VJ, Constable PM, 'Randomised controlled trial of cognitive behavioural therapy for comorbid psychotic illness and alcohol and other drug problems', Australian Journal of Psychology, 55 100 (2003) [C3]
Co-authors F Kaylambkin, Terry Lewin
2003 Baker A, 'Drug use and drug-related harm: A delicate balance', DRUG AND ALCOHOL REVIEW, 22 238-239 (2003)
DOI 10.1080/095952301001006705
2003 Baker A, 'Addictions', DRUG AND ALCOHOL REVIEW, 22 376-376 (2003)
DOI 10.1080/0959523031000154544
2003 Baker A, 'International handbook of alcohol dependence and problems', DRUG AND ALCOHOL REVIEW, 22 477-477 (2003)
DOI 10.1080/09595230310001614038
2002 Baker A, Hambridge J, 'Motivational interviewing: Enhancing engagement in treatment for mental health problems', BEHAVIOUR CHANGE, 19 138-145 (2002)
DOI 10.1375/bech.19.3.138
Citations Scopus - 5Web of Science - 2
2002 Baker AL, Roche A, 'From training to work-force development: a large and important conceptual leap', Drug and Alcohol Review, 21 205-207 (2002) [C3]
Citations Scopus - 5Web of Science - 3
2002 Baker AL, Lewin TJ, Reichler HM, Clancy R, Carr VJ, Garrett R, et al., 'Evaluation of a motivational interview for substance use within psychiatric in-patient services', Addiction, 97(10) 1329-1337 (2002) [C1]
Citations Scopus - 71Web of Science - 49
Co-authors Terry Lewin, Richard Clancy
2002 Baker AL, Lewin TJ, Reichler HM, Clancy R, Carr VJ, Garrett R, et al., 'Motivational interviewing among psychiatric in-patients with substance use disorders', ACTA Psychiatrica Scandinavica, 106 233-240 (2002) [C1]
Citations Scopus - 66Web of Science - 46
Co-authors Richard Clancy, Terry Lewin
2001 Baker A, 'Counselling for alcohol problems', DRUG AND ALCOHOL REVIEW, 20 462-463 (2001)
2001 Reichler HM, Baker AL, Lewin T, Carr VJ, 'Smoking among in-patients with drug-related problems in an Australian psychiatric hospital', Drug and Alcohol Review, 20 231-237 (2001) [C1]
Citations Scopus - 26Web of Science - 24
Co-authors Terry Lewin
2001 Baker AL, Boggs TG, Lewin TJ, 'Characteristics of regular amphetamine users and implications for treatment', Drug and Alcohol Review, 20 49-56 (2001) [C1]
Citations Scopus - 18Web of Science - 16
Co-authors Terry Lewin
2001 Baker AL, Heather N, Wodak A, Lewin TJ, 'Heroin use and HIV risk-taking behaviour among women injecting drug users', Drug and Alcohol Review, 20 205-211 (2001) [C1]
Citations Scopus - 7Web of Science - 10
Co-authors Terry Lewin
2001 Baker AL, Boggs TG, Lewin TJ, 'Randomized controlled trial of brief cognitive-behavioural interventions among regular users of amphetamine', Addiction, 96 1279-1287 (2001) [C1]
Citations Scopus - 55Web of Science - 48
Co-authors Terry Lewin
2001 Hambridge J, Baker AL, 'Medical Psychology in Australia', Jourjnal of Clinical Psychology in Medical Settings, 8 3-7 (2001) [C1]
Citations Scopus - 3Web of Science - 2
1996 O'Neill K, Baker A, Cooke M, Collins E, Heather N, Wodak A, 'Evaluation of a cognitive-behavioural intervention for pregnant injecting drug users at risk of HIV infection', Addiction, 91 1115-1125 (1996)

Pregnant injecting drug users were randomly assigned to: (i) individually receive a six-session cognitive-behavioural intervention in addition to their usual methadone maintenance... [more]

Pregnant injecting drug users were randomly assigned to: (i) individually receive a six-session cognitive-behavioural intervention in addition to their usual methadone maintenance treatment (intervention condition (I) (n = 40)); or (ii) their usual methadone maintenance treatment only (control condition (C) (n = 40)). There was no change in drug use per se in either group after the intervention. However, at 9-month follow-up the I group had significantly reduced some HIV risk-taking behaviours (in particular injecting risk behaviours). The I group reduced the needle risk associated both with 'typical' use (drug use in the month before interview) and 'binge' use (drug use in the month nominated as the heaviest month of drug use in the previous 6 months). The intervention had no effect on sexual risk behaviours. The finding of reduced injecting risk behaviour following the six-session intervention suggests that such an intervention may be of benefit for individuals persisting with injecting risk behaviours despite methadone maintenance treatment and the availability of sterile injection equipment.

DOI 10.1080/09652149639682
Citations Scopus - 27
Show 180 more journal articles

Review (2 outputs)

Year Citation Altmetrics Link
2013 Kay-Lambkin F, Baker A, 'Substance Use and Mood Disorders (2013) [D1]
DOI 10.1016/B978-0-12-398336-7.00052-8
Co-authors F Kaylambkin
2004 Baker AL, 'Tale of two classics', Drug and Alcohol Review (2004) [D2]

Conference (119 outputs)

Year Citation Altmetrics Link
2014 Cementon E, Baker A, Kirby D, 'SMOKING CESSATION IN CLINICAL PRACTICE', AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY (2014) [E3]
2014 Baker A, 'PSYCHOSOCIAL COMPONENTS OF SMOKING INTERVENTIONS FOR PEOPLE WITH MENTAL ILLNESS AND/OR ALCOHOL AND OTHER DRUG PROBLEMS', AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY (2014) [E3]
2014 Baker A, Cementon E, 'EVIDENCE - BASED INTERVENTIONS FOR COMORBIDITY: SUBSTANCE USE, MENTAL HEALTH AND PHYSICAL HEALTH', AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY (2014) [E3]
2014 Baker A, 'HEALTHY LIFESTYLE INTERVENTIONS AMONG PEOPLE WITH PSYCHOTIC ILLNESS', AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY (2014) [E3]
2014 Kelly PJ, Blatch C, Deane FP, Baker AL, 'SMART RECOVERY: NEW RESEARCH DIRECTIONS', DRUG AND ALCOHOL REVIEW (2014) [E3]
2014 McCarter K, Baker AL, Britton B, Beck A, Carter G, Bauer J, et al., 'PREVALENCE OF ALCOHOL USE AND DEPRESSIVE SYMPTOMS IN A SAMPLE OF HEAD AND NECK CANCER PATIENTS ABOUT TO UNDERGO RADIOTHERAPY', DRUG AND ALCOHOL REVIEW (2014) [E3]
Co-authors Gregory Carter, Patrick Mcelduff, Sean Halpin, Luke Wolfenden
2014 Stockings EA, Bowman JA, Baker AL, Terry M, Clancy R, Wye PM, et al., 'IMPACT OF A POST-DISCHARGE SMOKING CESSATION INTERVENTION FOR SMOKERS ADMITTED TO A SMOKE-FREE PSYCHIATRIC HOSPITAL: A RANDOMISED CONTROLLED TRIAL', ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY (2014) [E3]
Co-authors Kim Colyvas, John Wiggers, Jenny Bowman, Richard Clancy
2014 Stockings EA, Bowman JA, Bartlem KM, McElwaine KM, Baker AL, Terry M, et al., 'QUALITY OF IMPLEMENTATION OF A SMOKE-FREE POLICY IN AN INPATIENT PSYCHIATRIC FACILITY: ASSOCIATION WITH PATIENT ACCEPTABILITY', ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY (2014) [E3]
Co-authors Kim Colyvas, John Wiggers, Jenny Bowman, Richard Clancy
2014 McElduff P, Britton B, Baker A, 'CAUSAL MODELLING IN CANCER RESEARCH', ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY (2014) [E3]
Co-authors Patrick Mcelduff
2014 McCarter K, Forbes E, Baker A, Britton B, Beck A, Carter G, et al., 'PREVALENCE OF TOBACCO SMOKING IN A SAMPLE OF HEAD AND NECK CANCER PATIENTS ABOUT TO UNDERGO RADIOTHERAPY', ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY (2014) [E3]
Co-authors Gregory Carter, Patrick Mcelduff, Sean Halpin, Luke Wolfenden, Billie Bonevski
2014 Stain H, Hides L, Baker A, Jackson C, Lenroo R, Paulik-White G, et al., 'Social Well-being and Engaged Living (SWEL): results of a pilot trial and a RCT for re-engaging young Australians in education and work', EARLY INTERVENTION IN PSYCHIATRY (2014) [E3]
Co-authors Luke Wolfenden, Patrick Mcelduff, Helen Stain
2013 Kelly PJ, Hitsman B, Bonevski B, Baker AL, Ciecierski CC, Kang J, et al., 'MULTIPLE HEALTH RISK BEHAVIOURS', DRUG AND ALCOHOL REVIEW (2013) [E3]
Co-authors Chris Paul, Catherine Deste, Billie Bonevski
2013 Bailey K, Baker AL, McElduff P, Kavanagh D, 'EFFECTS OF ASSAULT ON DEPRESSION AND ALCOHOL CBT TREATMENT OUTCOMES', DRUG AND ALCOHOL REVIEW (2013) [E3]
Co-authors Patrick Mcelduff
2013 McKetin R, Lubman DI, Najman JM, Dawe S, Butterworth P, Baker AL, 'METHAMPHETAMINE USE PRODUCES A DOSE-RESPONSE INCREASE IN VIOLENT BEHAVIOUR AMONG CHRONIC USERS OF THE DRUG', DRUG AND ALCOHOL REVIEW (2013) [E3]
2012 Hides L, Baker A, Christie G, Kypri K, 'SYMPOSIUM - HOW EFFECTIVE ARE BRIEF MOTIVATIONAL INTERVIEWING INTERVENTIONS: ARE THEY NECESSARY? DO THEY REQUIRE ENHANCEMENT? CAN THEY BE TRANSLATED INTO ROUTINE CLINICAL PRACTICE?', DRUG AND ALCOHOL REVIEW (2012) [E3]
Co-authors Kypros Kypri
2012 Baker AL, Kay-Lambkin FJ, Gilligan C, Baker FA, Lewin TJ, 'When does change begin following screening and brief intervention among depressed problem drinkers?', Drug and Alcohol Review: Abstracts of the Australasian Professional Society on Alcohol and other Drugs Conference 2012, Melbourne, Vic (2012) [E3]
Co-authors F Kaylambkin, Conor Gilligan, Terry Lewin
2012 Baker AL, Richmond R, Kay-Lambkin FJ, Filia S, Castle D, Williams J, et al., 'Smoking and healthy lifestyles intervention among people with psychotic disorders: Preliminary results from a randomised controlled trial', Drug and Alcohol Review: Abstracts of the Australasian Professional Society on Alcohol and other Drugs Conference 2012, Melbourne, Vic (2012) [E3]
Co-authors F Kaylambkin, Terry Lewin
2012 McKetin R, Lubman DI, Baker AL, Dawe S, Ali RL, 'Changes in the risk of psychotic symptoms during periods of methamphetamine use: Evidence from a prospective longitudinal study', Drug and Alcohol Review: Abstracts of the Australasian Professional Society on Alcohol and other Drugs Conference 2012, Melbourne, Vic (2012) [E3]
2012 Mills KL, Teesson M, Barrett E, Ewer P, Back S, Baker AL, et al., 'The course of improvement in post traumatic stress disorder and substance use', Drug and Alcohol Review: Abstracts of the Australasian Professional Society on Alcohol and other Drugs Conference 2012, Melbourne, Vic (2012) [E3]
2012 Thornton LK, Baker AL, Johnson MP, Kay-Lambkin FJ, 'Perceived harmfulness of tobacco, alcohol or cannabis use', Drug and Alcohol Review: Abstracts of the Australasian Professional Society on Alcohol and other Drugs Conference 2012, Melbourne, Vic (2012) [E3]
Co-authors Martin Johnson, F Kaylambkin
2012 Thornton LK, Baker AL, Johnson MP, Kay-Lambkin FJ, ''I guess because sometimes cigarettes have been my only friend': Perceived positive effects of substance use', Drug and Alcohol Review: Abstracts of the Australasian Professional Society on Alcohol and other Drugs Conference 2012, Melbourne, Vic (2012) [E3]
Co-authors F Kaylambkin, Martin Johnson
2012 Kelly PJ, Baker AL, Deane FP, Townsend C, Kay-Lambkin FJ, Bonevski B, Hull P, 'Healthy recovery: Changes in smoking and smoking related behaviours', Drug and Alcohol Review: Abstracts of the Australasian Professional Society on Alcohol and other Drugs Conference 2012, Melbourne, Vic (2012) [E3]
Co-authors F Kaylambkin, Billie Bonevski
2012 Callister R, Giles AK, Dascombe BJ, Baker AL, Nasstasia Y, Halpin SA, et al., 'Healthy Body Healthy Mind: Development of an exercise intervention for the management of youth depression', Journal of Science and Medicine in Sport, Sydney, Australia (2012) [E3]
Co-authors Ben Dascombe, Brian Kelly, Robin Callister, Sean Halpin
2012 Baker AL, Richmond R, Kay-Lambkin F, Filia S, Castle D, Williams J, et al., 'A smoking intervention among people with psychotic disorders: Preliminary results from a randomized controlled trial', Asia-Pacific Journal of Clinical Oncology, Brisbane, Qld (2012) [E3]
Co-authors Terry Lewin, F Kaylambkin
2012 Baker AL, Beck AK, Carter GL, Bauer J, Wratten C, Bauer J, et al., 'Alcohol, tobacco use and readiness to change in an Australian sample of head and neck cancer patients undergoing radiotherapy', Asia-Pacific Journal of Clinical Oncology: Special Issue: Abstracts of the Joint Meeting of the COSA 39th Annual Scientific Meeting and IPOS 14th World Congress of Psycho-Oncology, Brisbane, Qld (2012) [E3]
Co-authors Luke Wolfenden, Gregory Carter, Patrick Mcelduff
2012 Beck AK, Baker AL, Britton B, Carter GL, Bauer J, Wratten C, et al., 'Therapeutic alliance between dietitians and patients with head and neck cancer: Relationship to quality of life and nutritional status following a dietitian delivered health behaviour intervention', Asia-Pacific Journal of Clinical Oncology: Special Issue: Abstracts of the Joint Meeting of the COSA 39th Annual Scientific Meeting and IPOS 14th World Congress of Psycho-Oncology, Brisbane, Qld (2012) [E3]
Co-authors Gregory Carter, Patrick Mcelduff, Luke Wolfenden
2012 Britton B, Baker AL, Bauer J, Wolfenden L, Wratten C, Beck AK, et al., 'Eat: A stepped wedge cluster randomised trial to improve nutrition in head and neck cancer patients undergoing radiotherapy', Asia-Pacific Journal of Clinical Oncology: Special Issue: Abstracts of the Joint Meeting of the COSA 39th Annual Scientific Meeting and IPOS 14th World Congress of Psycho-Oncology, Brisbane, Qld (2012) [E3]
Co-authors Gregory Carter, Luke Wolfenden, Patrick Mcelduff
2011 Mavratzakis AL, Turner A, Baker AL, White J, Nelson LJ, Hambridge J, 'Feasibility of self-assisted computer screening of depression symptoms in stroke patients', International Journal of Stroke, Adelaide, SA (2011) [E3]
2011 Startup MJ, Carr VJ, Baker AL, Schall UA, Stain HJ, 'Specificity of the effects of CBT in the prevention of transition among young people at ultra-high risk of developing a psychotic disorder', Australasian Society for Psychiatric Research (ASPR) 2011 Conference: From Idea to Implementation, Dunedin, NZ (2011) [E3]
Co-authors Ulrich Schall, Helen Stain
2011 Stain HJ, Crittenden KL, Startup MJ, Carr V, Baker AL, Schall UA, et al., 'Rural and urban youth at ultra high risk for psychosis: Baseline characteristics from the depth randomised controlled trial of cognitive behavior therapy', Schizophrenia Bulletin, Colorado Springs, CO (2011) [E3]
Co-authors Ulrich Schall, Sean Halpin, Helen Stain
2011 Kay-Lambkin FJ, Baker AL, Kelly BJ, Lewin TJ, 'Presentation 1: Randomised controlled trial of computerised cognitive behaviour therapy for depression and substance use comorbidity: 3 year follow-up', Drug and Alcohol Review, Hobart, Australia (2011) [E3]
Co-authors Brian Kelly, F Kaylambkin, Terry Lewin
2011 Baker AL, Kavanagh DJ, Kay-Lambkin FJ, Hunt SA, Lewin TJ, Carr VJ, McElduff P, 'Randomised controlled trial of CBT for co-existing depression and alcohol problems: 6-, 12-, 24-and 36-month outcomes', Drug and Alcohol Review, Hobart, Australia (2011) [E3]
Co-authors Patrick Mcelduff, F Kaylambkin, Terry Lewin
2011 Mills KL, Teesson M, Barrett E, Merz S, Rosenfeld J, Ewer P, et al., 'Presentation 2: Integrated treatment for substance use and post-traumatic stress disorder: predictors of treatment outcome', Drug and Alcohol Review, Hobart, Australia (2011) [E3]
2011 Bailey KA, Baker AL, Webster RA, Kavanagh D, McElduff P, 'Presentation 3: Depression and alcohol use treatment outcomes among people with and without comorbid post-traumatic stress disorder', Drug and Alcohol Review, Hobart, Australia (2011) [E3]
Co-authors Patrick Mcelduff
2011 Thornton LK, Baker AL, Johnson MP, 'Presentation 4 - Harm perception and knowledge of substances among people experiencing symptoms of mental illness recruited from 'Facebook'', Drug and Alcohol Review, Hobart, Australia (2011) [E3]
Co-authors Martin Johnson
2011 Ewer P, Mills K, Teesson M, Sannibale C, Baker AL, Kay-Lambkin F, Dore G, 'A brief intervention for alcohol and other drug users who have experienced trauma', Drug and Alcohol Review, Hobart, Australia (2011) [E3]
Co-authors F Kaylambkin
2011 McKetin R, Dunlop AJ, Holland R, Sutherland R, Baker AL, Hudson S, 'The NSW health stimulant treatment program evaluation', Drug and Alcohol Review, Hobart, Australia (2011) [E3]
2011 McKetin R, Sutherland R, Ross J, Najman J, Mamun A, Baker AL, et al., 'Three year treatment outcomes for methamphetamine use: Finding from the Methamphetamine Treatment Evaluation Study (MATES)', Drug and Alcohol Review, Hobart, Australia (2011) [E3]
2011 Baker AL, Kay-Lambkin FJ, Mills K, Bailey KA, Thornton L, 'Symposium - Comorbidity: Informing psychosocial interventions', Drug and Alcohol Review, Hobart, Australia (2011) [E3]
Co-authors F Kaylambkin
2010 Thornton LK, Baker AL, Johnson MP, 'Attitudes, Knowledge and Reasons for Use of Tobacco among People with Psychotic Disorders: A Mixed Method Exploration', 12th Annual Meeting of the SRNT Europe Programme, Bath, UK (2010) [E3]
Co-authors Martin Johnson
2010 Stockings EA, Bowman JA, McElwaine KM, Moore LH, Terry MA, Clancy RV, et al., 'Do Mental Health Inpatients Want To Quit Smoking?', 12th Annual Meeting of the SRNT Europe Programme, Bath, UK (2010) [E3]
Co-authors Jenny Bowman, Richard Clancy, John Wiggers
2010 Baker AL, 'Randomised controlled trial of CBT for co-existing depression and alcohol problems: 6-12 month outcomes', Proceedings of the Australasian Society for Psychiatric Research (ASPR) 2010 Conference, Sydney, NSW (2010) [E3]
Co-authors Patrick Mcelduff, Terry Lewin, F Kaylambkin
2010 Filia S, Baker AL, Richmond R, Kay-Lambkin FJ, Castle D, Williams J, et al., 'Randomised controlled trial of a healthy lifestyles intervention to reduce cardiovascular disease (CVD) risk among smokers with psychosis: Interim results', Australian & New Zealand Journal of Psychiatry, Sydney, Australia (2010) [E3]
Citations Web of Science - 1
Co-authors F Kaylambkin
2010 Baker AL, 'Psychological treatment of co-existing affective and anxiety disorders and alcohol use problems', Abstracts of the 27th International Congress of Applied Psychology, Melbourne, Vic (2010) [E3]
2010 Baker AL, 'Two randomised controlled trials of CBT for co-existing depression and substance use problems', Abstracts of the 27th International Congress of Applied Psychology, Melbourne, Vic (2010) [E3]
2010 Stain HJ, Crittenden K, Startup M, Carr V, Baker A, Schall U, et al., 'THE DEPTH RANDOMISED CONTROLLED TRIAL OF COGNITIVE BEHAVIOUR THERAPY FOR YOUTH AT ULTRA HIGH RISK FOR PSYCHOSIS: BASELINE CHARACTERISTICS FOR RURAL AND URBAN YOUTH', AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY (2010) [E3]
Co-authors Sean Halpin, Ulrich Schall
2010 Stain HJ, Crittenden KL, Startup MJ, Carr VJ, Baker AL, Schall UA, et al., 'The DEPTh randomised controlled trial of cognitive behaviour therapy for youth at ultra high risk for psychosis: Baseline characteristics for rural and urban youth', Australian & New Zealand Journal of Psychiatry, Sydney, Australia (2010) [E3]
Co-authors Helen Stain, Sean Halpin, Ulrich Schall
2010 Rasser PE, Cohen M, Peck G, Carr VJ, Ward PB, Thompson PM, et al., 'Cerebellar grey matter deficits, cannabis use and first-response schizophrenia in adolescents and young adults', Australian & New Zealand Journal of Psychiatry, Sydney, NSW (2010) [E3]
Co-authors Ulrich Schall
2010 Cohen M, Rasser PE, Peck G, Carr VJ, Ward PB, Thompson PM, et al., 'CEREBELLAR GREY MATTER DEFICITS, CANNABIS USE AND FIRST-EPISODE SCHIZOPHRENIA IN ADOLESCENTS AND YOUNG ADULTS', SCHIZOPHRENIA RESEARCH (2010) [E3]
DOI 10.1016/j.schres.2010.02.251
Co-authors Ulrich Schall
2010 Hiles SA, Attia JR, Baker AL, 'Changes in interleukin-6, C-reactive protein and interleukin-10 in people with depression following antidepressant treatment: A meta-analysis', Brain, Behavior, and Immunity, Dublin, Ireland (2010) [E3]
Co-authors John Attia
2010 Hiles SA, Attia JR, Baker AL, 'Interleukin-6 in people with and without depression: Exploring moderators using meta-analytic techniques', Brain, Behavior, and Immunity, Dublin, Ireland (2010) [E3]
Co-authors John Attia
2010 Cohen M, Rasser PE, Peck G, Carr VJ, Ward PB, Thompson PM, et al., 'CEREBELLAR GREY MATTER DEFICITS, CANNABIS USE AND FIRST-EPISODE SCHIZOPHRENIA IN ADOLESCENTS AND YOUNG ADULTS', SCHIZOPHRENIA RESEARCH, Florence, ITALY (2010) [E3]
DOI 10.1016/j.schres.2010.02.251
Co-authors Ulrich Schall
2010 Ayre M, Loughland CM, Bore MR, Baker AL, 'The relationship between social problem-solving and emotional regulation in people with schizophrenia', Schizophrenia Research, Florence, Italy (2010) [E3]
Co-authors Carmel Loughland, Miles Bore
2010 Kay-Lambkin FJ, Baker AL, Kavanagh D, Kelly B, Mcketin R, 'STEPPED CARE FOR DEPRESSION AND ALCOHOL/OTHER DRUG USE COMORBIDITY', DRUG AND ALCOHOL REVIEW (2010) [E3]
Co-authors Brian Kelly, F Kaylambkin
2009 Britton B, Clover K, Carter GL, Baker AL, 'The innovation in the intervention: Design, recruitment and treatment innovations in head and neck cancer psycho-oncology trials', Asia-Pacific Journal of Clinical Oncology, Gold Coast, QLD (2009) [E3]
DOI 10.1111/j.1743-7563.2009.01252.x
Co-authors Gregory Carter
2009 Bowman JA, McElwaine KM, Moore LH, Terry MA, Clancy RV, Knight JJ, et al., 'Do mental health inpatients want to quit smoking?', Oceania Tobacco Control 2009, Darwin, NT (2009) [E3]
Co-authors Jenny Bowman, John Wiggers, Richard Clancy
2009 Stockings EA, Bowman JA, Wiggers JH, Baker AL, Carr VJ, Terry MA, et al., 'An integrated smoking cessation intervention for mental health inpatients: From hospital to community', Oceania Tobacco Control 2009, Darwin, NT (2009) [E3]
Co-authors Richard Clancy, John Wiggers, Jenny Bowman
2009 Thornton LK, Baker AL, Johnson MP, 'Reasons for tobacco, alcohol and cannabis use among people with psychotic disorders: A method triangulation approach', Combined Abstracts of 2009 Australian Psychology Conferences, Darwin, NT (2009) [E3]
Co-authors Martin Johnson
2009 Stain HJ, Crittenden KL, Bennett EM, Startup MJ, Carr VJ, Baker AL, et al., 'The impact of geography and social context on ultra high risk for schizophrenia research in rural Australia', Schizophrenia Bulletin, San Diego, CA (2009) [E3]
Citations Web of Science - 1
Co-authors Helen Stain, Brian Kelly, Sean Halpin, Ulrich Schall
2009 Dunlop AJ, McKetin R, Salmon A, Holland R, Baker AL, 'The stimulant treatment program evaluation: Client characteristics and preliminary outcomes', Australasian Professional Society on Alcohol and Other Drugs Conference 2009 APSAD 2009 Conference, Darwin, NT (2009) [E3]
DOI 10.1111/j.1465-3362.2009.00130.x
2009 McKetin R, Ross J, Najman J, Baker AL, Lubman D, Dawe S, et al., 'Treatment outcomes for methamphetamine use: Finding from the methamphetamine treatment evaluation study (MATES)', Drug and Alcohol Review, Darwin, NT (2009) [E3]
2009 Mills K, Barrett E, Farrugia P, Rosenfeld J, Merz S, Teesson M, et al., 'Characteristics of clients with comorbid substance use and post traumatic stress disorder', Drug and Alcohol Review, Darwin, NT (2009) [E3]
DOI 10.1111/j.1465-3362.2009.00123.x
2009 Thornton LK, Baker AL, Johnson MP, 'Harm perceptions among people with psychotic disorders regarding tobacco, alcohol and cannabis: A mixed method exploration', Drug and Alcohol Review, Darwin, NT (2009) [E3]
DOI 10.1111/j.1465-3362.2009.00123.x
Co-authors Martin Johnson
2008 Crittenden KL, Fleming JL, Startup MJ, Carr VJ, Baker AL, Schall UA, et al., 'Recruitment and engagement of youth in an ultra high risk treatment study', Early Intervention in Psychiatry, Melbourne (2008) [E3]
Co-authors Ulrich Schall, Helen Stain, Brian Kelly, Sean Halpin
2008 Wye PM, Bowman JA, Wiggers JH, Baker AL, Knight JJ, Carr VJ, et al., 'Smoking care and policies in mental health services in Australia: Healthcare provision or behaviour management?', SRNT 14th Annual Meeting. Annual Meeting Proceedings, Portland, OR (2008) [E3]
Co-authors Richard Clancy, Jenny Bowman, John Wiggers
2008 Crittenden KL, Stain HJ, Bennett EM, Fleming JL, Startup MJ, Carr VJ, et al., 'Establishing referral pathways and engagement of ultra high risk youth in a rural research setting', Australian and New Zealand Journal of Psychiatry, Newcastle, NSW (2008) [E3]
Co-authors Helen Stain, Brian Kelly, Ulrich Schall
2008 Beck AK, Todd J, Baker AL, 'Smoking in schizophrenia: Impact of nicotine on cognitive function and relationship to self-reported motives for smoking', Australian and New Zealand Journal of Psychiatry, Newcastle, NSW (2008) [E3]
Co-authors Juanita Todd
2008 Kay-Lambkin FJ, Baker AL, Kelly BJ, Lewin TJ, Carr VJ, 'Randomised controlled trial of computerised cognitive behaviour therapy for depression and sustance use comoribidity', Australian and New Zealand Journal of Psychiatry, Newcastle, NSW (2008) [E3]
Co-authors F Kaylambkin, Brian Kelly, Terry Lewin
2008 Thornton LK, Baker AL, Johnson MP, Loughland CM, Lewin TJ, Kay-Lambkin FJ, 'An exploration of drug attitudes and knowledge among people with psychotic disorders', Australian and New Zealand Journal of Psychiatry, Newcastle, NSW (2008) [E3]
Co-authors Carmel Loughland, Terry Lewin, Martin Johnson, F Kaylambkin
2008 Hunt SA, Baker AL, Kavanagh D, Kay-Lambkin FJ, Lewin TJ, Carr VJ, 'A randomised controlled trial of integrated and single focused interventions for co-morbid depression and alcohol use disorders', Australian and New Zealand Journal of Psychiatry, Newcastle, NSW (2008) [E3]
Co-authors F Kaylambkin, Terry Lewin
2008 Turner A, Hambridge J, Baker AL, Kay-Lambkin FJ, Bowman JA, Oak S, 'Braveheart: Group cognitive behaviour therapy for cardiac depression', Australian and New Zealand Journal of Psychiatry, Newcastle, NSW (2008) [E3]
Co-authors F Kaylambkin, Jenny Bowman
2008 Wye PM, Bowman JA, Wiggers JH, Baker AL, Knight J, Carr VJ, et al., 'Smoking care in Australian psychiatric facilities: Healthcare or traditional behaviour management?', Australian and New Zealand Journal of Psychiatry, Newcastle, NSW (2008) [E3]
Co-authors John Wiggers, Jenny Bowman
2008 Ayre M, Baker AL, Carr VJ, Lewin TJ, 'Validation of the 'Difficulties in emotion regulation scale' (DERS) in two samples', Australian and New Zealand Journal of Psychiatry, Newcastle, NSW (2008) [E3]
Co-authors Terry Lewin
2008 Knock EJ, Cleworth S, Davies R, Hudson S, Robertson B, Salmon A, et al., 'Management of low level psychotic disorders in stimulant users participating in ambulatory treatment', Australian and New Zealand Journal of Psychiatry, Newcastle, NSW (2008) [E3]
2008 Phillips L, Turner A, Hambridge J, Baker AL, Bowman JA, Colyvas KJ, 'Clinical outcomes associated with depression, anxiety and social support among cardiac rehabiliation attendees', Australian and New Zealand Journal of Psychiatry, Newcastle, NSW (2008) [E3]
Co-authors Kim Colyvas, Jenny Bowman
2008 Adamson S, Sellman D, Kay-Lambkin FJ, Baker AL, Lewin TJ, Thornton LK, Kelly BJ, 'A revised screening measure for cannabis misuse: The Cannabis Use Disorders Identification Test', International Journal of Psychology, Berlin, Germany (2008) [E3]
Co-authors Brian Kelly, Terry Lewin, F Kaylambkin
2007 Lewin TJ, Loughland CM, Carr VJ, Baker A, 'A recruitment source impacts in schizophrenia research', Schizophrenia Bulletin, Colorado Springs, Colorado (2007) [E3]
Co-authors Carmel Loughland, Terry Lewin
2007 Crittenden KL, Stain HJ, Startup MJ, Carr VJ, Baker AL, Schall UA, et al., 'Delivering early intervention for rural areas: An RCT for youth at risk for psychosis', 2007 Rural Health Research Colloquium. Official Program, Tamworth, NSW (2007) [E3]
Co-authors Sean Halpin, Ulrich Schall, Brian Kelly, Helen Stain
2007 Baker AL, 'Stoned, cold sober: Psychological interventions for cannabis and alcohol use among people with psychosis and major depression', 2nd International Cannabis and Mental Health Conference: Programme and Abstract Book, London (2007) [E3]
2007 Filia S, Richmond R, Baker AL, Castle D, Kulkani PJ, Kay-Lambkin FJ, et al., 'The Healthy Lifestyles Project: Pilot data from a multicomponent risk factor intervention for people with severe mental illness', Australian and New Zealand Journal of Psychiatry, Melbourne (2007) [E3]
Co-authors F Kaylambkin
2007 Conrad A, Lewin TJ, Carr VJ, Baker AL, Terry M, Taylor A, 'Patterns of service use among patients with a dual diagnosis', Australian and New Zealand Journal of Psychiatry, Melbourne (2007) [E3]
Co-authors Terry Lewin
2007 Hides L, Lubman DI, Carroll S, Catania L, Kay-Lambkin FJ, Baker AL, 'The effectiveness of an integrated CBT intervention for co-occurring depression and substance abuse in young people: A pilot study', Australian and New Zealand Journal of Psychiatry, Melbourne (2007) [E3]
Co-authors F Kaylambkin
2007 Baker AL, Halpin SA, 'Treatment of comorbidity', Early Psychosis Forum 2007. Presentations, Westmead, NSW (2007) [E3]
Co-authors Sean Halpin
2007 Baker AL, 'Treatment of comorbid sustance use and psychosis', Early Psychosis Forum 2007. Presentations, Westmead, NSW (2007) [E3]
2007 Foster C, Wye PM, Bowman JA, Baker AL, Wiggers JH, Terry M, et al., 'Using smoke free workplace policy to mediate smoking cessation care in Mental Health services (Poster)', Oceania Tobacco Control Conference: From Vision to Reality. Programme and Presentations, Auckland (2007) [E3]
Co-authors Richard Clancy, John Wiggers, Jenny Bowman
2007 Bowman JA, Baker AL, Wiggers JH, Foster C, Terry MA, Knight JJ, et al., 'Attitudes, knowledge and skills: providing smoking cessation care for mental health inpatients', Oceania Tobacco Control Conference: From Vision to Reality. Programme and Presentations, Auckland, New Zealand (2007) [E3]
Co-authors Richard Clancy, John Wiggers, Jenny Bowman
2007 Baker AL, Richmond R, Kay-Lambkin F, Lewin TJ, Carr VJ, 'Randomized controlled trial of a smoking cessation intervention among people with a psychotic disorder: 3-year follow- up', SRNT's 13th Annual Meeting. Abstracts, Austin, Texas (2007) [E3]
Co-authors Terry Lewin
2007 Startup MJ, Carr VJ, Baker AL, Schall UA, Stain HJ, Halpin SA, Bucci SR, 'Cannabis use as a complication in psychological treatments for people at ultra-high risk of psychosis: Early findings from the DEPTH Trial', World Congress of Behavioural and Cognitive Therapies (BCN07). Abstracts, Barcelona (2007) [E3]
Co-authors Helen Stain, Sean Halpin, Ulrich Schall
2006 Baker AL, 'Psychological approaches to coexisting mental health and drug and alcohol problems', ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, Sydney, AUSTRALIA (2006)
2006 Kay-Lambkin FJ, Baker AL, Kelly B, Lewin TJ, Carr VJ, 'The SHADE project: Self-help for alcohol/other drug use and depression', ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, Sydney, AUSTRALIA (2006)
Co-authors Terry Lewin, F Kaylambkin, Brian Kelly
2006 Kavanagh DJ, Young R, Baker A, Saunders JB, Kay-Lambkin F, 'Outcomes of a correspondence-based trial to assist general practitioners to address cooccurrence of depression and alcohol-related problems', ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, Sydney, AUSTRALIA (2006)
Co-authors F Kaylambkin
2006 Baker AL, 'Psychological approaches to coexisting mental health and drug and alcohol problems', Alcoholism: Clinical and Experimental Research, Sofitel Wentworth Sydney, Sydney (2006) [E3]
2006 Kavanagh DJ, Young R, Baker AL, Saunders J, Kay-Lambkin FJ, 'Outcomes of a correspondence-based trial to assist general practitioners to address cooccurrence of depression and alcohol related problems', Alcoholism: Clinical and Experimental Research, Sofitel Wentworth Sydney, Sydney (2006) [E3]
Co-authors F Kaylambkin
2006 Kay-Lambkin FJ, Baker AL, Lewin TJ, Carr VJ, 'Integrated treatment for co-existing depression and alcohol/other drug use problems', Journal of Affective Disorders, Lisbon Portugal (2006) [E3]
Co-authors F Kaylambkin, Terry Lewin
2006 David K, Ross Y, John S, Baker AL, Kay-Lambkin FJ, 'Correspondence-based treatment for coexisting depression and alcohol misuse', Journal of Affective Disorders, Lisbon Portugal (2006) [E3]
Co-authors F Kaylambkin
2006 Dr LH, Lubman DD, Kay-Lambkin FJ, Baker AL, 'Treating coexisting depression and alcohol/other drug misuse in young people', Journal of Affective Disorders, Lisbon-Portugal (2006) [E3]
Co-authors F Kaylambkin
2006 Kay-Lambkin FJ, Baker AL, Lewin (Ext) T, 'Synthesis', Journal of Affective Disorders, Lisbon-Portugal (2006) [E3]
Co-authors F Kaylambkin, Terry Lewin
2006 Cohen M, Johnston PJ, Ehlkes T, Carr VJ, Ward P, Baker AL, Schall UA, 'An FMRI study of cerebral activation differences between cannabis users and schizophrenia patients during the Tower of London task', Abstracts from the XIIIth Biennial Winter Workshop on Schizophrenia Research (Schizophrenia Research (Vol 81, Sup 1)), Davos, Switzerland (2006) [E3]
Citations Web of Science - 1
Co-authors Ulrich Schall
2006 Stain HJ, Startup M, Carr V, Baker A, Schall U, 'The depth project: A multisite RCT for youths at risk for psychosis', SCHIZOPHRENIA RESEARCH, Birmingham, ENGLAND (2006)
DOI 10.1016/S0920-9964(06)70154-2
Citations Web of Science - 3
Co-authors Ulrich Schall
2006 Stain HJ, Startup MJ, Carr VJ, Baker AL, Schall UA, 'The DEPTH Project: A Multisite RCT for Youths at Risk for Psychosis', Schizophrenia Research, Birmingham UK (2006) [E3]
DOI 10.1111/j.1440-1614.2006.01859_1.x
Citations Web of Science - 1
Co-authors Helen Stain, Ulrich Schall
2006 Bucci SR, Lewin (Ext) T, Baker AL, Heathcote AJ, Startup MJ, 'Referential delusions of communication and self-monitoring deficits in psychosis', Acta Neuropschiatrica V18: Proceedings of the Australasian Society for Psychiatric Research Annual Meeting 2006 'Brainwaves', Sydney (2006) [E3]
Co-authors Andrew Heathcote
2006 Kay-Lambkin FJ, Carr VJ, Lewin (Ext) T, Kelly BJ, Baker AL, 'The Shade Project: self-help for alcohol/other drug use and depression', Acta Neuropsychiatrica, Sydney,Australia (2006) [E3]
Co-authors F Kaylambkin, Brian Kelly
2006 Startup MJ, Carr VJ, Baker AL, Stain HJ, Halpin SA, Bucci SR, 'Cannabis use as a complication in psychological treatments for people at ultra high risk of psychosis: early findings from the DEPTh trial', Acta Neuropsychiatrica, V18: Proceedings of the Australasian Society for Psychiatric Research, Annual Meeting 2006 'Brainwaves', Sydney (2006) [E3]
Co-authors Helen Stain, Sean Halpin
2006 Greig RL, Startup MJ, Baker AL, Lewin TJ, Halpin SA, Carr VJ, 'Cannabis use history and onset to psychosis in an ultrahigh-risk group', Acta Neuropsychiatrica, V18: Proceedings of the Australasian Society for Psychiatric research, Annual Meeting 2006 'Brainwaves', Sydney (2006) [E3]
Co-authors Terry Lewin, Sean Halpin
2006 Bucci SR, Startup MJ, Heathcote AJ, Baker AL, Lewin TJ, 'Referential delusions of communication and self-monitoring deficits in psychosis', Neuropsychiatric Disease and Treatment V2, Suppl 3: Proceedings of the 6th International Congress of Neuropsychiatry, Sydney (2006) [E3]
Co-authors Andrew Heathcote, Terry Lewin
2006 Bucci SR, Startup MJ, Heathcote AJ, Baker AL, Lewin TJ, 'Referential delusions of communication: ii. self-monitoring deficits', Proceedings of the Cognitive Neuropsychology and Cognitive Neuropsychiatry Research Forum, Sydney, Australia (2006) [E3]
Co-authors Terry Lewin, Andrew Heathcote
2006 Greig R, Baker AL, Startup MJ, Lewin TJ, Halpin S, 'Cannabis use history and onset to psychosis in an ultra high risk group', Acta Psychiatrica Scandinavica, Madrid, Spain (2006) [E3]
Co-authors Terry Lewin, Sean Halpin
2006 Bucci SR, Heathcote AJ, Startup MJ, Baker AL, Lewin TJ, 'Referential delusions of communication: II. Reality monitoring deficits', Acta Psychiatrica Scandinavica V114, Suppl 431: Proceedings of the XV International Congress for the Psychotherapy of the Schizophrenia and other Psychoses, Madrid, Spain (2006) [E3]
Co-authors Andrew Heathcote, Terry Lewin
2006 Stain HJ, Startup MJ, Carr VJ, Baker AL, Schall UA, 'The DEPTH project: A multisite RCT for youth at risk for psychosis', Australian & New Zealand Journal of Psychiatry, Fremantle WA Australia (2006) [E3]
Co-authors Ulrich Schall, Helen Stain
2006 Bucci SR, Startup MJ, Heathcote AJ, Baker AL, Lewin (Ext) T, 'Referential delusions of communication and self-monitoring deficits in psychosis', Australian and New Zealand Journal of Psychiatry V40, Suppl 2: Proceedings of the Australasian Schizophrenia Conference, Fremantle, Western Australia (2006) [E3]
Co-authors Andrew Heathcote, Terry Lewin
2005 Kay-Lambkin FJ, Baker AL, Kelly BJ, Lewin (Ext) T, Carr VJ, 'The Shade Project: self help for alcohol/other drug use and depression', Alcoholism: Clinical and Experimental Research, Sofitel Wentworth Sydney, Sydney (2005) [E3]
Co-authors F Kaylambkin, Brian Kelly
2005 Lewin (Ext) T, Carr VJ, Baker AL, 'Choice of subscales for the Brief psychiatric rating scale (BPRS-24)', Abstracts for The Royal Australian & NZ College of Psychiatrists Joint CINP/ASPR Scientific Meeting, Brisbane (2005) [E3]
2005 Conrad A, Lewin (Ext) T, Carr VJ, Terry M, Taylor AJ, Baker AL, Dunbar AL, 'Alcohol and other drug use disorders co-morbid with psychosis, depression and anxiety: treatment outcomes (TOES PROJECT)', Abstracts for The Royal Australian & NZ College of Psychiatrists Joint CINP/ASPR Scientific Meeting, Brisbane (2005) [E3]
2005 Kay-Lambkin FJ, Lewin (Ext) T, Kelly BJ, Carr VJ, Hunt SA, Baker AL, Kavanagh DJ, 'Combined versus single focused interventions for comorbid depression and alcohol problems: introduction to the daisi project', Abstracts for The Royal Australian & NZ College of Psychiatrists Joint CINP/ASPR Scientific Meeting, Brisbane (2005) [E3]
Co-authors Brian Kelly, F Kaylambkin
2005 Kay-Lambkin FJ, Baker AL, Lewin (Ext) T, Kelly BJ, Carr VJ, 'The shade project: Self help for alcohol/other drug use and depression', Abstracts for The Royal Australian & NZ College of Psychiatrists Joint CINP/ASPR Scientific Meeting, Brisbane (2005) [E3]
Co-authors F Kaylambkin, Brian Kelly
2005 Clack VM, Kay-Lambkin FJ, Baker AL, Kelly BJ, Lewin (Ext) T, Underwood (Ext) L, 'Computerised cognitive behaviour therapy for depression and comorbid substance misuse: rural and remote perspectives', Abstracts for The Royal Australian & NZ College of Psychiatrists Joint CINP/ASPR Scientific Meeting, Brisbane (2005) [E3]
Co-authors F Kaylambkin, Brian Kelly
2005 Baker AL, Kavanagh DJ, Carr VJ, Kay-Lambkin FJ, Lewin (Ext) T, 'Integrated approaches for co-existing depression and substance use problems', Journal of Affective Disorders, Lisbon-Portugal (2005) [E3]
Co-authors F Kaylambkin, Terry Lewin
2005 Baker AL, Carr V, Richmond R, Haile M, Lewin T, Taylor R, Wilhelm K, 'Intervention for tobacco dependence among people with a psychotic illness - Results from a randomised controlled trial', SCHIZOPHRENIA BULLETIN, Savannah, GA (2005)
Citations Web of Science - 1
Co-authors Terry Lewin
1999 Baker AL, Reichler HM, 'Evidence based treatment for slcohol and other drug problems: A review with clinical guidelines', Focusing the mind: effective and innovative interventions in counselling and psychotherapy, New Zealand (1999) [E1]
Show 116 more conferences

Report (5 outputs)

Year Citation Altmetrics Link
2009 Bailey KA, Baker AL, 'Manual for Brief Alcohol Intervention Group for Young People', NDARC, 43 (2009) [R1]
2008 Dunlop AJ, Tulloch B, McKetin R, Adam T, Baker AL, Wodak A, 'Preliminary evaluation of the NSW stimulant program', Mental Health Drug and Alcohol Office, NSW Department of Health, 28 (2008) [R1]
2004 Baker AL, Bucci SR, Kay-Lambkin FJ, 'Intervention for Alcohol, Cannabis and Amphetamine Use among People with a Psychotic Illness', National Drug & Alcohol Research Centre, Faculty of Medicine, University of New South Wales, 100 (2004) [R1]
Co-authors F Kaylambkin
2004 Baker AL, Kay-Lambkin FJ, Bucci SR, Haile MJ, Richmond R, Carr VJ, 'Intervention for Tobacco Dependence among People with a Mental Illness', National Drug & Alcohol Research Centre, Faculty of Medicine, University of New South Wales, 77 (2004) [R1]
Co-authors F Kaylambkin
2003 Baker AL, Kay-Lambkin FJ, Lee NK, Claire M, Jenner L, 'A Brief Cognitive Behavioural Intervention for Regular Amphetamine Users: A Treatment Guide', University of Newcastle for the Department of Health and Ageing, 80 (2003) [R1]
Co-authors F Kaylambkin
Show 2 more reports
Edit

Grants and Funding

Summary

Number of grants 71
Total funding $12,503,555

Click on a grant title below to expand the full details for that specific grant.


20145 grants / $454,407

Evaluation of a tailored online hospital and post-discharge smoking cessation program for orthopaedic trauma surgery patients$364,658

Funding body: NHMRC (National Health & Medical Research Council)

Funding body NHMRC (National Health & Medical Research Council)
Project Team Associate Professor Billie Bonevski, Professor Zsolt Balogh, Professor Amanda Baker, Professor Ian Harris, Professor John Attia, Conjoint Professor Christopher Doran, Dr Johnson George, Doctor Luke Wolfenden
Scheme Partnership Projects
Role Investigator
Funding Start 2014
Funding Finish 2014
GNo G1300686
Type Of Funding Aust Competitive - Commonwealth
Category 1CS
UON Y

An Evaluation of Transitional Care for Stroke Patients$25,000

Funding body: Hunter Medical Research Institute

Funding body Hunter Medical Research Institute
Project Team Associate Professor Ashley Kable, Professor Amanda Baker, Professor Dimity Pond, Doctor Alyna Turner, Conjoint Professor Chris Levi
Scheme Project Grant
Role Investigator
Funding Start 2014
Funding Finish 2014
GNo G1301294
Type Of Funding Grant - Aust Non Government
Category 3AFG
UON Y

Evaluation of a multi-component intervention to reduce screen-time in adolescents: The ‘Stand Up for Healthy Minds’ study$25,000

Funding body: Hunter Medical Research Institute

Funding body Hunter Medical Research Institute
Project Team Professor David Lubans, Professor Ronald Plotnikoff, Professor Philip Morgan, Professor Amanda Baker, Doctor Geoffrey Skinner, Doctor Narelle Eather
Scheme Project Grant
Role Investigator
Funding Start 2014
Funding Finish 2014
GNo G1301432
Type Of Funding Grant - Aust Non Government
Category 3AFG
UON Y

Prevent 2nd Stroke: The development and pilot testing of an online lifestyle behaviours program for stroke and TIA survivors$20,000

Funding body: National Stroke Foundation

Funding body National Stroke Foundation
Project Team Associate Professor Billie Bonevski, Dr Alyna Turner, Professor Amanda Baker, Conjoint Professor Chris Levi, Conjoint Associate Professor Michael Pollack, Mr Timothy Regan
Scheme Research Grant
Role Investigator
Funding Start 2014
Funding Finish 2014
GNo G1301114
Type Of Funding Grant - Aust Non Government
Category 3AFG
UON Y

Improving radiotherapy outcomes with smoking cessation: Pilot trial in had and neck cancer patients$19,749

Funding body: Calvary Mater Newcastle

Funding body Calvary Mater Newcastle
Project Team Mr Ben Britton, Professor Amanda Baker, Doctor Chris Wratten, Conjoint Professor Gregory Carter, Doctor Luke Wolfenden, Doctor Alison Beck, Doctor Craig Sadler, Associate Professor Judith Bauer
Scheme Project Grant
Role Investigator
Funding Start 2014
Funding Finish 2014
GNo G1400766
Type Of Funding Contract - Aust Non Government
Category 3AFC
UON Y

20134 grants / $1,525,457

Scalable Interventions for Co-existing Mental Health and Substance Use Problems: Innovation, Technology and Translation$640,785

Funding body: NHMRC (National Health & Medical Research Council)

Funding body NHMRC (National Health & Medical Research Council)
Project Team Professor Amanda Baker
Scheme Research Fellowships
Role Lead
Funding Start 2013
Funding Finish 2013
GNo G1200044
Type Of Funding Aust Competitive - Commonwealth
Category 1CS
UON Y

A randomised clinical trial of internet-based treatment for binge drinking and depression in young Australians$380,012

Funding body: NHMRC (National Health & Medical Research Council)

Funding body NHMRC (National Health & Medical Research Council)
Project Team Dr Frances Kay-Lambkin, Professor Amanda Baker, Professor Maree Teesson, Professor Kathleen Brady, Conjoint Associate Professor Terry Lewin
Scheme Call for Research (Mental Health)
Role Lead
Funding Start 2013
Funding Finish 2013
GNo G1300798
Type Of Funding Aust Competitive - Commonwealth
Category 1CS
UON Y

A randomised controlled trial of online versus telephone-based information and support: Can electronic platforms deliver effective care for lung cancer patients?$329,660

Funding body: NHMRC (National Health & Medical Research Council)

Funding body NHMRC (National Health & Medical Research Council)
Project Team Associate Professor Christine Paul, Doctor Allison Boyes, Ms Paula Vallentine, Professor Amanda Baker, Associate Professor Frans Henskens, Dr Ian Roos, Doctor Patrick McElduff, Doctor Tara Clinton-Mcharg
Scheme Partnership Projects
Role Investigator
Funding Start 2013
Funding Finish 2013
GNo G1200758
Type Of Funding Aust Competitive - Commonwealth
Category 1CS
UON Y

A randomised controlled trial of online versus telephone-based information and support: Can electronic platforms deliver effective care for lung cancer patients?$175,000

Funding body: Cancer Council NSW

Funding body Cancer Council NSW
Project Team Associate Professor Christine Paul, Doctor Allison Boyes, Ms Paula Vallentine, Professor Amanda Baker, Associate Professor Frans Henskens, Dr Ian Roos, Doctor Patrick McElduff, Doctor Tara Clinton-Mcharg
Scheme NHMRC Partnership Projects Partner Funding
Role Investigator
Funding Start 2013
Funding Finish 2013
GNo G1200784
Type Of Funding Aust Competitive - Commonwealth
Category 1CS
UON Y

20124 grants / $2,335,077

Eating As Treatment (EAT): A stepped wedge, randomised control trial of a health behaviour change intervention provided by dietitians to improve nutrition in head and neck cancer patients undergoing r$1,136,556

Funding body: NHMRC (National Health & Medical Research Council)

Funding body NHMRC (National Health & Medical Research Council)
Project Team Professor Amanda Baker, Conjoint Professor Gregory Carter, Associate Professor Judith Bauer, Doctor Luke Wolfenden, Doctor Chris Wratten, Mr Ben Britton
Scheme Project Grant
Role Lead
Funding Start 2012
Funding Finish 2012
GNo G1100093
Type Of Funding Aust Competitive - Commonwealth
Category 1CS
UON Y

Centre of Research Excellence in Mental Health and Substance Use: Translating innovative prevention and treatment.$722,206

Funding body: NHMRC (National Health & Medical Research Council)

Funding body NHMRC (National Health & Medical Research Council)
Project Team Professor Maree Teesson, Professor Amanda Baker, Dr Katherine Mills, Dr Frances Kay-Lambkin, Professor Paul Haber, Associate Professor Andrew Baillie, Professor Helen Christensen, Professor Max Birchwood, Professor Bonnie Spring, Professor Kathleen Brady
Scheme Centres of Research Excellence (CRE) - Centres of Clinical Research Excellence
Role Lead
Funding Start 2012
Funding Finish 2012
GNo G1200943
Type Of Funding Aust Competitive - Commonwealth
Category 1CS
UON Y

Randomised controlled trial of a telephone delivered social well-being and engaged living (SWEL) intervention for disengaged youth at risk of mental health and other adverse outcomes in urban and rura$398,998

Funding body: NHMRC (National Health & Medical Research Council)

Funding body NHMRC (National Health & Medical Research Council)
Project Team Professor Amanda Baker, Doctor Patrick McElduff, Doctor Luke Wolfenden, Dr Leanne Hides, Dr Helen Stain, Dr Chris Jackson, Professor Rhoshel Lenroot, Dr Georgie Paulik
Scheme Call for Research (Mental Health)
Role Lead
Funding Start 2012
Funding Finish 2012
GNo G1200052
Type Of Funding Aust Competitive - Commonwealth
Category 1CS
UON Y

Social wellbeing and engaged living (SWEL) of rural Australian youth$77,317

Funding body: Health Administration Corporation

Funding body Health Administration Corporation
Project Team Associate Professor Helen Stain, Dr Leanne Hides, Dr Chris Jackson, Professor Rhoshel Lenroot, Dr Georgie Paulik, Professor Amanda Baker, Doctor Patrick McElduff
Scheme Research Grant
Role Lead
Funding Start 2012
Funding Finish 2012
GNo G1200237
Type Of Funding Other Public Sector - State
Category 2OPS
UON Y

20113 grants / $702,267

Follow-up of Healthy Lifestyles Intervention for Cardiovascular Disease among People with a Psychotic Disorder$436,085

Funding body: NHMRC (National Health & Medical Research Council)

Funding body NHMRC (National Health & Medical Research Council)
Project Team Professor Amanda Baker, Professor Robyn Richmond, Professor David Castle, Doctor Frances Kay-Lambkin
Scheme Project Grant
Role Lead
Funding Start 2011
Funding Finish 2011
GNo G1000121
Type Of Funding Aust Competitive - Commonwealth
Category 1CS
UON Y

Healthy Body, Healthy Mind: An exercise intervention for the treatment of youth depression$189,115

Funding body: Beyond Blue Ltd

Funding body Beyond Blue Ltd
Project Team Professor Robin Callister, Professor Brian Kelly, Professor Amanda Baker
Scheme Research Grant
Role Investigator
Funding Start 2011
Funding Finish 2011
GNo G1100864
Type Of Funding Grant - Aust Non Government
Category 3AFG
UON Y

Improving social engagement of rural 'at risk' youth: A randomised effectiveness trial of a telephone delivered Cognitive and Dialectical Behaviour Therapy intervention$77,067

Funding body: Australian Rotary Health

Funding body Australian Rotary Health
Project Team Associate Professor Helen Stain, Dr Leanne Hides, Dr Chris Jackson, Professor Rhoshel Lenroot, Dr Georgie Paulik, Professor Amanda Baker, Doctor Patrick McElduff
Scheme Mental Health Research Grant
Role Lead
Funding Start 2011
Funding Finish 2011
GNo G1000820
Type Of Funding Aust Competitive - Non Commonwealth
Category 1NS
UON Y

20104 grants / $661,109

Men, Depression and Social Networks in Rural Communities: Linking Epidemiologic Evidence to Effective Interventions$324,809

Funding body: Beyond Blue Ltd

Funding body Beyond Blue Ltd
Project Team Professor Brian Kelly, Professor John Attia, Doctor Frances Kay-Lambkin, Conjoint Associate Professor Terry Lewin, Professor Amanda Baker, Mr Trevor Hazell, Doctor Kerry Inder
Scheme Research Grant
Role Investigator
Funding Start 2010
Funding Finish 2010
GNo G1000456
Type Of Funding Contract - Aust Non Government
Category 3AFC
UON Y

Xstrata Coal Fellow in Depression$300,000

Funding body: Xstrata Coal Australia Pty Ltd

Funding body Xstrata Coal Australia Pty Ltd
Project Team Professor Brian Kelly, Professor John Attia, Doctor Frances Kay-Lambkin, Conjoint Associate Professor Terry Lewin, Professor Amanda Baker, Mr Trevor Hazell, Doctor Kerry Inder
Scheme Xstrata Coal Fellow in Depression
Role Investigator
Funding Start 2010
Funding Finish 2010
GNo G0900102
Type Of Funding Contract - Aust Non Government
Category 3AFC
UON Y

Pilot of an intervention to increase the provision of nicotine dependence treatment in mental health inpatient settings$21,300

Funding body: Hunter Medical Research Institute

Funding body Hunter Medical Research Institute
Project Team Doctor Paula Wye, Professor John Wiggers, Associate Professor Jennifer Bowman, Professor Amanda Baker, Doctor Megan Freund, Ms Jenny Knight, Ms Margaret Terry, Conjoint Associate Professor Richard Clancy
Scheme Project Grant
Role Investigator
Funding Start 2010
Funding Finish 2010
GNo G0900190
Type Of Funding Grant - Aust Non Government
Category 3AFG
UON Y

Examining the effects of Nicotine on Working memory and Eye movements in Schizophrenia$15,000

Funding body: Hunter Medical Research Institute

Funding body Hunter Medical Research Institute
Project Team Doctor Juanita Todd, Professor Amanda Baker
Scheme Sparke Helmore/NBN Television Corporate Triathlon Award for Research Excellence
Role Lead
Funding Start 2010
Funding Finish 2010
GNo G1200710
Type Of Funding Grant - Aust Non Government
Category 3AFG
UON Y

20094 grants / $904,575

Healthy lifestyle intervention for cardiovascular disease risk reduction among people with psychotic disorders$773,000

Funding body: NHMRC (National Health & Medical Research Council)

Funding body NHMRC (National Health & Medical Research Council)
Project Team Professor Amanda Baker, Professor Robyn Richmond, Professor David Castle, Professor Jayashri Kulkarni, Associate Professor Jill Williams, Dr Frances Kay-Lambkin
Scheme Project Grant
Role Lead
Funding Start 2009
Funding Finish 2009
GNo G0188833
Type Of Funding Aust Competitive - Commonwealth
Category 1CS
UON Y

MRSP Infrastructure Grant$100,000

Funding body: Hunter Medical Research Institute

Funding body Hunter Medical Research Institute
Project Team Professor Amanda Baker
Scheme NSW MRSP Infrastructure Grant
Role Lead
Funding Start 2009
Funding Finish 2009
GNo G0190445
Type Of Funding Other Public Sector - State
Category 2OPS
UON Y

LDX analyser (fingerprick unit) x4, piCo Smokerlyzer (Carboxymeter)x4, Universal cardboard disposable mouthpieces for piCo smokerlyzer x4 and Universal d pieces for piCo Smokerlyzer x4$20,775

Funding body: NHMRC (National Health & Medical Research Council)

Funding body NHMRC (National Health & Medical Research Council)
Project Team Professor Amanda Baker, Doctor Frances Kay-Lambkin, Doctor Alyna Turner, Doctor Juanita Todd, Professor Robin Callister, Doctor Sally Hunt, Professor Brian Kelly, Professor John Attia, Associate Professor Jennifer Bowman, Doctor Paula Wye
Scheme Equipment Grant
Role Lead
Funding Start 2009
Funding Finish 2009
GNo G0189849
Type Of Funding Other Public Sector - Commonwealth
Category 2OPC
UON Y

The provision of strategies to support drug and alcohol online activities$10,800

Funding body: Department of Health

Funding body Department of Health
Project Team Professor Amanda Baker, Doctor Frances Kay-Lambkin
Scheme Consultancy/Tender
Role Lead
Funding Start 2009
Funding Finish 2009
GNo G0189926
Type Of Funding Other Public Sector - Commonwealth
Category 2OPC
UON Y

20086 grants / $1,015,013

Research Fellowship$537,500

Funding body: NHMRC (National Health & Medical Research Council)

Funding body NHMRC (National Health & Medical Research Council)
Project Team Professor Amanda Baker
Scheme Research Fellowships
Role Lead
Funding Start 2008
Funding Finish 2008
GNo G0187391
Type Of Funding Aust Competitive - Commonwealth
Category 1CS
UON Y

Long term follow-up of two randomised controlled trials of treatment for depression and alcohol/other drug comorbidity$244,150

Funding body: NHMRC (National Health & Medical Research Council)

Funding body NHMRC (National Health & Medical Research Council)
Project Team Professor Amanda Baker, Doctor Frances Kay-Lambkin, Professor David Kavanagh, Professor Brian Kelly
Scheme Project Grant
Role Lead
Funding Start 2008
Funding Finish 2008
GNo G0187640
Type Of Funding Aust Competitive - Commonwealth
Category 1CS
UON Y

Integrated smoking care linking mental health inpatients to community services: a randomised controlled trial$164,414

Funding body: Australian Rotary Health

Funding body Australian Rotary Health
Project Team Associate Professor Jennifer Bowman, Professor Amanda Baker, Professor John Wiggers, Conjoint Professor Vaughan Carr
Scheme Mental Health Research Grant
Role Investigator
Funding Start 2008
Funding Finish 2008
GNo G0188134
Type Of Funding Aust Competitive - Non Commonwealth
Category 1NS
UON Y

Integrated Smoking Care Linking Mental Health Inpatients to Community Services: a Pilot Study$24,784

Funding body: Hunter Medical Research Institute

Funding body Hunter Medical Research Institute
Project Team Associate Professor Jennifer Bowman, Professor Amanda Baker, Professor John Wiggers
Scheme Project Grant
Role Investigator
Funding Start 2008
Funding Finish 2008
GNo G0188473
Type Of Funding Contract - Aust Non Government
Category 3AFC
UON Y

Effects of nicotine on cognitive function in schizophrenia$24,165

Funding body: Schizophrenia Research Institute

Funding body Schizophrenia Research Institute
Project Team Doctor Juanita Todd, Professor Amanda Baker
Scheme Postgraduate Research Scholarship
Role Investigator
Funding Start 2008
Funding Finish 2008
GNo G0188534
Type Of Funding Donation - Aust Non Government
Category 3AFD
UON Y

Reducing cardiovascular risk among people with psychotic disorders$20,000

Funding body: University of Newcastle

Funding body University of Newcastle
Project Team Professor Amanda Baker, Professor Robyn Richmond, Professor Jayashri Kulkarni, Professor David Castle, Doctor Frances Kay-Lambkin
Scheme Near Miss Grant
Role Lead
Funding Start 2008
Funding Finish 2008
GNo G0188398
Type Of Funding Internal
Category INTE
UON Y

20072 grants / $71,391

CBT intervention for regular amphetamine use and depression: a stepped care approach$68,891

Funding body: NSW Health

Funding body NSW Health
Project Team Doctor Frances Kay-Lambkin, Professor Amanda Baker, Dr Rebecca McKetin, Professor Maree Teesson, Conjoint Professor Robert Batey, Dr N Lee
Scheme Mental Health Research Grant
Role Investigator
Funding Start 2007
Funding Finish 2007
GNo G0186994
Type Of Funding Other Public Sector - State
Category 2OPS
UON Y

Society for Research on Nocotine and Tobacco, 13th Annual Meeting, Austin Texas, USA, 21/2/2007 - 24/2/2007$2,500

Funding body: University of Newcastle

Funding body University of Newcastle
Project Team Professor Amanda Baker
Scheme Travel Grant
Role Lead
Funding Start 2007
Funding Finish 2007
GNo G0187359
Type Of Funding Internal
Category INTE
UON Y

20066 grants / $1,230,803

Randomised controlled trial of cognitive behaviour therapy to prevent psychosis among people with at-risk mental states$606,476

Funding body: NHMRC (National Health & Medical Research Council)

Funding body NHMRC (National Health & Medical Research Council)
Project Team Professor Mike Startup, Conjoint Professor Vaughan Carr, Professor Amanda Baker, Professor Ulli Schall, Associate Professor Helen Stain
Scheme Project Grant
Role Investigator
Funding Start 2006
Funding Finish 2006
GNo G0185161
Type Of Funding Aust Competitive - Commonwealth
Category 1CS
UON Y

PRC - Priority Research Centre for Brain & Mental Health Research (CBMHR)$524,282

Funding body: University of Newcastle

Funding body University of Newcastle
Project Team Conjoint Professor Chris Levi, Professor Amanda Baker, Professor Mike Calford, Professor Trevor Day, Emeritus Professor Peter Dunkley, Professor Michael Hazelton, Professor Andrew Heathcote, Professor Brian Kelly, Conjoint Professor Vaughan Carr, Emeritus Professor Patricia Michie, Professor David Pow, Emeritus Professor John Rostas, Professor Ulli Schall, Professor Alistair Sim, Professor Mike Startup
Scheme Priority Research Centre
Role Investigator
Funding Start 2006
Funding Finish 2006
GNo G0186947
Type Of Funding Internal
Category INTE
UON Y

BraveHeart: A psychosocial treatment for depression in people with cardiac disease$55,045

Funding body: Australian Rotary Health

Funding body Australian Rotary Health
Project Team Professor Amanda Baker
Scheme Research Grant
Role Lead
Funding Start 2006
Funding Finish 2006
GNo G0185688
Type Of Funding Aust Competitive - Non Commonwealth
Category 1NS
UON Y

Neurocognitive profiles of people receiving cognitive behaviour therapy$25,000

Funding body: NSW Health

Funding body NSW Health
Project Team Doctor Sally Hunt, Professor Amanda Baker, Emeritus Professor Patricia Michie, Conjoint Professor Vaughan Carr, Professor David Kavanagh, Mr Terry Lewin, Doctor Frances Kay-Lambkin
Scheme Drug and Alcohol Council Research Grants Program
Role Investigator
Funding Start 2006
Funding Finish 2006
GNo G0186724
Type Of Funding Other Public Sector - State
Category 2OPS
UON Y

An integrated approach to treating co-morbid diabetes type 2 and depression: The MADE-IT program$15,000

Funding body: Novo Nordisk Foundation

Funding body Novo Nordisk Foundation
Project Team Professor Brian Kelly, Ms Leigh Underwood, Professor Amanda Baker, Mr Wayne Burgess, Dr Channa Perera
Scheme Regional Diabetes Support Scheme
Role Investigator
Funding Start 2006
Funding Finish 2006
GNo G0186199
Type Of Funding Contract - Aust Non Government
Category 3AFC
UON Y

Australasian DAWN Award$5,000

Funding body: Novo Nordisk Foundation

Funding body Novo Nordisk Foundation
Project Team Ms Leigh Underwood, Professor Brian Kelly, Professor Amanda Baker, Mr Wayne Burgess, Dr Channa Perera, Ms Michelle Booth, Ms Julia Rak
Scheme Regional Diabetes Support Scheme
Role Investigator
Funding Start 2006
Funding Finish 2006
GNo G0186214
Type Of Funding Contract - Aust Non Government
Category 3AFC
UON Y

20052 grants / $800,545

Single-focussed versus integrated cognitive behaviour therapy for co-occurring depression and alcohol use problems$767,000

Funding body: NHMRC (National Health & Medical Research Council)

Funding body NHMRC (National Health & Medical Research Council)
Project Team Professor Amanda Baker, Professor David Kavanagh, Conjoint Professor Vaughan Carr
Scheme Project Grant
Role Lead
Funding Start 2005
Funding Finish 2005
GNo G0183909
Type Of Funding Aust Competitive - Commonwealth
Category 1CS
UON Y

2005 RIBG allocation$33,545

Funding body: University of Newcastle

Funding body University of Newcastle
Project Team Professor Amanda Baker
Scheme Research Infrastructure Block Grant (RIBG)
Role Lead
Funding Start 2005
Funding Finish 2005
GNo G0185793
Type Of Funding Internal
Category INTE
UON Y

20044 grants / $292,430

A comparative structural and functional cerebral MRI study of first episode schizophrenia and long-term cannabis use$241,250

Funding body: NHMRC (National Health & Medical Research Council)

Funding body NHMRC (National Health & Medical Research Council)
Project Team Conjoint Professor Vaughan Carr, Associate Professor Philip Ward, Professor Ulli Schall, Professor Amanda Baker, Mr Patrick Johnston
Scheme Project Grant
Role Investigator
Funding Start 2004
Funding Finish 2004
GNo G0182872
Type Of Funding Aust Competitive - Commonwealth
Category 1CS
UON Y

PysCheck II$43,680

Funding body: Turning Point Alcohol and Drug Centre

Funding body Turning Point Alcohol and Drug Centre
Project Team Professor Amanda Baker
Scheme Consultancy
Role Lead
Funding Start 2004
Funding Finish 2004
GNo G0184917
Type Of Funding Not Known
Category UNKN
UON Y

Intervention for anxiety among people with a major mental illness in the community$5,000

Funding body: University of Newcastle

Funding body University of Newcastle
Project Team Professor Amanda Baker, Professor Mike Startup
Scheme Project Grant
Role Lead
Funding Start 2004
Funding Finish 2004
GNo G0183494
Type Of Funding Internal
Category INTE
UON Y

34th Annual Congress of the European Association of Behavioural and Cognitive Therapies, 7-11 September 2004$2,500

Funding body: University of Newcastle

Funding body University of Newcastle
Project Team Professor Amanda Baker
Scheme Travel Grant
Role Lead
Funding Start 2004
Funding Finish 2004
GNo G0184563
Type Of Funding Internal
Category INTE
UON Y

20037 grants / $1,306,662

Computer-based cognitive behaviour therapy for alcohol use and coexisting depression in a rural and urban areas.$657,480

Funding body: Foundation for Alcohol Research and Education

Funding body Foundation for Alcohol Research and Education
Project Team Professor Amanda Baker
Scheme Research Grant
Role Lead
Funding Start 2003
Funding Finish 2003
GNo G0182684
Type Of Funding Aust Competitive - Non Commonwealth
Category 1NS
UON Y

Clinical Research Unit for Mental Health and Substance Abuse.$467,500

Funding body: NHMRC (National Health & Medical Research Council)

Funding body NHMRC (National Health & Medical Research Council)
Project Team Professor Amanda Baker
Scheme Career Development Fellowships
Role Lead
Funding Start 2003
Funding Finish 2003
GNo G0181883
Type Of Funding Aust Competitive - Commonwealth
Category 1CS
UON Y

Evaluation of treatments available for people with mental health and substance abuse problems.$100,000

Funding body: NHMRC (National Health & Medical Research Council)

Funding body NHMRC (National Health & Medical Research Council)
Project Team Conjoint Professor Vaughan Carr, Professor Amanda Baker
Scheme Strategic Research Development Committee (Consultancy/Tender)
Role Investigator
Funding Start 2003
Funding Finish 2003
GNo G0181984
Type Of Funding Aust Competitive - Commonwealth
Category 1CS
UON Y

Barriers and facilitators for HCV prevention among sex workers in the Hunter region.$65,890

Funding body: NSW Health

Funding body NSW Health
Project Team Doctor Erica Southgate, Professor Pamela Nilan, Professor Amanda Baker, Doctor Margaret Harris
Scheme Non Government Organisation Grant Program
Role Investigator
Funding Start 2003
Funding Finish 2003
GNo G0183141
Type Of Funding Other Public Sector - State
Category 2OPS
UON Y

A randomised controlled trial of compliance therapy among people with co-occurring psychosis and cannabis use problems$10,000

Funding body: University of Newcastle

Funding body University of Newcastle
Project Team Professor Amanda Baker, Professor Mike Startup
Scheme Project Grant
Role Lead
Funding Start 2003
Funding Finish 2003
GNo G0182483
Type Of Funding Internal
Category INTE
UON Y

PULSE Young Medical Researcher of the Year Award$5,000

Funding body: Hunter Medical Research Institute

Funding body Hunter Medical Research Institute
Project Team Professor Amanda Baker
Scheme Research Grant
Role Lead
Funding Start 2003
Funding Finish 2003
GNo G0183617
Type Of Funding Contract - Aust Non Government
Category 3AFC
UON Y

Australasian Society for Psychiatric Research Conference 2003 4 to 5 December 2003$792

Funding body: University of Newcastle

Funding body University of Newcastle
Project Team Professor Amanda Baker
Scheme Travel Grant
Role Lead
Funding Start 2003
Funding Finish 2003
GNo G0183777
Type Of Funding Internal
Category INTE
UON Y

20024 grants / $143,315

Update of the National Drug Strategy Monograph No. 32 'Models of intervention and care for psychostimulant users.$90,964

Funding body: Commonwealth Department of Health & Aged Care

Funding body Commonwealth Department of Health & Aged Care
Project Team Professor Amanda Baker, Conjoint Professor Vaughan Carr, Conjoint Professor Ian Whyte, Professor John Saunders, Dr N Lee
Scheme Illicit Drugs Section, Population Health Division
Role Lead
Funding Start 2002
Funding Finish 2002
GNo G0181873
Type Of Funding Aust Competitive - Commonwealth
Category 1CS
UON Y

The development of a CD-ROM intervention for people with comorbid alcohol use problems and depression.$27,746

Funding body: Australian Brewers Foundation

Funding body Australian Brewers Foundation
Project Team Professor Amanda Baker, Doctor Frances Kay-Lambkin, Professor P Wilson
Scheme Alcohol-related Medical Research Grant
Role Lead
Funding Start 2002
Funding Finish 2002
GNo G0180852
Type Of Funding Contract - Aust Non Government
Category 3AFC
UON Y

Twelve month follow-up on a smoking cessation intervention among people with a metal illness.$22,105

Funding body: Community Health and Anti-Tuberculosis Association

Funding body Community Health and Anti-Tuberculosis Association
Project Team Professor Amanda Baker, Conjoint Professor Vaughan Carr
Scheme Harry Windsor Medical Research Grants
Role Lead
Funding Start 2002
Funding Finish 2002
GNo G0181215
Type Of Funding Donation - Aust Non Government
Category 3AFD
UON Y

3rd International Conference on Early Psychosis, Copenhagen 25-28 September 2002$2,500

Funding body: University of Newcastle

Funding body University of Newcastle
Project Team Professor Amanda Baker
Scheme Travel Grant
Role Lead
Funding Start 2002
Funding Finish 2002
GNo G0182046
Type Of Funding Internal
Category INTE
UON Y

20014 grants / $729,512

Intervention for tobacco dependence among people with a psychotic illness.$386,674

Funding body: NHMRC (National Health & Medical Research Council)

Funding body NHMRC (National Health & Medical Research Council)
Project Team Professor Amanda Baker, Professor Robyn Richmond, Conjoint Professor Vaughan Carr
Scheme Project Grant
Role Lead
Funding Start 2001
Funding Finish 2001
GNo G0179656
Type Of Funding Aust Competitive - Commonwealth
Category 1CS
UON Y

Evaluation of cognitive-behavioural programs among regular amphetamine users.$287,648

Funding body: Commonwealth Department of Health & Aged Care

Funding body Commonwealth Department of Health & Aged Care
Project Team Professor Amanda Baker
Scheme Illicit Drugs Section, Population Health Division
Role Lead
Funding Start 2001
Funding Finish 2001
GNo G0179163
Type Of Funding Aust Competitive - Commonwealth
Category 1CS
UON Y

Randomised controlled trial of a smoking cessation intervention among people with a mental illness.$41,265

Funding body: Community Health and Anti-Tuberculosis Association

Funding body Community Health and Anti-Tuberculosis Association
Project Team Professor Amanda Baker, Conjoint Professor Vaughan Carr
Scheme Harry Windsor Medical Research Grants
Role Lead
Funding Start 2001
Funding Finish 2001
GNo G0179893
Type Of Funding Donation - Aust Non Government
Category 3AFD
UON Y

NeuroScan Curry 4.0 - Software tool integrating EEG and event-related potential measurement with structural and functional magnet resonance imaging$13,925

Funding body: NHMRC (National Health & Medical Research Council)

Funding body NHMRC (National Health & Medical Research Council)
Project Team Professor Amanda Baker, Professor Ulli Schall
Scheme Equipment Grant
Role Lead
Funding Start 2001
Funding Finish 2001
GNo G0181173
Type Of Funding Aust Competitive - Commonwealth
Category 1CS
UON Y

20003 grants / $239,958

Evaluation of cognitive-behaviour therapy for alcohol and other drug problems amoung people with a psychotic illness.$213,869

Funding body: NHMRC (National Health & Medical Research Council)

Funding body NHMRC (National Health & Medical Research Council)
Project Team Professor Amanda Baker, Conjoint Associate Professor Terry Lewin, Conjoint Professor Vaughan Carr
Scheme Project Grant
Role Lead
Funding Start 2000
Funding Finish 2000
GNo G0178449
Type Of Funding Aust Competitive - Commonwealth
Category 1CS
UON Y

Smoking Cessation Program for People with a Mental Illness.$25,000

Funding body: Australian Rotary Health

Funding body Australian Rotary Health
Project Team Professor Amanda Baker
Scheme Mental Illness Research Grant
Role Lead
Funding Start 2000
Funding Finish 2000
GNo G0178801
Type Of Funding Aust Competitive - Non Commonwealth
Category 1NS
UON Y

The Combined APSAD and National Methadone Conference, Melbourne 20-22 November 2000$1,089

Funding body: University of Newcastle

Funding body University of Newcastle
Project Team Professor Amanda Baker
Scheme Travel Grant
Role Lead
Funding Start 2000
Funding Finish 2000
GNo G0180441
Type Of Funding Internal
Category INTE
UON Y

19991 grants / $455

Australian Professinal Society on Alcohol and Other Drugs,Canberra, ACT,8-10November 1999$455

Funding body: University of Newcastle

Funding body University of Newcastle
Project Team Professor Amanda Baker
Scheme Travel Grant
Role Lead
Funding Start 1999
Funding Finish 1999
GNo G0179057
Type Of Funding Internal
Category INTE
UON Y

19982 grants / $11,316

Randomised controlled evaluation of two counselling interventions among regular users of amphetamine: seeding grant application.$10,000

Funding body: University of Newcastle

Funding body University of Newcastle
Project Team Professor Amanda Baker
Scheme Project Grant
Role Lead
Funding Start 1998
Funding Finish 1998
GNo G0177204
Type Of Funding Internal
Category INTE
UON Y

Comorbidity Across the Addictions: An International Symposium, UK 25-27 September 1998$1,316

Funding body: University of Newcastle

Funding body University of Newcastle
Project Team Professor Amanda Baker
Scheme Travel Grant
Role Lead
Funding Start 1998
Funding Finish 1998
GNo G0179731
Type Of Funding Internal
Category INTE
UON Y

19973 grants / $68,191

Dual Diagnosis: Impact of Intervention.$61,149

Funding body: Commonwealth Department of Health & Aged Care

Funding body Commonwealth Department of Health & Aged Care
Project Team Professor Amanda Baker
Scheme Research into Drug Abuse Grants (RIDA)
Role Lead
Funding Start 1997
Funding Finish 1997
GNo G0178716
Type Of Funding Aust Competitive - Commonwealth
Category 1CS
UON Y

Clinical skills training: motivational interviewing for alcohol and other drug problems$6,260

Funding body: University of Newcastle

Funding body University of Newcastle
Project Team Professor Amanda Baker
Scheme Teaching Committee Teaching Grants
Role Lead
Funding Start 1997
Funding Finish 1997
GNo G0176572
Type Of Funding Internal
Category INTE
UON Y

Annual National Conf. of the Australian Professional Society on Alcohol and Other Drugs, Adelaide, SA, 1-3 October 1997$782

Funding body: University of Newcastle

Funding body University of Newcastle
Project Team Professor Amanda Baker
Scheme Travel Grant
Role Lead
Funding Start 1997
Funding Finish 1997
GNo G0179404
Type Of Funding Internal
Category INTE
UON Y

19962 grants / $8,856

Seeding grant application: Impact of a brief intervention for patients with a dual diagnosis of mental illness and drug and alcohol abuse$8,265

Funding body: University of Newcastle

Funding body University of Newcastle
Project Team Professor Amanda Baker
Scheme New Staff Grant
Role Lead
Funding Start 1996
Funding Finish 1996
GNo G0176116
Type Of Funding Internal
Category INTE
UON Y

1996 National Methadone Conference, Melbourne, 21-23 November$591

Funding body: University of Newcastle

Funding body University of Newcastle
Project Team Professor Amanda Baker
Scheme Travel Grant
Role Lead
Funding Start 1996
Funding Finish 1996
GNo G0176936
Type Of Funding Internal
Category INTE
UON Y

19951 grants / $2,216

7th Intern. Conference on the Treatment of Addictive Behaviours, The Netherlands, 28 May - 1 June$2,216

Funding body: University of Newcastle

Funding body University of Newcastle
Project Team Professor Amanda Baker
Scheme Travel Grant
Role Lead
Funding Start 1995
Funding Finish 1995
GNo G0176847
Type Of Funding Internal
Category INTE
UON Y
Edit

Research Supervision

Number of supervisions

Completed15
Current7

Total current UON EFTSL

PhD1.58

Current Supervision

Commenced Level of Study Research Title / Program / Supervisor Type
2014 PhD Smoke-Free Recovery: Smoking Cessation for Hospitalised Patients
Behavioural Science, Faculty of Health and Medicine, The University of Newcastle
Co-Supervisor
2013 PhD Effectiveness of a Clinical Practice Change Intervention in Improving Screening and Referral of Head and Neck Cancer Patients for Distress
Psychology, Faculty of Science and Information Technology, The University of Newcastle
Co-Supervisor
2012 PhD Eating as Treatment (EAT) in Head and Neck Cancer
Psychiatry, Faculty of Health and Medicine, The University of Newcastle
Principal Supervisor
2012 PhD The Antidepressant Effects of of Exercise Among Young People: Pathways to Change; Mind, Body or Behaviour?
Psychiatry, Faculty of Health and Medicine, The University of Newcastle
Principal Supervisor
2012 PhD The Antidepressant Effects of of Exercise Among Young People: Pathways to Change; Mind, Body or Behaviour?
Psychiatry, Faculty of Science and Information Technology, The University of Newcastle
Principal Supervisor
2011 PhD Mathematical Methods for Molecular Drug Discovery, Biomarker Identification- Towards New Paradigms of Drug Efficacy and Safety
Statistics, Faculty of Science and Information Technology, The University of Newcastle
Co-Supervisor
2009 PhD Comparing Dialectical Behaviour Therapy and the Conversational Model in the Treatment of Borderline Personality Disorder - A Randomised Clinical Trial
Psychiatry, Faculty of Health and Medicine, The University of Newcastle
Principal Supervisor

Past Supervision

Year Level of Study Research Title / Program / Supervisor Type
2015 PhD Cigarette Smoking and Psychosis: An Examination of Motivations and Cognitive Factors
Psychiatry, Faculty of Health and Medicine, The University of Newcastle
Principal Supervisor
2015 PhD Neuropsychological Profiles of People Receiving Cognitive Behaviour Therapy for Co-Occurring Depression and Alcohol Misuse
Psychiatry, Faculty of Health and Medicine, The University of Newcastle
Principal Supervisor
2015 PhD Neuropsychological Profiles of People Receiving Cognitive Behaviour Therapy for Co-Occurring Depression and Alcohol Misuse
Psychiatry, Faculty of Science and Information Technology, The University of Newcastle
Principal Supervisor
2014 PhD The Inflammation Hypothesis of Depression: Cross Sectional Associations, Temporal Relationships and the Confounds of Comorbidity
Psychiatry, Faculty of Health and Medicine, The University of Newcastle
Principal Supervisor
2014 PhD Smoke-Free Psychiatric Hospitals: A Platform to Initiate Smoking Cessation Treatment
Psychology, Faculty of Science and Information Technology, The University of Newcastle
Co-Supervisor
2013 PhD The Psychometric Properties of the 'Difficulties in Emotion Regulation Scale' in Schizophrenia and Individuals with Co-Existing Depression and Substance Use Disorders
Psychiatry, Faculty of Health and Medicine, The University of Newcastle
Principal Supervisor
2013 PhD The Effects of Trauma on Cognitive Behaviour Therapy for Depression and Alcohol Misuse
Psychiatry, Faculty of Health and Medicine, The University of Newcastle
Principal Supervisor
2013 PhD The Effects of Trauma on Cognitive Behaviour Therapy for Depression and Alcohol Misuse
Psychiatry, Faculty of Science and Information Technology, The University of Newcastle
Principal Supervisor
2012 PhD Attitudes and Perceptions Regarding Tobacco, Alcohol or Cannabis Use Among People With and Without Mental Disorders
Psychiatry, Faculty of Health and Medicine, The University of Newcastle
Principal Supervisor
2011 PhD Smoking in Mental Health Hospitals: Policies, Practices and Perceptions
Psychology, Faculty of Science and Information Technology, The University of Newcastle
Co-Supervisor
2006 PhD Co-Occurring Depression and Alcohol / Other Drug Use Problems: Developing Effective and Accessible Treatment Options
Psychiatry, Faculty of Health and Medicine, The University of Newcastle
Principal Supervisor
2006 Masters Predictors of Retention in a Residential Drug Treatment Program for Women
Psychology, Faculty of Science and Information Technology, The University of Newcastle
Principal Supervisor
2004 Masters Evaluation of an Outpatient Group Therapy Program for Individuals Suffering a Severe Mental Illness and Comorbid Substance Use Problem
Psychiatry, Faculty of Health and Medicine, The University of Newcastle
Sole Supervisor
2002 Masters A brief motivational interviewing and harm minimisation alcohol intervention program for adolescents
Psychology, Faculty of Health and Medicine, The University of Newcastle
Principal Supervisor
2002 Masters A brief motivational interviewing and harm minimisation alcohol intervention program for adolescents
Psychology, Faculty of Science and Information Technology, The University of Newcastle
Principal Supervisor
Edit

Professor Amanda Baker

Position

Research Academic
School of Medicine and Public Health
Faculty of Health and Medicine

Focus area

Psychiatry

Contact Details

Email amanda.baker@newcastle.edu.au
Phone (02) 40335690
Fax (02) 40335692

Office

Room Level 5 McAuley Building Mater Hospital
Edit